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Abstract	
Vascular	endothelial	cells,	the	cells	that	line	blood	vessels,	play	roles	both	in	the	development	
of	the	circulatory	system	through	providing	blood	vessel	integrity,	and	its	homeostasis	through	
responding	 to	 changes	 in	 the	 local	 environment.	 During	 development,	 the	 acquisition	 of	
functionality	 of	 new	 blood	 vessels,	 some	 of	which	 form	 from	 pre-existing	 ones	 through	 the	
process	of	angiogenesis,	requires	generation	of	endothelial	lumens	to	carry	the	blood,	during	a	
process	known	as	lumenogenesis.	Throughout	new	blood	vessel	formation,	endothelial	cells	go	
through	 coordinated	 and	 complex	 cell	 shape	 changes	 and	 polarity	 changes	 driven	 by	 Rho	
GTPase	 activity.	 Rho	 GTPases	 control	 intracellular	 actin	 dynamics	 and	 therefore	 affect	 all	
stages	 of	 new	 vessel	 growth.	 Precise	 control	 of	 Rho	GTPase	 signalling	 is	 through	 a	 range	 of	
upstream	activator	and	downstream	effector	proteins.		
	
Here	 we	 have	 investigated	 the	 role	 of	 two	 proteins	 involved	 in	 the	 antagonistic	 Rho/	 Rac	
pathways	during	angiogenesis	and	lumen	formation.	Results	presented	in	this	thesis	describe	a	
role	 for	 the	Rac	guanine	nucleotide	exchange	 factor	 (GEF)	DOCK4,	and	Cdc42	GEF	DOCK9,	 in	
controlling	 lumen	 formation	 in	 an	 organotypic	 in	 vitro	 angiogenesis	 assay,	 through	 both	
common	 and	 distinct	 cellular	 mechanisms.	 The	 RhoA	 effector	 ROCK1/2	 controls	 RhoA-
mediated	 cytoskeletal	 remodelling	 and	 have	 been	 shown	 to	 control	 angiogenesis	 in	 tissue	
culture	assays.	Here	we	use	in	vivo	knockout	mouse	model	to	show	that	ROCK2	controls	actin-
based	filopodia	formation	and	vessel	integrity,	as	well	as	other	cytoskeletal	processes	such	as	
ciliogenesis.	 Further	 investigation	 showed	 that	 loss	 of	 ROCK2	 results	 in	 aberrant	 lumen	
formation.	 We	 also	 highlight	 a	 new	 role	 for	 ROCK2	 signalling	 in	 primary	 cilia	 growth	 and	
abundance	in	endothelial	cells	which	may	also	impact	on	lumen	formation.	
	
In	summary,	this	work	has	identified	novel	molecular	pathways	that	control	lumen	formation	
in	endothelial	cells.	These	results	build	on	the	current	understanding	of	molecular	mechanisms	
involved	 in	 lumen	 formation,	 and	may	 also	 lead	 to	 better	 understanding	 of	 the	 function	 of	
ROCK,	a	potential	therapeutic	target	in	therapeutic	angiogenesis	strategies.		
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1.	Blood	vessel	formation	
	
1.1	The	circulatory	system	
The	circulatory	 system	plays	a	 fundamental	 role	 in	homeostasis	 through	circulation	of	blood	
providing	tissues	with	oxygen	and	nutrients,	and	removal	of	waste	products.	It	also	plays	roles	
in	 transporting	 immune	 cells,	 growth	 factors,	 and	 inflammatory	 cytokines	 to	 distant	 sites	
within	 the	 body	 (Adams	 and	 Alitalo,	 2007).	 In	 smaller	 and	 more	 simple	 organisms,	 these	
functions	can	take	place	through	diffusion,	without	the	need	for	a	closed	circulatory	system.	
However,	 larger	and	more	complex	organisms	require	a	closed	circulatory	system,	capable	of	
transporting	 blood	 further	 and	 deeper	 into	 tissues.	 Closed	 circulatory	 systems	 comprise	 a	
pump,	 the	 heart,	 and	 a	 network	 of	 blood	 vessels	 that	 contain	 the	 blood	which	 is	 carried	 to	
distant	cells	and	tissues.	Blood	vessels	are	 lined	by	a	specialized	 layer	of	endothelial	cells.	 In	
humans,	 the	 complex	 network	 of	 blood	 vessels	 is	 almost	 60,000	 miles	 long,	 composed	 of	
arteries,	veins,	and	capillaries,	each	with	unique	functions	 (Pugsley	and	Tabrizchi,	2000).	The	
largest	vessels,	arteries,	function	in	transporting	large	volumes	of	oxygenated	blood	away	from	
the	heart	to	distance	tissues.	Smaller	vessels,	veins,	then	return	deoxygenated	blood	from	the	
tissues	back	to	the	heart.	Capillaries	function	in	delivering	blood	deeper	into	tissues	and	cells;	
this	is	made	possible	by	their	small	size	but	large	surface	areas.		
	
The	 development	 of	 the	 circulatory	 system	begins	 in	 the	 embryo	 and	 continues	 throughout	
adult	 life.	 The	 first	 stages	 of	 its	 development	 occur	 through	 a	 process	 known	 as	
vasculogenesis.	 During	 vasculogenesis,	 endothelial	 cell	 precursors,	 known	 as	 angioblasts,	
develop	 in	 the	 mesodermal	 compartment	 and	 form	 islands	 of	 cells	 which	 eventually	 form	
tubes	(Risau	and	Flamme,	1995).	This	process	takes	place	in	the	absence	of	blood	flow	and	is	
thought	 to	 be	 guided	 by	 genetics	 and	 local	 environmental	 and	mechanical	 inputs	 (Jones,	 le	
Noble	and	Eichmann,	2006).	This	de	novo	network	of	vessels	becomes	sufficient	to	supply	the	
developing	embryo	with	blood	and	oxygen.	As	the	embryo	develops,	the	need	for	oxygen	and	
nutrients	 increases	beyond	 this	 initial	network’s	 capability.	The	primitive	vascular	network	 is	
now	 further	 expanded	 through	 a	 different	 form	 of	 blood	 vessel	 development	 termed	
angiogenesis.		
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1.2	Developmental	angiogenesis		
Angiogenesis	is	defined	as	the	growth	and	development	of	new	vessels	from	pre-existing	ones.	
After	 the	 initial	 vascular	 plexus	 is	 formed	 in	 the	 embryo,	 the	majority	 of	 new	 growth	 takes	
place	via	angiogenesis	(Risau,	1997).	During	this	highly	dynamic	process,	endothelial	cells	lining	
the	vessels	go	through	diverse	cellular	processes	 including	sprouting,	migration,	proliferation	
and	 polarization;	 all	 in	 response	 to	 external	 stimuli	 (Risau,	 1997;	 Carmeliet	 and	 Jain,	 2011).	
This	 type	of	 growth	allows	massive	 expansion,	 and	 intricate	 specialisation	of	 the	developing	
network	through	growth,	pruning,	and	remodelling	of	blood	vessels.		
	
The	circulatory	system	is	the	first	organ	to	develop	in	vertebrates,	highlighting	its	evolutionary	
importance.	 It	 is	 necessary	 early	 in	 development,	 to	 provide	 oxygen	 and	 nutrients	 to	 the	
rapidly	 growing	 new	 tissue	 and	 organs	 (Patel-Hett	 and	 D’Amore,	 2011).	 Angiogenesis	 first	
occurs	after	the	early	primitive	vascular	structures	are	formed	via	vasculogenesis.	These	new	
angiogenic	 vessels	 sprout	 and	 reshape	 the	 entire	 circulatory	 system	 into	 a	 functional	 organ	
capable	 of	 reaching	 every	 tissue	 in	 the	 body.	 To	 fulfil	 this	 role	 certain	 vessels	must	 take	 on	
specific	and	specialized	roles	within	the	vasculature.	One	important	step	during	developmental	
angiogenesis	 is	 the	 specialization	 of	 vessels.	 Environmental	 factors	 including	 flow,	 pressure,	
speed	and	pattern	of	blood	flow	affect	this	process	called	arteriovenous	differentiation	(Kwei	
et	al.,	2004).	The	arteries	that	carry	blood	away	from	the	heart	must	be	capable	of	operating	
under	huge	pressure	and	accelerated	flow.	During	development	veins	and	arteries	are	seen	to	
express	distinct	molecular	markers.	Pre-arterial	vessels	express	higher	 levels	of	EphrinB2	and	
NRP1	in	response	to	pulsate	flow	and	other	environmental	cues.	In	turn	these	vessels	increase	
calibre	 and	 mural	 cell	 coverage	 (Adams	 and	 Alitalo,	 2007).	 The	 venous	 system,	 which	 is	
exposed	to	lower	pressures	and	flow	rates,	are	seen	to	express	higher	levels	of	EphB4	and	in	
turn	develop	valves	to	control	flow	direction	and	show	poorer	mural	cell	coverage.	In	support,	
altering	of	flow	rates	in	the	vasculature	of	the	chick	yolk	sac	has	been	shown	to	reverse	arterial	
expression	 of	 EphrinB2	 and	 NRP1	 (le	 Noble	 et	 al.,	 2004).	 Establishment	 of	 the	 functional	
vascular	 system	 in	development	 is	 an	 intricate	process	 controlled	by	 genetic	predetermines,	
signalling	molecules	and	environmental	ques.		
	
In	the	adult	the	growth	of	blood	vessel	ceases	except	for	in	wound	healing,	the	menstrual	cycle	
and	pregnancy,	and	also	 in	disease	states	discussed	in	detail	 in	the	pathological	angiogenesis	
section	(1.3).		
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1.2.1	Mechanisms	of	angiogenesis		
There	are	two	major	mechanisms	of	angiogenesis:	sprouting	angiogenesis	and	intussusceptive	
angiogenesis.	Sprouting	angiogenesis	involves	activation	of	endothelial	cells	within	pre-existing	
vessels,	 to	 break	 away	 from	 the	 vessel	 wall,	 and	migrate	 and	 sprout	 in	 order	 to	 form	 new	
conduits.	Sprouting	angiogenesis	extends	new	vessels	 into	hypoxic	regions,	or	regions	devoid	
of	 blood	 supply.	 Conversely,	 intussusceptive	 angiogenesis	 is	 the	 process	 by	 which	 a	 single	
vessel	 pinches	 in	 the	 middle	 and	 separates	 to	 form	 two	 new	 vessels	 side-by-side.	
Intussusceptive	angiogenesis	 increases	vessel	number	more	rapidly	and	without	the	need	for	
endothelial	proliferation.		
	
	
1.2.1.1	Sprouting	angiogenesis	
Sprouting	 angiogenesis	 is	 a	multi-stage	 process	 that	 results	 in	 newly	 formed	 vessels	 linking	
pre-existing	vessels,	or	vascularizing	new	areas	of	tissue.	Within	vessel	walls,	endothelial	cells	
remain	 quiescent	with	 luminal-ablumenal	 (apical-basal)	 polarity	 and	 orientation	 in	 line	with	
blood	 flow	 (Richards,	 Hetheridge	 and	 Mellor,	 2015).	 Growth	 factor	 stimulation	 of	 these	
endothelial	 cells	 causes	 release	 of	 matrix	 metallo-proteases	 (MMPs)	 that	 breakdown	 the	
surrounding	 basement	 membrane	 to	 allow	 for	 cell	 sprouting	 (van	 Hinsbergh	 and	 Koolwijk,	
2008).	Driven	by	local	gradients	of	growth	factors,	the	activated	endothelial	cells	degrade	the	
local	extracellular	matrix	to	sprout	(Figure	1.1)	(Gerhardt	et	al.,	2003).	Upregulation	of	VEGFR2	
signalling	also	causes	weakening	of	cell-cell	 junctions	by	endocytosis	of	VE-cadherin,	allowing	
cell	 detachment	 from	 its	neighbouring	 cells	 (Gavard	and	Gutkind,	 2006).	 The	 leading	 tip	 cell	
polarizes	with	its	migrating	front,	extending	actin	rich	filopodial	and	lamellipodial	protrusions	
that	probe	the	extracellular	environment	for	directional	ques	and	growth	factors.	The	position	
of	the	tip	cell	is	a	competitive	one,	and	under	the	control	of	local	growth	factors.	High	levels	of	
VEGF	signalling	in	the	tip	cell	cause	repression	of	tip	cell	fate	for	the	trailing	stalk	cells,	through	
a	 negative	 signal	 sent	 to	 the	 trailing	 stalk	 cells	 via	 the	 Dll4-Notch	 system,	 which	 prevents	
trailing	cells	from	responding	to	VEGF	(Blanco	and	Gerhardt,	2013).	The	stalk	endothelial	cells	
go	 through	 complex	 and	 controlled	 rearrangements	 and	 proliferate	 to	 extend	 the	 growing	
sprout.	They	elongate,	align	and	gain	apical-basal	polarity.	Polarized	endothelial	tubules	then	
open	 to	 form	 a	 hollow	 lumen	 capable	 of	 supporting	 blood	 flow.	 Finally,	 the	 newly	 formed	
vessels	mature	by	deposition	of	basement	membrane,	and	mural	cell	coverage.		
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The	 tip	 cell	 continues	 migration	 towards	 the	 VEGF-driven	 stimulus	 until	 it	 reaches	 another	
vessels	 or	 tip	 cell,	 and	 a	 connection	 is	 formed	 by	 anastomosis.	 In	 order	 to	 anastomose	
successfully,	tip	cells	must	downregulate	their	high	migratory	and	dynamic	behaviour	to	form	
secure	 connections	 with	 the	 new	 vessel.	 This	 phenotypic	 conversion	 is	 reported	 to	 be	
mediated	 by	 VEGFC-expressing	 macrophages,	 which	 migrate	 to	 the	 sites	 of	 anastomosing	
vessels.	 	 VEGFC	 binding	 to	 VEGFR3	 on	 tip	 cells	 increases	 notch	 signalling	within	 the	 tip	 and	
downregulates	 its	sensitivity	to	VEGF	to	enable	anastomosis	(Fantin	et	al.,	2010;	Tammela	et	
al.,	2011).	The	 tip	cell	 continues	migrating	 towards	 the	VEGF-driven	stimulus	until	 it	 reaches	
another	 vessel	 or	 tip	 cell	 and	 a	 connection	 is	 formed	by	 anastomosis.	 Prior	 to	 anastomosis,	
lumen	formation	takes	place	behind	the	leading	sprout	front.	Continuation	of	this	process	will	
enable	the	functionality	of	the	vessel	in	carrying	blood	flow	to	new	conduits.	Lumen	formation,	
which	is	described	in	more	detail	in	section	1.3,	is	a	highly	complex	process	involving	multiple	
inputs	from	signalling	pathways	controlled	by	cell	 junctions,	polarity,	and	extracellular	matrix	
proteins,	to	mechanical	stimulus	like	blood	flow,	pressure,	and	tissue	architecture.	These	cues	
may	 result	 in	 endothelial	 cell	 morphological	 changes	 mediated	 by	 Rho	 GTPases	 and	 their	
control	on	the	actin	cytoskeleton.		
	
In	addition	to	the	aforementioned	processes	taking	place	during	new	blood	vessel	formation,	
further	 organization	 of	 vessels	 takes	 place	 via	 vessel	 regression.	 Vessel	 regression	 describes	
the	pruning	of	unconnected,	or	unnecessary	vascular	branches	or	sprouts,	and	is	thought	to	be	
a	consequence	of	withdrawal	of	growth	factors	or	insufficient	blood	flow.		
	
	
1.2.1.2	Intussusceptive	angiogenesis	
Distinct	 from	 sprouting	 angiogenesis,	 which	 relies	 on	 proliferation	 and	 growth	 of	 vessels,	
intussusceptive	 angiogenesis	 involves	 the	 splitting	 of	 a	 pre-existing	 vessels.	 The	 initial	 stage	
involves	the	pinching	of	vessel	walls	to	allow	two	opposing	endothelial	cells	to	make	contact.	
This	contact	becomes	known	as	a	‘trans-vascular	pillar’.	Generation	of	the	trans-vascular	pillars	
within	 vessels	 then	 allow	 invagination	 of	 the	 basal	 membrane	 and	 redistribution	 of	 cell	
borders	and	 junctional	molecules	to	form	two	new	vessels	side-by-side	(Djonov	et	al.,	2000).	
This	behaviour	allows	for	expansion	of	vascular	networks	without	the	need	for	proliferation	as	
with	 sprouting	 angiogenesis.	 Commonly	 seen	 in	 the	 growth	 of	 	 vascular	 beds	 and	 plexuses,	
intussusceptive	angiogenesis	is	tightly	associated	with	high	blood	pressure	and	changes	in	flow	
patterns	(Burri,	Hlushchuk	and	Djonov,	2004).	
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Figure	1.1	Stages	of	sprouting	angiogenesis	and	lumen	formation	
Sprouting	angiogenesis	requires	activation	of	endothelial	cells	within	pre-existing	vessel	wall,	
growth	of	 the	sprout,	and	formation	of	a	 functional	 lumen.	A)	Pre-existing	vessels	 lined	with	
elongated	quiescent	endothelial	 cells.	B)	 Initiation	of	 sprouting	angiogenesis	 through	growth	
factor	 stimuli	 from	 the	 surrounding	 environment	 such	 as	 VEGF.	 The	 tip	 cell	 degrades	 the	
extracellular	matrix	and	sprouts	into	the	extracellular	matrix.	C)	Stalk	cells	behind	the	leading	
tip,	 suppressed	 by	 Notch-Dll4	 signalling,	 proliferate	 and	 align	 next	 to	 each	 other	 to	 form	
multicellular	 chords.	 Stalk	 cells	 gain	 apical	 lateral	 adhesions	 where	 lumens	 will	 eventually	
open.	 Tip	 cells	 anastomose	 with	 neighbouring	 tips	 or	 established	 blood	 vessels.	 D)	 Lumens	
open	 typically	 at	 sites	 with	 later	 cell-cell	 adhesions.	 Blood	 vessels	 become	 perfused	 and	
mature	via	extracellular	matrix	deposition	and	mural	cell	coverage.	Adapted	from	Herbert	and	
Stainier	(Herbert	and	Stainier,	2011).		
	
	
	
	
	
	 7	
1.3	Pathological	angiogenesis		
Due	to	the	importance	of	angiogenesis	during	development,	defects	in	its	regulation	can	result	
in	a	variety	of	diseases	including	ischemic	and	inflammatory	conditions.	Vascular	abnormalities	
contribute	 to	 the	 pathology	 of	 diseases	 including	 primary	 and	 metastatic	 tumour	 growth,	
diabetic	retinopathy,	and	macular	degeneration,	and	cardiovascular	disease.	
	
The	 vasculature	 can	 provide	 tumours	 with	 the	 nutrients	 and	 oxygen	 they	 require	 and	 also	
provide	 a	 direct	 route	 for	 metastasis	 to	 distant	 sites	 in	 the	 body.	 As	 cancerous	 tumours	
increase	in	size,	above	a	million	cells	or	more,	they	need	to	take	advantage	of	this	angiogenic	
process	 (Gupta	 and	 Qin,	 2003).	 By	 manipulating	 the	 pro-	 and	 anti-angiogenic	 signalling	
molecules,	 tumours	 encourage	 growth	 and	 development	 of	 their	 own	 blood	 supply	 from	
nearby	vessels	through	sprouting	angiogenesis.		
	
Many	 tumours	 have	 been	 shown	 to	 express	 high	 levels	 of	 pro-angiogenic	 growth	 factors,	
including	VEGF,	through	genetic	mutation.	They	can	also	stimulate	angiogenesis	through	other	
mechanisms	 like	 increased	 inflammation,	 mobilization	 of	 host	 cells	 like	 microphages,	 and	
release	of	hypoxic	molecules	(Gupta	and	Qin,	2003).	However,	due	to	consistently	high	levels	
of	angiogenic	signalling	in	the	tumour,	the	resulting	vasculature	remains	highly	active	with	high	
permeability,	 and	 becomes	 leaky	 and	 functions	 sub-optimally	 (Nagy	 et	 al.,	 2009).	 Failure	 of	
endothelial	 cells	 within	 the	 vessels	 to	 quiesce	 and	 form	 mature	 junctions,	 basement	
membranes	 and	 attract	 mural	 cell	 coverage,	 all	 lead	 to	 vascular	 instability	 seen	 within	
tumours.	Poor	penetration	of	blood	vessels	thorough	tumours	results	in	many	of	the	problems	
encountered	 in	 treating	 this	 disease	 including	 reduced	 chemotherapeutic	 delivery,	 hypoxic	
regions	 resistant	 to	 radiotherapy,	 and	 high	 likelihood	 of	 circulation	 of	 cancer	 cells	 through	
leaky	vessels.	 	As	this	process	is	such	a	vital	element	of	tumour	growth,	many	attempts	have	
been	made	to	target	the	tumour	vasculature	with	relatively	high	success	and	anti-angiogenic	
therapy	is	now	standard	of	care	for	many	cancers	including	metastatic	colorectal	cancers,	non-
small	cell	lung	cancers	and	metastatic	renal	cell	cancers.		
	
Bevacizumab	(Avastin)	is	a	humanised	monoclonal	antibody	that	targets	all	isoforms	of	VEGF-
A.	 Clinical	 use	 of	 Avastin	 has	 been	 shown	 to	 slow	 angiogenesis	 and	 increase	 survival,	 and	
consequently	 Avastin	 has	 been	 approved	 for	 use	 in	 colorectal,	 kidney	 and	 lung	 cancer	
(Petrovic,	 2016).	 Although	 successful	 in	 slowing	 growth	 of	 those	 cancers,	 other	 trials	 have	
shown	less	promising	results	for	treatment	of	cancers	including	metastatic	breast	cancers	and	
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pancreas	cancers	(El-Kenawi	and	El-Remessy,	2013).	This	may	possibly	be	due	to	high	levels	of	
heterogeneity	within	tumours	and	the	range	of	angiogenetic	signalling	molecules	available,	as	
many	 tumours	 find	ways	 to	 overcome	 the	 initial	 effects	 of	 these	 inhibitors	 on	 blood	 vessel	
growth.	Recent	evidence	has	also	shown	the	growth	of	cancer	around	blood	vessels	can	take	
place	without	the	induction	of	angiogenesis,	through	co-option	of	vessels.	Endothelial	cells	are	
known	 to	 cleave	 kinins	 like	 bradykinin,	 which	 has	 been	 shown	 to	 increase	 migration	 and	
invasion	 of	 patient-derived	 glioma	 cells	 towards	 blood	 vessels	 without	 the	 need	 for	
angiogenesis	(Montana	and	Sontheimer,	2011).	However,	co-option	of	these	vessels	by	glioma	
cells	may	lead	to	regression,	hypoxia	and	subsequent	initiation	of	angiogenesis.	This	highlights	
the	 importance	 of	 timing	 of	 treatments	 and	 further	 understanding	 of	 pro-angiogenic	 switch	
which	takes	place	in	the	tumour	environment.				
	
Defective	angiogenesis	 in	 the	eye	 can	 lead	 to	a	 range	of	pathological	 conditions	which	have	
detrimental	 effects	 on	 vision	 including,	 diabetic	 retinopathy	 and	 macular	 degeneration.	
Diabetic	 retinopathy	 (DR)	 is	 the	 leading	cause	of	vascular	 related	sight	 loss	 in	 the	world	and	
results	 as	one	of	 the	 consequences	of	poorly	 controlled	diabetes	mellitus.	Damage	 to	blood	
vessel	in	the	retina	occurs	from	exposure	to	high	blood	sugar	levels	and	leads	to	eventual	loss	
of	vision.	Release	of	VEGF	by	damaged	vessels	stimulates	angiogenesis	and	leakage	of	healthy	
vessels	which	can	lead	to	further	sight	loss.	Intravitreal	injections	of	anti-angiogenic	inhibitors	
such	 as	 Avastin	 (bevacizumab)	 have	 shown	 efficacy	 in	 treating	 later	 stages	 of	 proliferative	
diabetic	retinopathy	(PDR)	(di	Lauro	et	al.,	2010).	The	blocking	of	the	VEGF	receptor	through	
Avastin	 treatment	 decreases	 vessel	 leakage	 and	 angiogenic	 sprouting	 and	may	 improve	 the	
sight	or	allow	a	window	for	other	approaches	like	laser	treatment.			
	
A	 number	 cardiovascular	 diseases	 are	 associated	with	 narrowing	 or	 closing	 of	 blood	 vessels	
and	loss	of	blood	supply	to	affected	areas.	Therapeutic	angiogenesis	in	cardiovascular	disease	
is	a	method	used	to	re-supply	blood	flow	through	stimulating	regrowth	of	vessels	using	growth	
factor	 or	 cell	 based	 therapies	 (Deveza,	 Choi	 and	 Yang,	 2012).	 Delivery	 of	 genes,	 proteins	 or	
cells	have	shown	promising	therapeutic	results	in	animal	models	to	date	but	translation	to	the	
clinic	 has	 been	 less	 successful	 for	 a	 number	 of	 reasons	 including	 growth	 factors	 delivery	
methods	and	lack	of	maturation	of	these	new	vessels.		
Intramuscular	 injection	 of	 angiogenic	 tissue	 growth	 factors	 or	 bone	 marrow	 stem	 cells	 has	
shown	 short	 term	 efficiency	 in	 animal	 models	 of	 critical	 limb	 ischemia	 with	 no	 off-target	
angiogenesis	or	occult	growth	of	tumours	(Ko	and	Bandyk,	2014).		
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Other	 therapeutic	 approaches	 include	 the	 targeting	 of	 individual	 molecules	 responsible	 for	
cardiovascular	diseases	or	their	associated	symptoms.	Signalling	molecules	involved	in	the	Rho	
GTPase	 signalling	 pathways	 (discussed	 in	 detail	 in	 section	 1.6.3)	 including	 the	 Rho	 kinases	
(ROCK1	 and	 ROCK2)	 (discussed	 in	 detail	 in	 section	 1.6.5)	 have	 been	 shown	 to	 play	 roles	 in	
many	 cardiovascular	 function	 due	 to	 their	 control	 of	 the	 actin	 cytoskeleton	 and	 in	
proliferation,	contraction,	migration	and	adhesion.	RhoA/ROCK	signalling	has	been	highlighted	
as	a	major	player	 in	 the	pathogenesis	of	many	cardiovascular	 related	diseases	and	therefore	
efforts	have	been	made	to	target	ROCK	activity.	Promising	results	using	ROCK	inhibitors	(such	
as	 Y27632	 or	 Fasudil)	 in	 animal	 models	 have	 shown	 this	 to	 be	 effective	 in	 reducing	 blood	
pressure	and	vasoconstriction	in	models	of	cardiovascular	disease	(see	review	(Surma,	Wei	and	
Shi,	2011)).	Fasudil	is	the	only	Rho	kinase	inhibitor	currently	approved	for	clinical	use	and	only	
available	in	Japan	where	it	is	used	to	treat	vasospasm	after	acute	ischemic	stroke.		
	
	
1.4	Angiogenic	signalling	
Multiple	 signalling	 pathways	 control	 the	 complex	 process	 of	 angiogenesis,	 which	 is	 highly	
regulated	 under	 the	 control	 of	 pro-	 and	 anti-angiogenic	 factors.	 The	 VEGF	 receptor	 system	
signalling	 under	 the	 control	 of	 hypoxia	 and	 Dll4-Notch	 signalling	 are	 some	 of	 the	 most	
important	and	best	characterized	angiogenic	signalling	pathways.	
	
Angiogenesis	is	controlled	by	a	large	number	of	soluble	growth	factors	and	molecules	released	
by	 hypoxic,	 growing	 or	 damaged	 tissues.	 Angiogenic	 behaviour	 is	 organized	 by	 gradients	 of	
pro-	 and	 anti-angiogenic	 signals	 which	 modulate	 how	 vessels	 develop	 and	 mature.	 Other	
effectors	 of	 angiogenic	 behaviour	 include	mechanical	 cues	 such	 as	 blood	 flow	 and	 pressure	
within	vessels.		
	
The	VEGF	family	of	growth	factors	and	their	receptors	are	key	regulators	of	both	angiogenesis	
and	vasculogenesis	 (Ferrara,	Gerber	and	LeCouter,	2003).	There	are	6	VEGF	family	members,	
VEGF-A	to	D,	the	related	placental	growth	factor	(PLGF),	and	VEGF-E	which	is	a	virally	encoded	
growth	factor	(Li	and	Eriksson,	2001).	VEGF-A	is	highly	conserved	throughout	evolution	and	is	
the	most	 important	member	of	 the	 family	 in	 controlling	blood	 vessel	 growth	 (Tischer	et	 al.,	
1991).	VEGF	family	members	show	varying	affinities	towards	multiple	VEGF	receptors:	VEGFR1	
(Flt-1),	VEGFR2	(KDR,	Flk-1)	and	VEGFR3	(Flt-4).	VEGFR1	and	VEGFR2	are	mainly	expressed	on	
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vascular	 endothelial	 cells	 while	 VEGFR3	 is	 mostly	 expressed	 on	 lymphatic	 endothelial	 cells.		
VEGF-A	binds	strongest	to	VEGFR2	and	this	signalling	 is	 thought	to	be	the	main	driving	force	
for	angiogenic	growth.	When	a	VEGF	ligand	binds	its	receptor,	the	receptors	may	form	homo-	
or	 hetero-dimers,	 which	 activate	 the	 receptors	 through	 auto-phosphorylation	 of	 multiple	
tyrosine	residues	within	the	intracellular	domains.	Signalling	downstream	of	VEGFR2	activates	
multiple	 signalling	 pathways	 that	 collectively	 promote	 cell	 proliferation,	 survival,	 migration	
and	 changes	 in	 gene	 expression	 (Dvorak	 et	 al.,	 1995).	 VEGFR1	 is	 thought	 to	 act	 as	 a	 decoy	
receptor	 with	 an	 inhibitory	 role	 in	 angiogenesis	 through	 its	 interaction	 with	 VEGF	 but	
subsequent	weak	ability	to	transmit	downstream	signals.	Furthermore,	a	soluble,	catalytically	
inert	 form	 of	 VEGFR1	 may	 also	 sequester	 VEGF	 and	 inhibit	 angiogenic	 signalling	 through	
VEGFR2	(Kendall	and	Thomas,	1993).	Recently,	 it	was	shown	that	VEGFR1	is	expressed	in	the	
stalk	 cells	 of	 a	 sprouting	 tubules,	 thus	 also	 inhibiting	 response	 by	 VEGFR2	 (Chappell,	
Mouillesseaux	and	Bautch,	2013).		
	
	
Hypoxia	is	one	of	the	main	drivers	of	angiogenic	growth	in	regions	lacking	adequate	oxygen	for	
survival,	 through	 regulation	 of	 VEGF.	 Endothelial	 cells	 react	 in	 hypoxic	 regions	 by	 stabilizing	
hypoxia	 inducible	 factors	 (HIFs)	 which	 are	 a	 set	 of	 transcription	 factors	 that	 control	 the	
formation	of	blood	vessels	as	well	as	a	number	of	other	roles	in	other	cell	types	(Shweiki	et	al.,	
1992).	 HIF1	 is	 a	 heterodimeric	 transcription	 factor	 that	 contains	 two	 subunits,	 HIF1a	 and	
HIF1b.	 During	 normoxic	 conditions,	 HIF1a	 gets	 degraded	 by	 the	 ubiquitin-proteasome	
pathway	through	binding	to	the	tumour	suppressor	von	Hippel-Lindau	protein	(Ratcliffe	et	al.,	
1999).	This	binding	is	under	the	control	of	enzymes	that	use	cellular	O2	as	a	substrate.	Under	
hypoxic	conditions	this	binding	is	disrupted	due	to	reduced	cellular	O2	levels	and	HIFa	 is	able	
to	accumulate	 in	 the	cytoplasm	and	 translocate	 to	 the	nucleus	where	 it	dimerizes	with	HIFb	
and	binds	to	target	genes	at	hypoxia	response	elements	(HREs)	(Semenza	et	al.,	1996).	Target	
genes	 include	 a	 huge	 range	 of	 genes	 involved	 in	 angiogenic	 responses	 to	 hypoxia	 including	
upregulation	of	VEGF	(Wang	et	al.,	1995;	Forsythe	et	al.,	1996).		
	
The	Notch	signalling	pathway	plays	an	important	role	in	regulating	VEGF	signalling	in	stalk	cells	
during	angiogenic	sprouting.	During	sprouting	angiogenesis,	the	selected	tip	cell,	stimulated	by	
VEGF,	 upregulates	 its	 expression	 of	 Delta	 like	 ligand	 4	 (DLL4)	 (Liu	 et	 al.,	 2003).	 DLL4	 is	 a	
transmembrane	ligand	for	Notch,	and	binds	Notch	expressed	on	trailing	stalk	cells.	Notch	then	
signals	to	downregulate	levels	of	VEGFR2	in	the	stalk	cells,	hence	reducing	competition	for	tip	
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cell	position	 in	 the	growing	sprout;	a	process	necessary	 for	proper	vascular	patterning	 (Phng	
and	Gerhardt,	2009).		
	
	
1.5	Lumen	formation	
A	lumen	is	defined	as	the	central	cavity	space	inside	of	a	tubular	structure	or	hollow	tissue	like	
a	blood	vessel	or	the	intestine.		Many	tissues	and	organs	within	the	body	need	to	form	tubes	
within	 lumens	 to	 carry	 out	 their	 physiological	 function.	 The	 importance	 of	 these	 tubular	
structures	is	in	the	transport	of	a	luminal	cargo	isolated	from	the	surrounding	tissues.	In	blood	
vessels	 for	example,	 the	 transport	of	blood	and	 its	cargo	 takes	place	 inside	vascular	 lumens,	
which	transport	oxygen	and	nutrients	to	distant	sites	and	deep	into	tissues.		
	
There	 are	 different	 mechanisms	 for	 lumen	 development	 and	 growth	 within	 the	 body	
depending	on	tissue	and	function.	Lumens	in	blood	vessels	and	lymphatic	vessels	are	lined	by	
endothelial	 cells,	 whereas	 cavities	 in	 the	 gastrointestinal	 tract,	 kidneys,	 liver,	 lungs	 or	 the	
salivary	glands	are	lined	by	epithelial	cells.	Defective	lumen	development	or	maintenance	can	
result	 in	 disease	 such	 as	 cardiovascular	 disease	 for	 example,	 in	 the	 case	 of	 blood	 vessel	
lumens.	
	
	
1.5.1	Cellular	mechanisms	of	blood	vessel	lumen	formation	
To	meet	 the	demand	 for	 the	wide	 range	of	vital	processes	 that	 lumens	 take	part	 in,	 such	as	
delivering	nutrients,	oxygen	and	circulating	antibodies	and	immune	cells,	diverse	mechanisms	
are	 in	 operation	 for	 their	 formation:	 cord	 hollowing,	 cell	 hollowing,	 plasma	 membrane	
invagination	 and	 sheet	 folding	 shown	 in	 Figure	 1.2	 operating	 in	 both	 blood	 vessel	 and	
epithelial	 lumen	 formation	 (Sigurbjörnsdóttir,	Mathew	 and	 Leptin,	 2014).	 Endothelial	 lumen	
formation	 is	 similar	 to	 epithelial	 lumen	 formation	 in	 that	 it	 originates	 by	 some	 of	 the	
mechanisms	 previously	 discussed.	 Namely,	 chord	 hollowing,	 cell	 hollowing	 and	 membrane	
invagination	have	been	described	in	the	literature	for	both	in	vitro	and	in	vivo	endothelial	cell	
lumen	 formation.	 Other	 similarities	 include	 the	 necessity	 for	 acquisition	 of	 polarity	 and	 the	
importance	of	cell-cell	junctions.		
	
Different	 processes	 are	 thought	 to	 operate	 during	 the	 formation	 of	 different	 calibre	 blood	
vessels	(Arispe	and	Davis	Dev	Cell	2009),	but	the	same	mechanisms	are	often	seen	within	the	
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same	vascular	bed,	as	for	example	in	the	case	of	intersegmental	vessels	in	zebrafish	embryos	
where	both	cord	and	cell	hollowing	mechanisms	are	in	operation	(Gebala	et	al.,	2016).	
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Figure	1.2	Cellular	mechanisms	of	tube	formation	
(A)	Chord	hollowing	takes	place	when	multicellular	tubes	rearrange	their	 junctions	to	form	a	
lumen	surrounded	by	at	least	two	cells.	Apical	proteins	are	delivered	to	the	cell-cell	junctions	
were	they	are	 involved	 in	separation	of	apical	 junctions	and	 lumen	formation.	Cell	hollowing	
occurs	in	single	cells	when	intracellular	vacuoles	coalesce	to	form	a	lumen	inside	the	cell.	This	
small	lumen	then	expands	and	joins	with	adjacent	cells	to	create	seamless	lumens.	Membrane	
invagination	involves	the	invagination	of	the	outer	plasma	membrane	to	form	an	intracellular	
space.	This	lumen	invagination	is	aided	by	the	addition	of	intracellular	vacuoles.	(B)	Cavitation	
is	 the	 hollowing	 of	 a	multicellular	 tube	 via	 death/apoptosis	 of	 the	 central	most	 cells.	 Sheet	
folding	describes	formation	of	a	lumen	by	a	layer	of	cells	folding	back	on	its	self	to	enclose	a	
hollow	region.	Adapted	from	(Strilić	et	al.,	2009).		
Cavitation
Nucleus
Lumen
Cell boundary
Apoptotic nucleus
B
multicellular tube
Cell sheet folding
Cell sheet
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1.5.1.1	Chord	hollowing	
Chord	hollowing	describes	a	mechanism	involving	multicellular	tubes	forming	lumens	between	
cells	 with	 lateral	 adhesions	 (Figure	 1.2	 A).	 This	 process	 takes	 place	 between	 at	 least	 two	
polarized	cells,	where	lateral	cell-cell	junctions	have	formed	and	apical	(lumenal)	proteins	start	
localizing	at	 those	 junctions.	An	 important	 aspect	of	 chord	hollowing	 is	 the	 redistribution	of	
junctional	proteins	to	the	outer	membrane	(Figure	1.2	A).		
	
During	the	cord	hollowing	process	of	lumen	formation	opposing	cells	polarize	and	gain	apical-
basal	 (lumenal-ablumenal)	 polarity.	 The	 cell-cell	 junctions	 become	 the	 site	 of	 apical	
specification	where	 the	 new	 lumen	 forms	 (Figure	 1.2A).	 This	mechanism	 therefore	 relies	 on	
endothelial	 cells	 having	 lateral	 adhesions	 where	 apical	 proteins	 localize	 prior	 to	 lumen	
formation.		
	
Strilic	et	al	showed	that	the	mouse	aorta	develops	through	chord	hollowing	(Strilić	et	al.,	2009)	
(Lammert	 &	 Axnick	 2012).	 The	 aortic	 lumen	was	 shown	 to	 develop	 extracellularly	 between	
adjacent	 endothelial	 cells	 (Figure	 1.2A).	 Endothelial	 cell	 junctions	 enriched	 with	 vascular	
endothelial	 cadherin	 where	 shown	 to	 be	 necessary	 for	 the	 initial	 stages	 of	 formation	 of	 a	
multicellular	lumen	through	recruitment	of	apical	proteins	to	the	cell	junctions.	Localization	of	
highly	negatively	charged	CD34-sialomucins	such	as	podocalyxin	to	this	early	lumenal	site	and	
re-distribution	 of	 junctional	 proteins	 to	 the	 lateral	 positions	 allows	 opening	 of	 the	 lumen	
potentially	 through	 electrostatic	 repulsion	 (Figure	 1.2A).	 Further	 work	 from	 Strillic	 and	 co-
workers	 demonstrated	 that	 the	 role	 of	 podocalyxin	 is	 fundamental	 for	 lumen	 development,	
and	that	its	negative	charge	does	indeed	drive	electrostatic	repulsion	between	apposing	cells	
to	initiate	lumen	opening.	In	those	experiments	sialidases	were	injected	into	the	mesenchyme	
of	developing	embryos	to	remove	sialic	acid	before	aortic	lumen	opening	(Gelberg	H1,	Healy	L,	
Whiteley	H,	Miller	 LA,	1996).	This	 resulted	 in	 loss	of	electrostatic	 repulsive	 forces	and	 fewer	
lumenised	 aorta	 compared	 with	 controls,	 confirming	 the	 role	 of	 sialomucins	 in	 lumen	
formation	in	this	system	(Strilić	et	al.,	2010).	Importantly,	the	defect	could	be	rescued	through	
addition	 of	 another	 apical	 binding	 negatively	 charged	 protein,	 dextran	 sulfate,	 into	 mouse	
embryos,	confirming	that	requirement	for	sialomucins	is	dependent	on	their	charge	(Strilić	et	
al.,	2010).	In	addition	to	aortic	lumen	formation	multicellular	lumens	can	also	be	observed	in	
intersegmental	 vessels	 (ISVs)	 in	 zebrafish	 embryos	 (Blum	 et	 al.,	 2008)	 (Gebala	 et	 al.,	 2016),	
suggesting	that	that	the	mechanism	of	chord	holloing		may	not	limited	to	larger	calibre	vessels.	
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Cavitation	 describes	 the	 death	 of	 cells	 within	 the	 centre	 of	 a	 multicellular	 tube	 and	 it	 is	
another	 way	 by	 which	 a	 multicellular	 lumen	may	 form	 (Figure	 1.2	 B).	 	 This	 form	 of	 lumen	
formation	is	seen	in	much	larger	scale	lumens	in	epithelial	cells	(Qi	et	al.,	2015)	however	there	
has	been	no	evidence	that	it	may	operate	in	the	formation	of	blood	vessel	lumens.		
	
	
1.5.1.2	Cell	hollowing		
In	contrast	to	chord	hollowing,	cell	hollowing	describes	formation	of	a	lumenal	space	within	a	
single	 cell,	 thus	 negating	 the	 need	 for	 multicellular	 tubes	 and	 takes	 place	 in	 individual	
endothelial	cells.	This	 is	typically	achieved	through	coalescing	of	 intracellular	vacuoles,	which	
combine	 to	 form	 the	 lumenal	 space	 without	 the	 need	 for	 multiple	 cells.	 Vacuoles	 develop	
within	endothelial	cells	 lined	head-to-tail	 that	coalesce	and	 fuse	 to	 form	a	small	 intracellular	
lumen	(Figure	1.2A).	(Bayless,	Salazar	and	Davis,	2000;	Bayless	and	Davis,	2002;	Davis,	Koh	and	
Stratman,	2007;	Gore	et	al.,	2012).	The	vacuoles	traverse	cell	boundaries	to	form	tubes	lacking	
cell	junctions.	These	tubes	are	termed	“seamless	tubes”	as	they	lack	cell-cell	junctions	around	
their	 circumference	 (Figure	 1.2	 A).	 This	 mechanism	 has	 been	 observed	 in	 endothelial	 cells	
forming	tubules	in	collagen	(Bayless,	Salazar	and	Davis,	2000;	Koh,	Mahan	and	Davis,	2008).	In-
vivo	cell	hollowing	has	been	described	in	the	intersomitic	vessels	(ISVs)	within	the	developing	
zebrafish	embryo	(Kamei,	W	Brian	Saunders,	et	al.,	2006).	In	this	study	vacuoles	appeared	and	
fused	to	form	large	intracellular	spaces	which	took	up	most	of	the	space	within	the	cell.	Using	
fluorescently	labelled	beads	the	authors	were	able	to	show	continuation	of	the	lumen	starting	
at	 the	 dorsal	 aorta	 through	 these	 hollow	 cells	 proving	 that	 separate	 endothelial	 cells	 had	
become	 linked	 to	 create	 a	 common	 endothelial	 tube	 via	 vacuole	 formation	 (Kamei	 et	 al.,	
2006).	 However	 similar	 studies	 in	 ISVs	 by	 Blum	 and	 colleagues	 disagrees	 and	 strongly	
suggested	that	zebrafish	ISVs	are	formed	through	the	process	of	chord	hollowing,	as	the	lumen	
appears	mostly	 juxtaposed	by	 two	endothelial	 cells	 containing	 lateral	 cell	 junctions	 (Blum	et	
al.,	2008).	Additional	studies	by	Wang	and	co-workers	showed	similarly	that	the	ISVs	do	indeed	
form	via	chord	hollowing,	particularly	at	the	base	of	the	ISV,	while	intracellular	vacuoles	were	
also	observed	which	contributed	at	least	in	part	to	the	expansion	of	the	lumen	(Wang et al., 
2010).	A	latest	publication	by	the	Gerhardt	group	confirmed	that	in	the	ISVs	lumens	are	mostly	
multicellular,	although	unicellular	segments	were	also	observed,	albeit	to	a	much	lesser	extent	
(Gebala	et	al.,	2016).	
	
	 17	
Altogether	 these	 studies	 suggest	 that	 different	mechanisms	may	 operate	 in	 different	 blood	
vessels,	or	 in	 the	development	of	 the	same	blood	vessel.	The	cell	hollowing	mechanism	may	
prevail	 in	 vessels	 with	 smaller	 diameter,	 single	 cell	 thick,	 which	 lack	 the	 thickness	 seen	 in	
lumen	 developing	 via	 chord	 hollowing;	 cell	 hollowing	 may	 also	 act	 as	 a	 lumen	 expansion	
mechanism	 by	 exporting	 intracellular	 vacuoles	 into	 an	 already	 formed	 extracellular	 lumen	
surrounded	by	at	least	two	endothelial	cells	as	proposed	by	Wang	et	al	(Wang	et	al.,	2010).		
	
	
1.5.1.3	Membrane	invagination	
Plasma	membrane	 invagination	 involves	expansion	the	apical	cell	membrane	of	one	cell	 into	
the	lumen	of	another	cell	to	form	a	continuous	lumen.	This	process	was	shown	to	play	a	role	in	
lumen	formation	during	anastomosis	of	a	sprouting	vessel	with	a	pre-existing	vessel	(Herwig	et	
al.,	 2011).	 In	 this	 study,	unicellular	 zebrafish	 ISVs	where	 shown	 to	have	 transcellular	 lumens	
that	originated	through	plasma	membrane	 invagination	through	anastomosis	with	the	dorsal	
longitudinal	 anastomotic	 vessel	 (DLAV).	 The	 invaginating	 lumen	 forms	 a	 pouch	 in	 the	 cell	 it	
anastomoses	with,	expands	its	lumen		through	the	entire	length	of	the	cell	and	fuses	with	the	
distal	membrane	 to	 form	a	 tube	 (Herwig	et	al.,	 2011).	 This	process	may	be	accompanied	by	
complex	 junctional	 and	 cell	 shape	 rearrangements	 which	 can	 also	 be	 aided	 formation	 of	
vacuoles	 that	 fuse	 with	 the	 invaginating	 membrane,	 resulting	 in	 overall	 expansion	 of	 the	
lumenal	surface	within	the	interior	of	the	cell	(Lenard	et	al.,	2013).		
	
	
1.5.1.4	Inverse	blebbing	
A	recent	study	by	Gerhardt	and	co-workers	showed	both	intracellular	and	extracellular	lumens	
exist	 away	 from	 the	 base	 of	 the	 ISV,	 with	 extracellular	 lumens	 prevailing	 over	 intracellular	
lumens	(Gebala	et	al.,	2016).	Furthermore,	while	the	provisional	extracellular	lumen	forms	at	
the	base	of	the	ISV	in	absence	of	blood	flow	(Wang	et	al.,	2010),	expansion	of	the	lumen	along	
the	ISV	requires	blood	flow	(Gebala	et	al.,	2016)		
	
Interestingly,	this	blood	pressure	driven	expansion	of	the	lumen,	termed	inverse	blebbing,	was	
shown	 to	 take	 place	 through	 a	 common	mechanism	 that	 operates	 both	 in	 single	 cells	 and	
laterally	adjacent	cells	within	the	ISV.	Inverse	blebbing	describes	the	process	of	blood	pressure	
induced	spherical	deformations	 in	the	apical	membrane	of	endothelial	cells	 to	which	the	cell	
	 18	
responds	by	 local	contraction	that	enables	 lumen	expansion	 in	one	direction	only	 (Gebala	et	
al.,	2016).		
	
The	existence	of	diverse	mechanisms	of	lumen	formation	depending	on	changes	at	the	cellular	
level,	cell	rearrangements	and	blood	flow,	potentially	also	controlled	spatially	and	temporally	
may	 be	 genetically	 driven,	 at	 least	 partially,	 depending	 on	 the	 final	 vessel	 morphology	
necessary	for	particular	function.	As	the	aforementioned	mechanisms	of	lumen	formation	may	
occur	under	different	conditions,	 the	range	of	methods	available	to	endothelial	cells	 to	 form	
lumenised	 structures	 potentially	 reflects	 the	 importance	 of	 this	 dynamic	 process	 for	 the	
function	of	complex	organ	systems.	
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Figure	1.3	Endothelial	lumen	formation	-	chord	hollowing	
Schematic	 shows	 stages	 of	 lumen	 formation	 between	 two	 adjacent	 endothelial	 cells	 during	
chord	hollowing.	(A)	Adjacent	endothelial	cells	within	tubes	form	lateral	adhesions	where	VE-
cadherin	 is	 expressed.	 (B)	 CD34	 sialomucins	 (podocalyxin)	 are	 recruited	 to	 the	 developing	
apical	membrane.	 (C)	Accumulation	of	podocalyxin	at	 the	apical	membrane	 results	 in	 lumen	
opening,	potentially	through	electrostatic	repulsive	forces.	Adapted	from	(Strilić	et	al.,	2009).	
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1.5.2	Molecular	mechanisms	of	lumen	formation		
The	signalling	pathways	that	control	lumen	formation	have	been	linked	with	many	aspects	of	
actin	 cytoskeletal	 dynamics.	 Not	 surprisingly	 such	 dramatic	 changes	 in	 cell	 shape	 and	
morphology	 are	 controlled	 by	 a	 plethora	 of	 cues	 including	 changes	 in	 extracellular	 matrix	
sensed	 by	 integrins	 and	 cell	 junctional	 organisation.	 Signalling	 pathways	 activated	 by	 these	
stimuli	control	the	previously	discussed	cellular	mechanisms	of	lumen	formation.		
	
	
1.5.2.1	Integrins		
Endothelial	cell	interaction	with	the	extracellular	matrix	(ECM)	is	conducted	through	integrins.	
These	 transmembrane	 proteins	 sense	 the	 surrounding	 environment	 and	 induce	 cytoskeletal	
changes	 in	 response	 to	 changes	 in	 the	 ECM.	 As	most	 endothelial	 lumen	 studies	 have	 been	
carried	out	in	 in	vitro	3D	matrices	that	can	be	manipulated,	a	great	of	deal	of	knowledge	has	
been	 gained	 regarding	 the	 role	 of	 integrin	 in	migration,	 sprouting,	 and	 lumen	 formation	 in	
endothelial	 tubes.	 	Engagement	of	collagen	 I	and	fibronectin	by	 integrins	has	been	shown	to	
have	 proangiogenic	 effects	 (Davis	 and	 Senger,	 2005;	 Iruela-Arispe	 and	 Davis,	 2009),	 while	
engagement	 of	 basement	membrane	 components	 such	 as	 collagen	 IV	 promotes	 quiescence	
and	lumen	formation	(Davis	&	Senger,	2008;	Iruela-Arispe	&	Davis,	2009).		
	
The	b1	family	of	 integrins	has	been	shown	to	be	important	in	both	epithelial	and	endothelial	
lumen	formation.		Inhibition	of	b1	integrin	via	blocking	antibodies	results	in	total	loss	of	lumen	
formation	in	the	aorta	of	chicken	embryos	(Drake,	Davis	and	Little,	1992).	Loss	of	endothelial	
recognition	of	the	basement	membrane	through	b1	integrin	genetic	deletion	has	been	shown	
to	impact	on	lumen	formation	in	mice	through	defects	in	the	polarity	protein	Par3		(Zovein	et	
al.,	 2010).	 	 The	 av	 family	 of	 integrins	 have	 also	 been	 shown	 to	 control	 lumen	 formation	
through	 their	 interaction	 with	 extracellular	 matrix	 proteins	 such	 as	 collagen	 (Davis	 and	
Camarillo,	 1996;	 Hood	 et	 al.,	 2003).	 Davis	 and	 co-workers	 showed	 that	 the	 integrin	 a2b1	
controlled	 formation	 of	 intracellular	 vacuoles	 which	 coalesce	 and	 are	 involved	 in	 capillary	
lumen	 formation	 (Davis	 and	 Camarillo,	 1996).	 Integrin	 engagement	 is	 also	 known	 to	 be	 key	
activator	 of	 Rho	 GTPase	 signalling	 involved	 in	 lumen	 formation	 (Bryan	 and	 D’Amore,	 2007)	
which	is	discussed	in	detail	in	Section	1.6.5.		
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1.5.2.2	Junctional	molecules	
Cell-cell	contact	is	prerequisite	for	most	of	the	described	mechanisms	of	lumen	formation.	Like	
epithelial	 cells,	 endothelial	 cells	 in	 contact	 form	 adherens	 junctions	 and	 tight	 junctions.	
Vascular	endothelial	cadherin	(VE-cadherin)	is	an	endothelial	specific	cadherin	and	is	involved	
in	 different	 aspects	 of	 endothelial	 growth	 and	 behaviour	 such	 as	 adhesion,	 vascular	
permeability	 and	 leukocyte	 extravasation	 (Bazzoni	 and	 Dejana,	 2004;	 Vestweber,	 2008).	
Fundamental	to	endothelial	cell	behaviour	 it	has	been	shown	that	 loss	of	VE-cadherin	 in	vivo	
results	 in	 major	 vascular	 defects	 due	 to	 loss	 of	 vascular	 morphogenesis	 including	 loss	 of	
lumens	 in	mice	 (Carmeliet	et	 al.,	 1999;	Gory-Faure	et	 al.,	 1999).	 Consistent	with	 the	 notion	
that	 lateral	 cell-cell	 adhesion	 is	 important	 in	 vascular	 lumen	 formation,	 early	 work	 by	
Carmeliet	 and	 co-workers	 had	 shown	 that	 VE-cadherin	 genetic	 deletion	 or	 truncation	 of	 its	
cytosolic	 domain	 which	 binds	 b-catenin	 results	 in	 endothelial	 defects	 in	 remodelling,	
maturation	 and	 also	 tubule	 opening	 (Carmeliet	 et	 al.,	 1999).	 Correct	 localization	 of	 VE-
cadherin	 is	 known	 to	 regulate	 and	 organize	 the	 localization	 of	 important	 apical	 and	 basal	
proteins	leading	to	lumen	formation	(Wang	et	al.,	2010)	including,	podocalyxin,	moesin1,	and	
collagen	IV	which	all	fail	to	localize	properly	when	VE-cadherin	is	lost	in	vitro	and	in	vivo	(Strilić	
et	al.,	2009;	Lampugnani	et	al.,	2010;	Wang	et	al.,	2010).	Moesin1	has	been	shown	to	control	
endothelial	cell	polarisation	in	zebrafish	ISVs	and	loss	of	moesin1	leads	to	complete	failure	of	
ISV	 lumenisation	and	also	delayed	aortic	 lumen	formation	 in	knockout	mice	 in	another	study	
(Strilić	et	al.,	2009;	Wang	et	al.,	2010).	These	moesin1	defects	are	hypothesised	to	be	due	to	
the	organization	of	the	actin	cytoskeleton	and	its	role	in	directing	luminal/ablumenal	polarity.		
	
Interestingly,	more	recent	work	has	shown	that	VE-cadherin	localized	at	filopodia	on	migrating	
tip	cells	induces	polarity	changes	in	stable	quiescent	endothelial	cells	within	a	tube.	Interaction	
of	 VE-cadherin	 at	 the	 tips	 with	 the	 basal	 (ablumenal)	 side	 of	 endothelial	 cells	 within	 an	
established	blood	vessel,	resulted	in	re-distribution	of	apical	proteins	to	that	site	and	initiation	
of	 apical	 membrane	 invagination	 to	 begin	 the	 process	 of	 lumen	 formation	 (Lenard	 et	 al.,	
2013).		
	
	
1.5.2.3	Polarity	complex	
In	 order	 to	 form	 tubes,	 endothelial	 cells,	 like	 epithelial	 cells,	 gain	 apical-basal	 polarity	 (also	
described	 as	 lumenal-ablumenal	 polarity	 in	 endothelial	 cells).	 This	 acquisition	 of	 polarity	
orchestrates	 the	 correct	 localization	 of	 apical	 and	 basal	 proteins	 in	 order	 to	 commence	 the	
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process	of	lumen	formation.	Cell-cell	junctions	between	endothelial	cells	act	as	sites	of	apical	
polarization	where	 VE-cadherin	 plays	 an	 important	 role	 as	well	 as	 the	 CD34	 related	 protein	
podocalyxin	 (Lampugnani	 et	 al.,	 2010;	 Y.	 Wang	 et	 al.,	 2010).	 The	 CD34	 sialomucin	 family	
members	 are	 known	 to	 localize	 to	 the	 apical	 membrane	 of	 endothelial	 cells	 where	 their	
electrostatic	properties	aid	 in	 lumen	opening	 (Strilić	et	al.,	2009).	At	 the	same	time	cell-ECM	
contacts	maintain	basal	(ablumenal)	identity	(Bryant	and	Mostov,	2008).		
	
Loss	of	endothelial	 recognition	of	 the	basement	membrane	through	b1	 Integrin	deletion	has	
been	shown	to	be	critical	for	lumen	formation	in	mice	through	defects	in	Partitioning	defective	
3,	 Par3	 	 (Zovein	et	al.,	 2010).	b1	 Integrin	 loss	 resulted	 in	 loss	of	 endothelial	 cells	 shape	and	
mislocalisation	of	 apical	 proteins	 and	adhesion	proteins	 through	 transcriptional	 decreases	 in	
the	Par3	 (Zovein	et	al.,	2010).	Par3	 is	a	member	of	 the	Par	complex	which	consists	of	Par-3,	
Partitioning	defective	6	(Par-6),	Atypical	protein	kinase	C	(aPKC),	and	Cdc42	which	localises	to	
tight	 junctions	 and	 has	 been	 shown	 to	 be	 essential	 during	 endothelial	 lumen	 formation	
(Lizama	and	Zovein,	2013).	Par3	and	VE-cadherin	interaction	(Iden	et	al.,	2006)	has	also	been	
shown	 to	 regulate	 endothelial	 polarity	 and	 junctional	 organization	 which	 is	 subsequently	
necessary	for	lumen	formation.			
	
Integrin	 b1	 loss	 also	 affected	 localization	 of	 VE-cadherin	 and	 podocalyxin	 known	 to	 be	
essential	for	lumen	formation.	After	loss	of	integrin		b1,	VE-cadherin	which	is	normally	seen	at	
cell-cell	 junctions,	 was	 now	 present	 around	 the	 entire	 circumference	 of	 the	 cell	 while	
podocalyxin	had	lost	its	specific	localization	at	the	apical	membrane	only	(Zovein	et	al.,	2010).	
It	 is	 therefore	 evident	 that	 endothelial	 cell	 (EC)	 interaction	 with	 the	 ECM	 and	 other	 ECs	
regulate	apical	basal	differentiation	and	signalling	to	polarity	proteins	like	Par3.	Par3,	together	
with	PAK2,	PAK4	and	PKC	are	 known	 to	 interact	with	Cdc42	and	other	members	of	 the	Rho	
GTPase	 family	 which	 in	 turn	 control	 endothelial	 cytoskeletal	 changes	 necessary	 for	 lumen	
formation	(Koh,	Mahan	and	Davis,	2008).	Additional	studies,	however,	are	needed	to	assess	if	
these	regulatory	mechanisms	exist	in	vivo	due	to	the	likelihood	of	multiple	functions	for	these	
polarity	proteins.	Loss	of	or	gain	of	function	studies	would	need	temporal	and	cellular	control	
to	fully	assess	roles	of	these	molecules	in	vivo.		
	
After	polarization	of	cells	within	a	tubule,	trafficking	of	apical	proteins	to	the	apical	membrane	
controls	 lumen	 formation	 and	 opening.	 As	 discussed	 earlier,	 the	 CD34	 family	 of	 sialomucins	
are	known	to	be	involved	in	the	initial	opening	of	tubules	through	their	highly	glycosylated	and	
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sialic	acid	adorned	extracellular	domain	(Nielsen	and	McNagny,	2008).	This	domain	provides	a	
negative	charge	which	pushes	opposing	apical	membranes	apart	and	 initiates	the	opening	of	
lumens.	Deletion	of	one	of	the	CD34	related	family	members,	podocalyxin,	results	in	delays	or	
defects	 in	 lumen	 opening	 in	 epithelial	 lumens	 (Doyonnas	 et	 al.,	 2001;	 Cheng	 et	 al.,	 2005;	
Meder	et	al.,	2005).	Interestingly,	vascular	endothelial	cells	within	these	podocalyxin	deficient	
models	 develop	 normally,	 possibly	 through	 compensation	 by	 other	 sialomucins	 like	 CD34	
(Doyonnas	et	al.,	2001).		
	
	
1.5.2.4	Blood	flow	and	sheer	stress	
Vessel	 diameter	 appears	 to	 be	 controlled	 genetically	 but	 it	 has	 been	 shown	 that	 flow	 and	
sheer	 stress	 are	 essential	 for	 the	maintenance	 and	 the	 regulation	 of	 the	 diameter	 of	 blood	
vessels	 (Jones,	 le	Noble	 and	Eichmann,	 2006).	Not	only	does	 the	physical	 effect	of	 flow	and	
pressure	 shape	 the	 developing	 lumen,	 but	 the	 recognition	 of	 flow-induced	 sheer	 stress	 by	
endothelial	cells	also	controls	vessel	morphology.	The	endothelial	 response	to	shear	stress	 is	
necessary	to	maintain	the	homeostasis	of	the	circulatory	system,	and	loss	of	this	response	can	
lead	 to	 the	development	of	 vascular	 diseases	 such	 as	 hypertension,	 thrombosis,	 aneurysms,	
and	atherosclerosis	(Ando	and	Yamamoto,	2013).	Changes	 in	 lumen	size	can	also	be	affected	
by	levels	of	nitric	oxide	induced	by	blood	flow	and	pressure.	Recognition	of	flow-induced	sheer	
stress	by	the	calcium	ion	channel	Piezo1	was	shown	to	be	essential	for	lumen	formation	(Li	et	
al.,	 2014).	 Loss	 of	 piezo	was	 embryonically	 lethal	 after	 the	 heart	 had	 started	 beating	while	
haploinsufficiency	led	to	abnormalities	in	the	major	vessels	(Li	et	al.,	2014).		
	
An	 important	property	of	endothelial	 lumens	 is	their	ability	to	sense	and	respond	to	 internal	
flow	 and	 pressure.	 After	 lumen	 formation	 is	 complete,	 unlike	 epithelial	 lumens,	 vascular	
lumens	 remain	highly	dynamic	and	continue	 to	 remodel	 in	 response	 to	 forces.	During	vessel	
growth	endothelial	lined	lumens	must	form	behind	a	growing	sprout	when	the	growing	sprout	
may	be	elongating	and	migrating	at	a	high	rate,	while	endothelial	cells	 forming	a	new	lumen	
must	 maintain	 integrity	 through	 dramatic	 increases	 blood	 pressure	 and	 flow	 (Pelton	 et	 al.,	
2014).	Being	in	direct	contact	with	pulsate	blood	flow	enables	the	endothelial	cells	to	monitor	
flow	rates	and	pressures	and	respond	to	these	cues	accordingly.	
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1.6	Actin		
Actin	monomers	are	one	of	the	most	important	and	abundant	proteins	within	eukaryotic	cells	
because	 of	 their	 ability	 to	 play	 roles	 in	 a	 huge	 range	 of	 cellular	 functions	 and	 processes.	
Whether	 found	on	 its	 own	as	G-actin	 or	 coupled	 together	 as	 F-actin,	 the	 actin	machinery	 is	
involved	 in	 all	 aspects	 of	 cell	 structure	 and	 shape	 changes.	 	 Therefore,	 it	 is	 evident	 that	 all	
processes	of	angiogenesis	including,	sprouting,	migration,	and	lumen	formation,	which	rely	on	
tightly	regulated	control	of	cell	shape	require	control	of	the	actin	machinery.		
	
Actin	 is	 a	 highly	 conserved	monomeric	 protein	 that	 has	 the	 ability	 to	 polymerize	 and	 form	
sheets,	 filaments	 and	 bundles	 involved	 in	 controlling	 cell	 morphology	 (Figure	 1.4)(Roberto	
Dominguez	and	Kenneth	C.	Holmes,	2011).	Actin	filament	growth	begins	at	an	actin	nucleation	
site	 composed	 of	 2	 or	 more	 actin	 monomers.	 Assembled	 head	 to	 tail,	 actin	 monomers	
elongate	into	chains	of	F-actin	filaments	with	pointed	and	barbed	ends.	The	barbed	end	of	the	
filament	grows	rapidly	 through	addition	of	ATP	bound	actin	which	has	weak	GTPase	activity.	
Chains	of	F-actin	form	by	a	process	known	as	“actin	filament	treadmilling”	where	ATP-bound	
actin	monomers	join	the	elongating	barbed	end,	get	hydrolysed	to	ADP,	and	then	disassociate	
off	 the	pointed	end	 (Wegner	 and	 Isenbergt,	 1983)	 (Figure	 1.4B).	While	 in	 the	 filament	 actin	
monomers	hydrolyse	 to	ADP	and	 inorganic	phosphate,	 their	 affinity	 for	 each	other	weakens	
which	results	in	dissociation	(Bugyi	and	Carlier,	2010).	The	speed	at	which	actin	monomers	are	
added	or	lost,	as	well	as	the	abundance	of	actin	monomers	dictate	weather	filaments	elongate	
or	shrink.	Through	the	growth	and	organization	of	these	simple	filament	shapes	more	complex	
structures	can	form	through	actin	branching	and	binding	proteins	(Figure	1.4	C-D).		
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Figure	1.4	Actin	structure	and	assembly		
(A)	Actin	monomers	combine	in	a	helical	structure	to	form	filaments.	ATP-actin	is	added	at	the	
barbed	 end	 of	 the	 filament.	 (B)	 The	 ADP	 gets	 hydrolysed	 in	 the	 filament,	 loses	 its	 strong	
affinity	for	actin	monomers	and	gets	removed	from	the	pointed	end;	this	turnover	of	actin	is	
termed	 actin-treadmilling.	 Through	 this	 simple	 process	 more	 complex	 structures	 may	 be	
formed.	(C)	Filopodia	are	actin	rich	protrusions	that	extend	from	the	cell	membrane.	Filaments	
are	 bundled	 together	 by	 actin	 binding	 proteins	 to	 form	 long	 unbranched	 protrusions.	 (D)	
Lamellipodia	 are	 actin	 dense	 flat	 sheets	 that	 protrude	 from	 the	membrane.	 Actin	 filaments	
branch	via	actin	binding	proteins	and	form	complex	flat	networks.	Adapted	from	Blanchoin	et	
al	2014	(Blanchoin	et	al.,	2014).		
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To	 create	 an	 actin	 filament,	 a	 nucleation	 point	 must	 be	 produced	 for	 the	 addition	 of	
monomeric	actin	to	take	place	and	grow	the	filament.	This	process	is	highly	controlled	within	
the	 cell	 and	 is	 under	 the	 influence	 of	 a	 range	 of	 actin	 nucleating,	 severing	 and	 elongation	
proteins	and	their	associated	factors.		
	
	
1.6.1	Actin	machinery		
	
1.6.1.1	ARP2/3	
The	 ARP2/3	 complex	 is	 composed	 of	 7	 protein	 subunits	 of	 which	 two	 have	 close	 structural	
relationship	 with	 actin	 monomers.	 Of	 the	 seven	 subunits,	 Arp2	 and	 Arp3	 have	 the	 closest	
structural	similarity	to	actin	monomers	and	this	is	where	the	complex	gets	its	name	(RD,	2008).	
The	 Arp2/3	 complex	 cannot	 initiate	 actin	 nucleation	 or	 polymerization	 without	 the	 help	 of	
actin	nucleation	promoting	factors	(NPFs).	WASP,	WAVE	and	WASH	are	some	of	the	most	well-
studied	NPFs	and	are	regulated	by	Rho	GTPase	activity	(Goley	and	Welch,	2006).	They	function	
through	their	WCA	domain,	binding	ARP2/3	and	presenting	 it	with	an	actin	monomer,	which	
together	with	the	2	and	3	subunits	form	an	actin	nucleation	point	(Kelly	et	al.,	2006).		
	
The	Arp2/3	complex	can	also	bind	F-actin	filaments	and	become	activated.	The	complex	drives	
actin	branching	activity	through	binding	F-actin	and	increasing	the	number	of	barbed	ends	free	
for	 polymerization.	 	 By	 binding	 onto	 the	 side	 of	 a	 pre-existing	 actin	 filament	 at	 the	 pointed	
end,	 the	Arp2	and	Arp3	subunits	 form	the	base	of	a	new	branch	of	 filament	growing	off	 the	
side	at	an	angle	of	70o	(Egile	et	al.,	2005).	This	behaviour	results	in	highly	branched	networks	
seen	 in	 lamellipodia	 (Figure	1.4D).	The	complex	also	affects	actin	 filaments	by	binding	at	 the	
pointed	ends	 and	 acting	 as	 a	 capping	protein.	 This	 results	 in	 prevention	of	 disassociation	of	
actin	 monomers	 from	 the	 pointed	 end.	 Hydrolysis	 of	 ATP	 on	 Arp2	 eventually	 leads	 to	 a	
decreased	 affinity	 of	 Arp2/3	 for	 the	 pointed	 end,	 releasing	 itself,	 in	 turn	 allowing	 further	
disassociation	of	actin	monomers	(MF,	2003).		
	
Branched	 actin	 filaments	 play	 roles	 in	 many	 areas	 of	 the	 cell	 depending	 on	 the	 desired	
outcome.	The	branching	activity	of	Arp2/3	is	controlled	by	NPFs	which	are	in	turn	controlled	by	
Rho	GTPases.	Specific	 localization	of	Arp2/3	NPFs	control	were	branching	will	 take	place;	 for	
example,	activation	of	Arp2/3	at	the	leading	edge	of	a	cell,	by	NPFs	localized	there,	will	result	
in	the	growth	of	lamellipodia	(Campellone	and	Welch,	2010).	
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1.6.1.2	Formins	
Formins	function	as	actin	regulators	and	play	many	different	roles.	They	are	identified	by	their	
FH2	 domain	 which	 has	 actin	 nucleation	 and	 elongation	 capabilities	 (Pruyne	 et	 al.,	 2002).	
Formins	bind	the	barbed	end	of	growing	actin	filaments	and	aid	in	elongation	while	protecting	
them	 from	 capping	 proteins	 (Kovar	 and	 Pollard,	 2004).	 This	 process	 is	 much	 quicker	 than	
addition	of	cytosolic	free	actin	monomers	to	the	barbed	end	of	a	growing	filament.	As	well	as	
actin	nucleation,	formins	also	have	the	ability	to	control	actin	depolymerisation,	bundling	and	
severing	(Breitsprecher	and	Goode,	2013).	Rho	GTPases	are	known	to	regulate	formins.	
	
Different	 GTPases	 have	 the	 ability	 to	 bind	 the	 same	 formin	 GTPase	 binding	 domain	 (GBD)	
resulting	 in	 activation	 in	 different	 cell	 compartments.	 Normally	 found	 in	 an	 autoinhibitory	
folded	form,	formins	become	activated	when	bound	to	active	Rho	GTPases	which	release	the	
auto-inhibition.	 (Eisenmann	 et	 al.,	 2005).	 Further	 activation	 may	 be	 needed	 for	 full	 formin	
activity,	and	actin	binding	may	play	a	role	in	this	process.			
	
	
1.6.1.3	Profilin	
Profilin	 is	 an	 another	 important	 actin	 binding	 protein	 that	 regulates	 actin	 monomer	
polymerization.	Upon	discovery,	profilin	was	thought	to	be	an	actin	depolymerizing	protein	as	
it	bound	monomeric	actin	in	vitro	(Carlsson	et	al.,	1976).	Later	it	was	shown	that	upon	binding	
actin,	 profilin	 significantly	 accelerated	 the	 exchange	 of	 ADP	 for	 ATP	 thus	 providing	 more	
available	actin	for	polymerization	(Plank	and	Ware,	1987).	It	was	also	implicated	in	promoting	
binding	of	actin-profilin	complexes	 to	 the	barbed	end	over	 the	pointed	end	of	growing	actin	
filaments	 (Pollard	and	Cooper,	1984).	 It	 is	now	known	that	profilin	binds	 to	actin	monomers	
and	 is	 involved	 in	 the	 exchange	 of	 ADP	 for	 ATP	 (Goldschmidt-Clermont	 et	 al.,	 1992).	 The	
affinity	 of	 profilin	 for	 phosphoinositides	 found	 in	 the	 plasma	 membrane,	 which	 has	 been	
shown	to	disrupt	the	profilin-actin	binding,	is	suggested	to	be	a	mechanism	for	delivery	of	ATP-
actin	 monomers	 to	 the	 plasma	 membrane	 ready	 for	 polymerization	 (Lassing	 and	 Lindberg,	
1985;	Witke	et	al.,	2001).		
	
Profilin	 is	 regulated	by	Rho	A	 and	has	been	 shown	 to	be	part	 of	 a	 complex	with	Rho	A	 and	
p140mDia	which	is	recruited	to	lamellipodia	in	fibroblasts	and	membrane	ruffles	in	MDCK	cells	
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controlling	changes	in	the	actin	cytoskeleton	(Watanabe	et	al.,	1997).		Due	to	the	importance	
of	 profilin	 in	 such	 fundamental	 processes,	 genetic	 knockout	 of	 profilin	 results	 in	 embryonic	
lethality	as	early	as	the	two-cell	stage	due	to	severe	defects	in	cytokinesis	(Witke	et	al.,	2001).	
Recent	 studies	 have	 linked	 mutations	 in	 the	 profilin1	 gene	 with	 pathological	 conditions	
including	 contribution	 to	 the	 pathogenesis	 of	 amyotrophic	 lateral	 sclerosis	 and	
neurodegeneration	(Alkam	et	al.,	2016).		
	
In	 addition	 to	 actin	 nucleation	 and	 elongation	 factors	 precise	 regulation	 of	 actin	 dynamics	
necessitates	 the	action	of	 actin	 severing	and	depolymerizing	proteins.	 These	proteins	 cleave	
actin	 filaments	 to	 prevent	 excessive	 growth	 and	 return	 actin	 monomers	 to	 the	 free	 pool	
available	for	incorporation	into	new	filaments.		
	
	
1.6.1.4	ADF/Cofilin	
Cofilin	 is	an	actin	binding	protein	 involved	in	the	de-polymerization	of	actin	filaments.	Cofilin	
can	interact	with	both	G-actin	and	F-actin	and	has	a	strong	affinity	for	ADP-bound	actin	over	
the	two	other	forms	actin,	ATP-actin	and	ADP-Pi-actin.	Cofilin	also	plays	a	positive	role	in	actin	
treadmilling	through	severing	growing	filaments	and	hence	replenishing	the	monomeric	actin	
pool	for	new	filament	growth.		
	
Cofilin	 can	nucleate	 actin	 filaments	 directly	 and	 also	 be	 involved	 in	 increasing	or	 decreasing	
filament	branching.	Its	severing	activity	on	F-actin	filaments	creates	new	barbed	ends	available	
for	nucleation	and	filament	growth	(Ichetovkin,	Grant	and	Condeelis,	2002;	Andrianantoandro	
and	 Pollard,	 2006).	 After	 severing	 of	 F-actin	 filaments,	 cofilin	 allows	 for	 the	 binding	 and	
branching	 of	 these	 filaments	 through	 ARP2/3	 mediated	 branching	 activities,	 as	 newly	
polymerized	filaments	allow	for	a	10-fold	more	stable	branching	over	older	ones	(Ichetovkin,	
Grant	 and	 Condeelis,	 2002;	 TD,	 2006).	 Furthermore,	 it	 can	 sever	 ARP2/3	 complex	 produced	
branches	on	older	filaments.	(TD,	2009).	The	severing	activity	shown	by	cofilin	is	known	to	take	
place	between	 separate	 cofilin	bound	 sections	of	 F-actin	 filaments.	Cofilin	binding	 to	F-actin	
alters	the	existing	filaments’	conformational	twist.	 Its	binding	activity	on	the	filament	creates	
flexibility	 in	 the	 F-actin	 filament	 which	 can	 spread	 up	 the	 filament	 to	 regions	 unbound	 by	
cofilin.	These	unbound	regions	between	cofilin	molecules	become	weak	and	split	as	they	lack	
the	 structural	 support	 given	 by	 cofilin	mediated	 stabilization	 (Bravo-Cordero	et	 al.,	 no	 date;	
Galkin,	Orlova	and	Kudryashov,	2011).		
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Rho	GTPase	signalling	controls	at	least	in	part	the	activity	of	cofilin.	Rho	GTPases	effectors	such	
as	ROCK1/2,	activate	LIM-kinase	which	phosphorylates	cofilin	at	its	Ser	3	residue	and	render	it	
inactive	 (Caroni	 et	 al.,	 1998).	 Other	 kinases	 also	 control	 cofilin	 activity,	 such	 as	 testicular	
protein	 kinase	 (TESK),	 which	 also	 phosphorylates	 cofilin	 at	 Ser	 3	 independently	 of	 LIMK	
(Toshima	et	al.,	2001).	The	activity	of	cofilin	can	be	further	coordinated	by	phosphatases	that	
control	 its	 reactivation.	 Slingshot	 (SSH1)	 for	 example	 is	 transported	 to	 the	 lamellipodia	 by	
coronin	 1B	 and	dephosphorylates	 cofilin,	 thus	 increasing	 its	 activity	 at	 lamellipodia	 (Niwa	et	
al.,	 2002).	 Balanced	 expression	 of	 kinases	 and	 phosphatases	 modulate	 cofilin	 activity	 at	
different	cell	sites.		
	
	
1.6.1.5	Myosins		
As	well	as	playing	a	structural	role	within	the	cell,	actin	also	contributes	to	cell	contractility	and	
trafficking.	 This	 is	 through	 the	 interaction	 of	 actin	 with	myosins,	motor	 proteins	 that	move	
along	actin	filaments	and	hydrolyse	ATP	as	they	move.	Myosins	convert	chemical	energy	in	the	
form	of	ATP	to	mechanical	energy,	used	to	generate	force	and	movement	along	actin	filaments	
(Cooper,	 2000).	 They	 can	 be	 involved	 in	 shuttling	 of	 cargo	 along	 F-actin	 chains,	 or	 in	
contractility	by	creating	pulling	forces	(Schnittler	et	al.,	1990).	The	generated	force	 is	used	in	
the	contraction	of	stress	fibres	and	pulling	of	the	extracellular	matrix	that	cells	are	attached	to.		
	
	
1.6.2	The	actin	cytoskeleton		
The	actin	cytoskeleton	functions	not	only	as	structural	support	for	the	cell,	but	also	as	a	vital	
scaffold	 involved	 in	 important	 cellular	 functions.	 Through	 coordinated	 action	 of	 the	 actin	
machinery,	 cells	 control	 their	 shape	 changes,	 migration	 and	morphology.	 Cell	 movement	 is	
necessary	 for	 the	 majority	 of	 cell	 functions	 and	 is	 accomplished	 through	 coordinated	
protrusion,	 adhesion	 and	 contraction	 of	 the	 cell	 membrane.	 The	 cell	 takes	 advantage	 of	
previously	 discussed	 actin	 regulators	 to	 modulate	 the	 cell	 shape	 for	 numerous	 processes.	
Filopodia	are	actin-rich	cell	protrusions	that	aid	migration,	through	sensing	of	growth	factors,	
extracellular	 matrix	 proteins,	 and	 cues	 from	 other	 cells.	 They	 protrude	 from	 the	 cell	
membrane	through	elongation	of	actin	 filaments	 linked	by	actin	crosslinkers	 (Figure	1.4C).	 In	
endothelial	 cells,	 filopodia	are	highly	dynamic	and	have	high	 turnover	 rate.	One	of	 the	main	
drivers	of	 filopodial	protrusions	 is	 the	Rho	GTPase	Cdc42	(Ridley	and	Hall	Cell,	Cdc42	paper).	
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Lamellipodia	on	 the	other	hand	are	 flat	 sheets	of	actin-rich	membrane	which	protrude	 from	
the	cells	edge	to	aid	 in	migration	(Figure	1.4	D).	Actin	branching	behaviour	 is	known	to	drive	
lamellipodia	 through	 ARP2/3	 complex	 activity.	 Rac	 signalling	 is	 known	 to	 drive	 lamellipodia	
formation	 (Ridley	 et	 al.,	 1992).	 Many	 of	 the	 important	 cellular	 actin	 cytoskeletal	
rearrangements	are	under	the	control	of	the	Rho	family	of	small	GTPases.			
	
	
1.6.3	Rho	GTPases		
Rho	 GTPases	 are	 small	 (~21kDa)	 signalling	 G	 proteins	 that	 act	 as	 molecular	 switches	 in	
signalling	pathways.	Rho	proteins	are	known	best	for	the	control	of	the	actin	cytoskeleton	but	
they	 also	 control	 many	 other	 processes	 including	 proliferation,	 survival,	 differentiation	 and	
gene	expression,	 through	actin	dependent	and	 independent	mechanisms	 	 The	Rho	 family	of	
small	GTPases	are	a	subclass	of	the	larger	Ras	superfamily	which	consists	of	over	150	members	
divided	in	to	5	subgroups	Rho,	Ras,	Arf,	Ran,	and	Rab	(Madaule	and	Axel,	1985).	Rho	GTPases	
are	 highly	 conserved	 and	 have	 been	 found	 in	 yeast,	 plants,	worms	 and	 flies	 (Jaffe	 and	Hall,	
2005).		
	
Several	 studies	have	 implicated	Rho	proteins	 in	 the	process	of	angiogenesis	 (Hoang,	Whelan	
and	Senger,	2004;	Mavria	et	al.,	2006;	Bryan	and	D’Amore,	2007;	Abraham	et	al.,	2009,	2015;	
Kaur	 et	 al.,	 2011).	 The	 complex	 changes	 in	 shape	 undergone	 by	 endothelial	 cells	 during	
sprouting,	migration	and	lumen	formation	require	precise	control	of	the	actin	cytoskeleton	by	
Rho	 proteins.	 Within	 the	 family	 of	 small	 Rho	 GTPases,	 cell	 division	 control	 protein	 42	
homologue	(Cdc42),	Ras-related	C3	botulinum	toxin	substrate,	Rac	(Rac	1,	2,	and	3),	and	Ras	
homology	gene	family,	Rho	(Rho	A,	B,	and	C)	are	the	best	studied.	Of	 these	GTPases,	CDC42	
has	been	shown	to	control	filopodia	formation	(Kozma	et	al.,	1995;	Nobes	and	Hall,	1995),	Rac	
shown	to	be	 involved	 in	 lamellipodia	 formation	 (Ridley	et	al.,	1992)	and	Rho	 to	play	 roles	 in	
stress	 fibre	 formation	 and	 actomyosin	 contractility.	With	 such	 important	 regulatory	 roles	 in	
diverse	functions,	deregulation	of	Rho	GTPase	signalling	is	seen	in	many	cancers	and	numerous	
other	diseases	(Vega	and	Ridley,	2008).		
	
1.6.3.1	Cdc42	
Cdc42	was	first	discovered	in	yeast	and	shown	to	important	for	budding	behaviour	through	its	
control	of	the	actin	cytoskeleton	(Johnson	and	Pringle,	1990).	Cdc42	is	one	of	the	main	actin	
nucleator	 proteins	 and	 is	 therefore	 implicated	 in	many	 cellular	 processes.	 Its	 best	 described	
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role	in	mammalian	cells	is	the	induction	of	filopodia	formation	but	has	also	been	implicated	in	
controlling	 cell	 polarity,	 proliferation	 and	 migration	 through	 the	 control	 of	 actin	
polymerization,	depolymerisation,	branching,	bundling	and	contractility	(Erickson	and	Cerione,	
2001;	 Peng	 et	 al.,	 2003;	 Etienne-Manneville,	 2004;	Wilkinson,	 Paterson	 and	Marshall,	 2005;	
Derivery	and	Gautreau,	2010).		
	
During	 angiogenesis,	 endothelial	 sprouting	 behaviour	 is	 led	 by	 filopodia-rich	 tip	 cells.	 As	
discussed	 in	 Section	 1.6.2,	 filopodia	 are	 actin-rich	 structures	 that	 extend	 the	 membrane	
forward	 into	 the	 extracellular	 environment	 and	 help	with	 detecting	 growth	 factor	 gradients	
necessary	 for	 directional	 migration	 (Gerhardt	 et	 al.,	 2003).	 Extension	 of	 filopodia	 by	
endothelial	 cells	 is	 highly	 dynamic,	 and	 filopodia	 are	 turned	 over	 rapidly	 during	 endothelial	
sprouting.		
	
Cdc42	 endothelial-specific	 knockout	 mice	 show	 early	 embryonic	 death	 between	 E8.5	 and	
E10.5	(Hu	et	al.,	2011;	Barry	et	al.,	2015),	only	slightly	later	than	lethality	in	the	global	Cdc42	
knockout	 models	 (E7.5)(Chen	 et	 al.,	 2000;	 Wang	 et	 al.,	 2013).	 Early	 investigations	 in	
endothelial	 specific	 knockout	 embryos	 showed	 that	 embryos	 lacking	 endothelial	 Cdc42	 are	
smaller	 with	 fewer	 blood	 vessels,	 suggesting	 an	 important	 role	 for	 Cdc42	 in	 vascular	
development	(Hu	et	al.,	2011).	Barry	et	al.	subsequently	showed	that	early	deletion	of	Cdc42	
(E8.5)	 results	 in	 blocked	 endothelial	 lumen	 formation	 in	 the	 yolk	 sac,	 while	 later	 deletion	
(E14.5)	results	in	defects	in	endothelial	junctional	organization	and	vascular	integrity	(Barry	et	
al.,	2015).	Their	results	suggested	that	Cdc42	plays	a	role	in	angiogenic	remodelling,	filopodia	
formation	and	sprouting	through	two	mechanisms:	through	the	effectors	Pak2	and	Pak4	and	
their	control	of	the	actin	cytoskeleton	through	pMLC;	and	Cdc42	and	N-WASP	control	on	actin	
polymerization	and	EC	junctions	(Barry	et	al.,	2015).		
	
	
1.6.3.2	Rac1,	2,	3	
Rac1,	 2	 and	 3	 are	 all	members	 of	 Rac	 subclass	which	 are	 expressed	 differentially	 in	 tissues.	
Rac1	 is	 ubiquitously	 expressed,	Rac	2	 is	 only	 expressed	 in	hematopoietic	 cells,	while	Rac3	 is	
only	found	in	the	nervous	system	during	development.	Rac1	is	known	to	control	 lamellipodia	
and	membrane	protrusions.	Association	of	Rac	with	the	actin	nucleator	and	branching	complex	
ARP2/3	 drives	 these	 protrusions	 and	 are	 both	 found	 localized	 at	 the	 front	 of	 the	 growing	
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protrusion	(GG,	1999).	Rac	 is	 involved	in	membrane	ruffling	thus	impacting	on	migration	and	
also	controls	focal	adhesions	(Hall,	1998;	Steffen	et	al.,	2013).	
	
During	 angiogenesis,	 Rac	 has	 been	 shown	 to	 control	 the	 actin	 cytoskeleton	 during	 capillary	
formation	 in	 vitro	 in	 a	 3D	 angiogenesis	 assay	 (John	O.	 Connolly‡	 ,	 Nandi	 Simpson,*	 Lindsay	
Hewlett,	2002).	Endothelial	Rac1	deletion	using	Tie2	Cre	 is	embryonic	 lethal	mid-gestation	at	
E9.5	 due	 to	 defects	 in	 the	 development	 of	 the	 major	 vessels,	 and	 abnormal	 loss	 of	 small	
branched	vessels	both	in	the	yolk	sac	and	embryo	(Tan	et	al.,	2008).	Endothelial	cells	isolated	
from	the	Rac1	knockout	mice	showed	defects	in	a	range	of	important	processes	necessary	for	
angiogenesis	 including	migration,	adhesion	and	tubulogenesis	 (Tan	et	al.,	2008).	However,	 in	
another	 study	 using	 Tie1	 Cre	 recombinase	 to	 drive	 endothelial	 deletion,	 the	 investigators	
found	 that	 endothelial	 cell	 migration	 early	 during	 development	 was	 unaffected,	 whereas	
lymphangiogenesis	was	perturbed	with	Rac1	deletion.	This	was	due	to	improper	migration	of	
endothelial	 progenitors	 away	 from	 the	 cardinal	 vein	 early	 in	 development	 to	 form	 the	
lymphatic	 vascular	 system,	 and	 resulted	 blood	 filled	 lymphatic	 vessels	 and	 death	 in	 utero	
(D’Amico	et	al.,	2009).		
	
	
1.6.3.3	RhoA,	B	and	C	
RhoA	also	 functions	 in	 the	control	and	 regulation	of	 the	actin	cytoskeleton.	As	a	member	of	
the	Rho	subclass	(Rho	A,	B	and	C),	Rho	A	has	been	shown	to	control	aspects	of	cell	contractility	
(Ridley	 and	Hall,	 1992).	 Rho	 B	 on	 the	 other	 hand	 is	 involved	 in	 cytokine	 trafficking	 and	 cell	
survival	 while	 Rho	 C	 is	 important	 for	 cell	 motility	 and	 invasive	 behaviour	 (WHEELER	 and	
RIDLEY,	 2004).	 The	 three	 members	 of	 the	 subclass	 share	 structural	 similarities	 and	 may	
interact	with	the	same	effectors.	
	
RhoA	 is	 vital	 in	 development	 as	 evident	 by	 several	 mouse	 knockout	 studies	 (Herzog	 et	 al.,	
2011;	Jackson	et	al.,	2011;	Melendez	et	al.,	2011).	RhoA	knockout	embryonic	fibroblasts	show	
increased	cell	spreading	in	culture	compared	with	wild	type	fibroblasts	(Melendez	et	al.,	2011).	
RhoA	 loss	 in	keratinocytes	was	shown	to	be	essential	 for	contraction	and	directed	migration	
(Jackson	et	al.,	2011).	Studies	of	mouse	macrophages	show	that	loss	of	RhoA	or	RhoB	results	in	
defects	in	tail	end	retraction	during	cell	migration,	and	loss	of	the	ability	of	the	cell	to	retract	
lamellipodia	resulting	in	extreme	elongation	(Koenigs	et	al.,	2014).	Interestingly,	migration	was	
increased	suggesting	that	Rho	may	play	diverse	roles	in	the	regulation	of	migration	(Koenigs	et	
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al.,	2014).	The	diversity	of	roles	and	also	the	report	of	some	contradictory	findings	in	the	RhoA	
literature	may	be	explained	by	an	overlap	in	function	of	the	three	family	members,	and	a	level	
of	redundancy	amongst	them.				
	
Pharmacological	inhibitors	of	the	RhoA	pathway	are	known	to	block	angiogenesis	in	vitro	(van	
Nieuw	Amerongen	et	al.,	2003).	In	endothelial	cells,	RhoA	has	been	shown	to	be	essential	for	
angiogenesis	downstream	of	VEGF	 signalling	 (Bryan	et	al.,	 2010).	 It	has	been	 suggested	 that	
through	 its	 effector	 ROCK,	 RhoA	 activation	 results	 in	 cytoskeletal	 changes	 necessary	 for	
angiogenesis	driven	by	VEGF,	while	other	studies	have	shown	that	ROCK	inhibition	stimulates	
endothelial	 sprouting	and	angiogenesis	 (Abraham	et	al.,	2009).	 In	a	mouse	skin	angiogenesis	
model,	 dominant	 negative	 RhoA-expressing	 endothelial	 cells,	 stimulated	 by	 VEGF,	 failed	 to	
form	 tubules	 while	 the	 active	 RhoA-expressing	 cells	 formed	 tubules	 with	 lumens	 (Hoang,	
Whelan	 and	 Senger,	 2004).	 Interpretation	 of	 studies	 employing	 dominant	 negative	
counterparts	 of	 Rho	 GTPases	 may	 be	 complicated	 by	 interaction	 with	 GEFs	 that	 control	
different	Rho	family	members.	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	 34	
	
	
Figure	1.5	Overview	of	Rho/Rho	kinase	signalling	
Schematic	 of	 Rho	 GTPase	 activation	 via	 guanine	 nucleotide	 exchange	 factors	 (GEFs)	 and	
downstream	 effectors	 and	 their	 function.	 Activated	 ROCKI/II	 phosphorylates	 Myosin	 light	
chain	 (MLC)	 directly	 or	myosin	phosphate	 target	 subunit	 1	 (MYPT1)	 of	myosin	phosphatase.	
They	may	also	phosphorylate	LIM	kinase	(LIMK1,	2)	resulting	in	phosphorylation	of	Cofilin	and	
inhibition	 of	 its	 actin	 severing	 activities.	 Ezrin,	 radixin,	 and	 moesin	 (ERM)	 phosphorylation	
leads	 to	 changes	 in	 actin	 membrane	 linkage	 while	 Map2	 and	 Tau	 activation	 controls	
microtubule	stabilization.	Adapted	from	(Matsuoka	and	Yashiro,	2014).	
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1.6.4	Guanine	nucleotide	exchange	factors	(GEFs)	
Rho	 GTPases	 cycle	 between	 two	 states:	 inactive	 when	 GDP	 bound,	 and	 active	 when	 GTP	
bound.	 Regulation	 of	 activation	 status	 is	 under	 control	 of	 three	 classes	 of	 proteins:	 positive	
regulators,	 specifically	guanine	nucleotide	exchange	 factors	 (GEFs);	negative	regulators,	 such	
as	 GTPase	 activating	 proteins	 (GAPs);	 and	 guanine	 nucleotide	 dissociation	 inhibitors	 (GDIs).	
GEFs	 catalyse	 the	 exchange	 of	 GDP	 for	 GTP	 (Rossman,	 Der	 and	 Sondek,	 2005),	 while	 GAPs	
promote	 the	 intrinsic	 GTPase	 activity	 of	 Rho	 proteins	 and	 dissociation	 of	 GTP	 to	 allow	GDP	
binding	which	switching	GTPases	to	their	inactive	state.	GDIs	bind	to	Rho	GTPases	in	their	GDP	
bound	state	and	inhibit	both	activation	by	exchange	to	GTP,	and	translocation	to	the	plasma	
membrane	(Hoffman	and	Cerione,	2013).	GEFs	and	GAPs	introduce	a	high	level	of	complexity	
to	GTPase	signalling	cascades.	There	are	over	80	Rho	GEFs	with	many	able	to	activate	multiple	
GTPases.		
	
There	 are	 two	 families	 of	 Rho	 GEFs,	 the	 larger	 Dbl	 homology-pleckstrin	 homology	 (DH-PH)	
GEFs,	 and	 the	 dedicator	 of	 cytokinesis	 (DOCK)	 180	 family	 GEFs.	 In	 the	 DH-PH	 GEFs	 the	 DH	
domain	 catalyses	 the	 exchange	 of	 GDP	 for	 GTP	 thus	 activating	 the	 GTPase,	 while	 the	 PH	
domain	 is	 thought	 to	 control	 localization	 of	 the	 GEFs	 at	 the	 plasma	 membrane,	 through	
binding	 phosphoinositides	 (Maffucci	 and	 Falasca,	 2001).	 The	 Dbl	 family	 GEFs	 contain	
nucleotide	and	Mg2+	binding	pockets.	The	nucleotide	binding	(GTP	or	GDP)	controls	the	activity	
of	 the	GEF	while	 the	Mg2+	pocket	 is	 involved	 in	high-affinity	binding	of	GTP	and	discharge	of	
the	activated	Rho	GTPase.	A	similar	mechanism	of	catalysis	of	the	activation	process	has	been	
described	for	DOCK180	family	GEFs	(Yang	et	al.,	2009)	despite	the	lack	of	sequence	similarity	
between	the	activating	domains	of	the	two	family	GEFs.	Other	domains	may	vary	considerably	
amongst	different	DH-PH	GEFs,	which	are	 involved	 in	tissue	specificity,	dictate	what	GTPases	
the	GEFs	activate,	and	also	mediate	interactions	with	other	proteins,	or	mediate	Rho	GTPase	
independent	functions.			
	
The	DOCK180	family	GEFs,	named	after	the	prototypical	member	DOCK180	(DOCK1),	comprise	
11	family	members	(DOCK1-11).	Nucleotide	exchange	is	catalysed	by	the	DOCKER,	also	known	
as	 DHR2	 domain	 which	 bears	 no	 sequence	 similarity	 with	 the	 DH	 domain	 of	 DH-PH	 GEFs	
(Meller,	 Merlot	 and	 Guda,	 2005).	 The	 DHR1	 domain	 may	 be	 involved	 in	 the	 localization	 of	
DOCK180	 proteins	 at	 the	 plasma	membrane	 	 through	 binding	 to	 phosphatidylinositol	 3,4,5-
triphosphate	(Meller	et	al.,	2005).	
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DOCK180	 family	 GEFs	 are	 subdivided	 into	 four	 categories	 depending	 on	 their	 amino	 acid	
sequence	 homology:	 DOCK-A	 comprising	 DOCK180,	 DOCK2	 and	 DOCK5;	 DOCK-B	 comprising	
DOCK3	and	DOCK4;	DOCK-C	 (Zir;	 Zizimin	 like	DOCKs)	 comprising	DOCK6,	DOCK7	and	DOCK8;	
and	DOCK-D	 comprising	DOCK9	 (zizimin	 1),	DOCK10	 and	DOCK11	 (Meller,	Merlot	 and	Guda,	
2005).	Members	of	groups	A	and	B	possess	a	Src	homology	3	(SH3)	domain	at	the	N-terminus	
and	proline-rich	motif	at	the	C-terminus	for	protein	interactions	(Mayer,	2001).	Groups	A	and	
B	are	Rac	GEFs,	while	group	D	are	Cdc42	GEFs.	Group	C	are	 less	well	 studied	but	have	been	
shown	to	activate	both	Cdc42	and	Rac	(Miyamoto	et	al.,	2007).		
	
Regulation	of	DOCK180	proteins	is	in	part	carried	out	through	interaction	with	engulfment	and	
motility	 (ELMO)	 proteins,	 ELMO1,2	 and	 3	 are	 members	 of	 a	 family	 of	 scaffolding	 proteins.	
Studies	 have	 shown	 that	 DOCK180	 is	 only	 active	 towards	 Rac	 when	 in	 complex	 with	 ELMO	
(Brugnera	 et	 al.,	 2002).	 On	 the	 other	 hand,	 conflicting	 results	 have	 shown	 that	 an	 isolated	
DHR-2	domain	of	DOCK180	is	sufficient	for	activation	of	Rac	in	the	absence	of	ELMO	(Côté	and	
Vuori,	 2002).	 This	 could	 be	 down	 to	 the	 localisation	 role	 ELMO	 is	 playing	 on	 DOCK180,	
delivering	the	complex	to	different	compartments	of	the	cell	for	Rac	activation.		
	
	
1.6.4.1	DOCK4		
DOCK4	was	 first	 described	 as	 a	 tumour	 suppressor	 and	 activator	 of	 Rap	GTPase	 in	 a	mouse	
tumour	model	(Yajnik	et	al.,	2003).	In	this	study,	Yajnik	and	co-workers	showed	that	genomic	
deletion	of	DOCK4	in	mouse	NF2	and	TP53	tumour	models	resulted	in	defects	in	formation	of	
adherens	junctions	which	promote	tumorigenesis,	while	DOCK4	mutations	were	also	identified	
in	 human	 prostate	 and	 ovary	 tumours	 which	 failed	 to	 activate	 Rap1	 (Yajnik	 et	 al.,	 2003).	
Experiments	in	mouse	osteocarcinoma	cells	lacking	the	endogenous	Dock4	gene	showed	that	
expression	of	wild	type	but	not	mutant	DOCK4	reduced	tumour	cell	growth	and	migration	 in	
soft	agar	(Yajnik	et	al.,	2003).		
	
Further	 studies	 showed	DOCK4	 has	 the	 ability	 to	 activate	 the	 Rho	GTPase,	 Rac1	 (Hiramoto,	
Negishi	and	Katoh,	2006).	Hiramoto	and	co-workers	showed	that	overexpression	of	DOCK4	in	
mouse	 fibroblasts	 induced	Rac1	activation,	which	was	 further	 regulated	by	RhoG	 (Hiramoto,	
Negishi	and	Katoh,	2006).	They	went	on	to	show	that	when	the	catalytic	DHR2	domain	(Figure	
1.6)	was	deleted,	there	was	reduced	interaction	between	DOCK4	and	Rac1.	The	RhoG	effector	
ELMO	 facilitates	 this	 DOCK4	mediated	 activation	 of	 Rac1	 by	 acting	 as	 a	 scaffolding	 protein.	
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RhoG	 activation	 promotes	 the	 binding	 of	 ELMO	 to	 the	 sh3	 domain	 of	 DOCK4.	 This	 in	 turn	
allows	translocation	of	DOCK4	to	the	plasma	membrane	where	it	activates	Rac1	and	drives	cell	
migration	(Hiramoto,	Negishi	and	Katoh,	2006).		
	
	
1.6.4.2	DOCK9		
DOCK9	(Zizimin	1)	is	another	member	of	the	DOCK	family	of	GEFs	which	belongs	to	group	D	of	
DOCK180	family	GEFs.	 It	was	first	discovered	through	an	affinity	proteomic	approach	 looking	
at	 novel	 activators	 of	 Cdc42	 in	 fibroblasts	 and	 was	 shown	 to	 be	 responsible	 for	 inducing	
filopodia	(Meller	et	al.,	2002).	Like	DOCK4,	DOCK9	contains	a	DHR1	and	DHR2	domain		(Yang	et	
al.,	2009),	and	additionally	a	pleckstrin	homology	(PH)	domain	(Figure	1.6).	Both	the	DHR1	and	
PH	 domains	 are	 involved	 in	 translocation	 of	 DOCK9	 to	 the	 plasma	 membrane	 (Kuramoto,	
Negishi	and	Katoh,	2009).		
	
DOCK9	has	been	shown	to	be	responsible	for	cellular	protrusive	activity	and	essential	for	the	
growth	of	dendrites	 in	neuronal	cells,	while	depletion	of	DOCK9	 in	glioblastoma	cells	 inhibits	
formation	of	pseudopodia	resulting	in	reduced	invasion	in	vivo	(Kuramoto,	Negishi	and	Katoh,	
2009;	Hirata	et	al.,	2012).		
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Figure	1.6	DOCK4	and	DOCK9	protein	domain	maps	
DOCK4	and	DOCK9	are	members	of	the	DOCK	family	of	GEFs	and	therefore	contain	the	DHR1	
and	DHR2	domains.	The	DHR2	domain	 is	responsible	for	activation	of	Rho	GTPases	while	the	
DHR1	domain	is	 involved	in	localization.	DOCK4	belongs	to	the	subgroup	B	of	the	DOCK	GEFs	
and	contains	a	N-terminal	SH3	domain	and	C-terminal	proline	rich	sequence	motif	that	binds	
SH3	domains	and	mediate	protein-protein	interactions	respectively.	DOCK9	is	a	member	of	the	
D	 subclass	 (Zizimin)	 of	 DOCKs	 and	 possess	 a	 PH	 domain	 responsible	 for	 interaction	 with	
phosphoinositides	and	binding	the	plasma	membrane.		
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1.6.5	Rho	effectors	
Rho	GTPases	 are	 involved	 in	 a	 huge	 range	of	 signalling	pathways	 controlling	diverse	 cellular	
functions.	When	activated,	Rho	proteins	have	the	ability	to	interact	with	multiple	downstream	
effectors	which	coordinate	the	diverse	cellular	responses	and	contribute	to	the	specificity	of	a	
particular	signal	transmitted	by	a	Rho	protein.	The	effector	proteins	typically	bind	Rho	GTPases	
in	 their	 GTP-bound	 form	 and	 may	 remain	 bound	 for	 activity,	 or	 gain	 activity	 by	
phosphorylation	or	binding	to	another	activation	protein	(Bishop	and	Hall,	2000).		
	
	
1.6.5.1	Rho	associated	coiled	coil	kinases	(ROCK1	and	2)	
The	Rho	associated	kinases	of	which	there	are	two,	ROCK1	and	ROCK2	(collectively	referred	to	
as	ROCK),	are	highly	conserved	serine	threonine	kinases	that	are	involved	in	signalling	cascades	
that	control	actin	dynamics.	They	share	a	64%	overall	identity	in	humans	with	89%	identity	in	
their	 kinase	 domains	 (Figure	 1.7).	 Activation	 occurs	 through	 interaction	with	 RhoA,	 B,	 or	 C,	
through	the	Rho	binding	domain	(RBD),	while	 inactivation	can	take	place	through	 interaction	
with	RhoJ	 (another	Rho	family	member),	RAD	(a	member	of	 the	Ras	 family	overexpressed	 in	
muscle	of	type	II	diabetic	humans),	and	GEM	(another	Ras	family	member)	at	sites	other	than	
the	RBD	of	the	ROCK	proteins	(Riento	and	Ridley,	2003).			
	
One	of	the	most	common	mechanisms	of	effector	activation	by	GTPases	is	disruption	of	auto-
inhibitory	 interactions	 to	 expose	 functional	 domains	 within	 the	 effector	 (Bishop	 and	 Hall,	
2000).	This	is	true	for	ROCK,	normally	found	folded	in	an	auto-inhibitory	conformation,	which	
shields	the	kinase	domain.	Binding	of	Rho	proteins	to	the	Rho	binding	domain	(RBD)	of	ROCK	
relieves	 auto-inhibition	 of	 the	 kinase	 domain	 for	 activity	 (Riento	 and	 Ridley,	 2003).	 Auto-
phosphorylation	of	ROCK1	at	Ser1333	and	ROCK2	at	Ser1366	reflects	the	activation	status	of	
the	 kinases	 (Figure	 1.7).	 Other	 phosphorylation	 sites	 on	 ROCK2	 increase	 (Thr967,	 Ser1099,	
Ser1133,	 or	 Ser1374)	 or	 decrease	 (Thy722)	 its	 activation	 status	 (Hartmann,	 Ridley	 and	 Lutz,	
2015).	
	
ROCK	 is	 one	 of	 the	 main	 downstream	 effectors	 of	 Rho-mediated	 actin	 cytoskeleton	
rearrangements,	 stress	 fibres	 and	 focal	 adhesions	 (Chrzanowska-Wodnicka	 and	 Burridge,	
1996).	 Through	 its	 kinase	 domain,	 ROCK	 phosphorylates	 and	 activates	 further	 downstream	
targets	 including	 the	 Lim	 kinases,	Map2	 tau	 and	myosin	 light	 chain	 (MLC)	 which	 impact	 on	
actin	 polymerization,	 protrusive	 activity	 and	 cellular	 contractility.	 ROCKs	may	 phosphorylate	
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MLC	 directly	 or	 indirectly	 through	 inhibitory	 phosphorylation	 of	myosin	 phosphatase	 target	
subunit	1	(MYPT1)	which	dephosphorylates	MLC2	(a	regulatory	 light	chain	of	myosin)	(Figure	
1.5)(Ito	 et	 al.,	 2004).	 Hence,	 they	 increase	 actomyosin	 contractile	 force	 generation	 by	
phosphorylation	 of	 MLC2,	 which	 causes	 a	 ATP-dependant	 change	 in	 myosin	 structure	 and	
shifts	its	position	in	relation	to	actin,	resulting	in	a	contractile	pulling	on	actin	filaments.	ROCK	
and	myosin	binding	subunits	play	roles	 in	many	downstream	Rho	signalling	outputs	 including	
stress	fibres,	focal	adhesions,	smooth	muscle	cell	contraction	and	vasodilation	of	blood	vessels	
(Hartmann,	Ridley	and	Lutz,	2015).	Another	target	of	ROCK	is	LIM	kinase	1	and	2,	which	upon	
phosphorylation,	 phosphorylate	 cofilin	 and	 inhibit	 its	 F-actin	 cleaving	 ability	 (Ohashi	 et	 al.,	
2000)	 (Figure	1.5).	Further	 reports	have	 implicated	ROCK	and	myosin	 light	chain	signalling	 in	
cadherin-based	 adhesion	 and	 regulation	 of	 morphological	 and	 permeability	 changes	 of	
endothelial	cells	(McKenzie	and	Ridley,	2007).		
	
Expression	of	the	two	isoforms,	ROCK1	and	ROCK2,	differs	depending	on	the	tissue.	ROCK1	is	
ubiquitously	 expressed	 in	 all	 tissues	 except	 for	 the	 brain	 and	 muscles	 whereas	 ROCK2	 is	
expressed	 heavily	 in	 the	 brain	 and	 muscles	 and	 also	 in	 the	 heart,	 blood	 vessels,	 lung	 and	
placenta	 (Nakagawa	et	al.,	1996;	Montalvo	et	al.,	2013).	Similar	roles	 for	each	ROCK	 isoform	
have	 been	 reported	 including	 roles	 in	 actin	 cytoskeleton	 organization,	 migration,	 cellular	
morphology	 and	 progression	 of	 the	 cell	 cycle,	 apoptosis,	 and	 extracellular	 matrix	 assembly	
(ORLANDO,	STONE	and	PITTMAN,	2006;	Shi	and	Wei,	2007;	Mong	and	Wang,	2009;	 Inaba	et	
al.,	 2010;	 Leong	 et	 al.,	 2011).	 However,	 the	 knockdown	 of	 individual	 paralogues	 of	 either	
ROCK1	 or	 ROCK2	 and	 less	 use	 of	 the	 pan-ROCK	 inhibitors	 e.g.	 Y27632,	 have	 highlighted	
isoform-specific	roles	in	endothelial	cells.	Co-staining	for	ROCK1	and	ROCK2	in	pancreatic	islet	
endothelial	cells	in	vitro	has	shown	distinct	localisation	of	both	paralogues	suggesting	differing	
roles	within	 this	 cell	 type.	 In	 the	same	study	 it	was	shown	that	ROCK2,	and	not	ROCK1,	was	
responsible	for	the	phosphorylation	of	the	actin	regulating	proteins	MBS	and	cofilin,	and	also	
that	 ROCK2	 knockdown	 cells	 displayed	 better	 survival	 rates	 under	 serum	 starvation	 when	
compared	to	ROCK1	(Montalvo	et	al.,	2013).		This	was	shown	to	be	due	to	a	ROCK2	reduction	
in	caspase	3	cleavage	not	seen	with	ROCK1.		
	
ROCK1	 and	 ROCK2	 global	 knockout	 mice	 have	 also	 been	 generated	 and	 display	 distinct	
phenotypes.	The	ROCK2	global	knockout	was	the	first	to	be	described	(Thumkeo	et	al.,	2003)	
and	showed	that	over	90%	of	Rock2-/-	embryos	died	 in	utero	due	to	defects	 in	the	placental-
embryo	 interaction.	 The	mice	 that	 survived	were	 smaller	 but	 did	 not	 show	 any	 histological	
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difference	to	the	wild	type	and	subsequently	caught	up	later	in	growth	(Thumkeo	et	al.,	2003).	
ROCK1	global	knockout	mouse	models	showed	a	less	severe	phenotype	than	ROCK2.	Deletion	
of	ROCK1	 resulted	 in	global	developmental	defects	 including	 failure	of	 closure	of	 the	eyelids	
and	of	 the	ventral	body	wall	 (Shimizu	et	al.,	2005).	Defects	 in	actin	cytoskeletal	organisation	
and	MLC	phosphorylation	were	shown	to	be	responsible	for	this	phenotype.		
	
	
1.6.5.2	Rho	signalling	in	angiogenesis	and	lumen	formation	
During	 lumen	opening	 and	expansion,	 control	 of	Rho	GTPase	 signalling	 responsible	 for	 actin	
based	shape	changes	 is	essential.	The	regulation	of	RhoA	has	been	shown	to	have	effects	on	
lumenisation,	both	positive	and	negative.	Activation	of	RhoA	has	been	shown	to	lead	to	lumen	
collapse	 in	 vitro	 through	 control	of	microtubules	 (Bayless	 and	Davis,	 2004).	 Xu	et	 al	 showed	
that	mice	lacking	Raspi1	had	increased	RhoA/	ROCK/	myosin	II	activity	and	blockade	of	Cdc42	
and	Rac1	and	was	responsible	for	the	loss	of	lumens	(Bayless	and	Davis,	2002;	Xu	et	al.,	2011).		
The	same	effect	was	seen	with	downregulation	of	RhoA	downstream	of	Rasip1	and	ArhGAP29,	
which	results	in	promotion	of	lumen	formation	in	these	mice	(Xu	et	al.,	2011).	Likewise,	RhoA	
induced	actomyosin	contraction	downstream	of	PP2A-Ba	has	shown	to	be	a	negative	regulator	
of	lumen	formation	(Martin	et	al.,	2013).	Conversely,	other	reports	have	shown	opposite	roles	
for	 RhoA	 in	 lumen	 formation.	 Hoang	 et	 al	 showed	 that	 a	 dominant	 negative	 form	 of	 RhoA	
reduced	the	number	of	 lumenised	blood	vessels	 in	a	mouse	skin	angiogenesis	model	(Hoang,	
Whelan	and	Senger,	2004),	although	these	studies	are	complicated	by	potential	interaction	of	
dominant	negative	RhoA	with	GEFs	 for	other	GTPases.	Another	 report	suggested	that	during	
the	formation	of	the	mouse	dorsal	aorta,	RhoA	had	an	essential	role	in	activation	of	ROCK	and	
localization	of	myosin	II	to	actin	filaments	surrounding	the	lumen	to	initiate	cell	shape	changes	
and	lumen	opening	(Strilić	et	al.,	2009).			
	
Endothelial	 and	mural	 cell	 contractility	play	 important	 roles	 in	 regulating	vessel	 stability	and	
diameter.	 The	 actin-myosin	 interaction	 in	 endothelial	 cells	 is	 controlled	 by	 MLC	
phosphorylation	 (Cai	et	 al.,	 1998)	 and	MLC	 phosphorylation	 in	 ECs	 is	 controlled	 by	 ROCKI/II	
(Abraham	 et	 al,	 2009).	 Control	 of	 contractility	 through	 myosin	 plays	 important	 roles	 in	
endothelial	permeability,	sprouting	(Abraham	et	al,	2009),	and	has	also	been	shown	recently	
to	 be	 important	 for	 cell	 curvature	 regulated	 branching	 morphogenesis	 in	 3D	 collagen	 gels	
(Elliott	et	al.,	2015).		
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Figure	1.7	ROCK1	and	ROCK2	structure,	homology	and	phosphorylation	sites.		
Both	ROCK1	and	ROCK2	contain	N-terminal	kinase	domain	and	C-terminal	PH	domain	with	a	
cysteine	rich	(CRD)	domain	therein.	Between	these	domains	the	coiled-coil	region	contains	the	
Rho	binding	domain	(RBD).	Activation	of	 the	kinases	 is	 through	binding	of	Rho	A,	B,	C	to	the	
RBD	release	of	the	auto	inhibitory	folding	complex	(not	shown)	they	are	held	in,	and	freeing	of	
the	 kinase	 for	 activity.	 ROCK1	 and	 ROCK2	 share	 65%	 overall	 homology	 with	 the	 highest	
sequence	homology	in	the	kinase	domains.	Adapted	from	(Hartmann,	Ridley	and	Lutz,	2015).	
Stars	indicate	phosphorylation	sites.	
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1.7	Primary	cilia	
Cilia	 are	 specialized	 cell	 organelles	 found	 on	 nearly	 all	 cells	 of	 the	 body	 that	 function	 as		
extracellular	antennae	(Christensen	et	al.,	2007).	They	are	microtubule-based	organelles	that	
have	a	wide	range	of	diverse	functions	ranging	from	mechanical	 functions	such	as	sensing	of	
fluid	flow	and	pressure,	to	sensing	of	chemicals	and	light	(Singla,	Veena,	2006).	There	are	two	
separate	forms	of	cilia	described	to	date.	The	best-described	form	is	the	motile	cilium,	which	
can	be	present	in	large	numbers	on	epithelial	cells	of	the	airways	and	oviduct.	These	cilia	are	
motile	and,	 in	the	case	of	the	airway	epithelium,	act	to	move	mucus	away	from	the	 lungs.	A	
second	form	of	cilium	is	the	non-motile	sensory	cilium,	also	known	as	the	primary	cilium.	The	
vertebrate	 primary	 cilium	 is	 a	 solitary	 hair-like	 structure	 that	 protrudes	 from	 the	 plasma	
membrane	 into	 the	 extracellular	 space,	 and	 functions	 for	 detecting	 diverse	 chemical	 and	
mechanical	stimuli	(Christensen,	Clement,	Satir,	&	Pedersen,	2012,	Praetorius	&	Spring,	2001).	
Primary	cilia	are	intricately	linked	with	the	cell	cycle	as	the	base	of	the	cilium	is	formed	from	
the	mother	centriole	and	it	is	usually	expressed	during	cell	cycle	arrest	in	G0	(Goto,	Inoko	and	
Inagaki,	2013).		
	
	
1.7.1	Primary	cilia	structure	and	function	
The	microtubule	 configuration	of	both	motile	 and	non-motile	 cilia	 have	been	well-described	
and	show	minor	differences.	They	consist	of	anchoring	basal	bodies	which	originate	from	the	
mother	 centriole	and	are	 situated	near	 the	plasma	membrane.	 From	 this	basal	body	anchor	
then	 protrudes	 the	 axoneme,	 composed	 of	 microtubules	 surrounded	 by	 specialized	 plasma	
membrane	 which	 protrudes	 beyond	 the	 cell	 boundary	 and	 out	 into	 the	 extracellular	 space	
(Figure	 1.8).	 Between	 the	 basal	 body	 and	 the	 axoneme	 is	 a	 specialized	 region	 termed	 the	
transition	 zone	 which	 controls	 what	 molecules	 and	 proteins	 enter	 and	 exit	 the	 axonemal	
microtubules	 and	 the	 ciliary	membrane.	 Both	 types	 of	 cilia	 are	 described	 and	 identified	 by	
their	axonemal	microtubule	organisation.	Motile	cilia	have	a	“9	+	2”	microtubule	make-up	as	
their	 axoneme	 contains	 9	 pairs	 of	microtubules	 surrounding	 an	 inner	 pair.	 Primary	 cilia	 lack	
this	 inner	 pair	 of	microtubule,	 and	 have	 a	 “9	 +	 0”	make	 up	 as	 well	 as	 lacking	many	 of	 the	
structural	 components	 found	 in	 motile	 cilia	 including	 the	 dynein	 arms	 responsible	 for	
producing	their	motility.		
	
Assembling	 of	 the	 primary	 cilia	 involves	 intricate	 transport	 of	 proteins	 and	 structural	
components	 up	 and	 down	 the	 microtubule	 axoneme.	 This	 shuttling	 is	 carried	 out	 by	
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intraflagellar	 transport	 proteins	 (IFTs)	 and	 comprises	 two	 modes	 of	 motion	 along	 ciliary	
microtubules	though	IFT-A	and	IFT-B	complexes.	 IFT-B	anterograde	motion	 is	towards	the	tip	
of	the	cilia	and	uses	heterotrimeric	kinesin-2	motors,	while	the	IFT-A	retrograde	motion	back	
towards	 the	 cilia	 base	 is	 carried	 out	 by	 cytoplasmic	 dynein	 1b	 motors	 (Pedersen	 and	
Rosenbaum,	 2008).	 Assembly	 of	 the	 primary	 cilium	 and	 transport	 of	 the	 necessary	 building	
blocks	 up	 the	 axoneme	 is	 carried	 out	 by	 the	 IFT-B	 complexes,	 while	 signalling	 components	
from	the	ciliary	membrane	are	shuttled	down	the	axoneme	towards	the	cilium	base	by	the	IFT-
A	complexes	(Pedersen	and	Rosenbaum,	2008).	Due	to	the	importance	of	these	IFT	proteins	in	
construction	and	maintenance	of	primary	cilia,	defects	 in	 their	 regulation	can	 lead	 to	 severe	
developmental	defects.			
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Figure	1.8	The	structure	and	compartments	of	the	primary	cilium.	
The	 primary	 cilium	 acts	 as	 a	 cellular	 antenna,	 responsible	 for	 detecting	 a	 wide	 range	 of	
external	 influences	 including	sheer	stress,	pressure,	and	both	chemical	and	mechanical	ques.	
The	primary	cilium	is	anchored	in	the	basal	body	by	the	mother	and	daughter	centrioles	from	
where	doublet	microtubules	originate	and	grow	through	the	transition	zone	to	form	the	ciliary	
axoneme.	 Shipping	 of	 cargo	 up	 and	 down	 the	 ciliary	 microtubules	 is	 carried	 out	 by	
Intraflagellar	transport	proteins	IFTs.	The	ciliary	membrane	is	continuous	with	the	cell	plasma	
membrane,	 however,	 a	 selection	 of	 molecules	 to	 be	 displayed	 here	 takes	 place	 in	 the	
transition	 zone,	 resulting	 in	 exclusivity	 of	 expression	 of	 ciliary	molecules	 on	 this	membrane	
alone.	Adapted	from	(Malicki	and	Johnson,	2016).		
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Once	thought	to	be	evolutionary	defunct,	the	role	of	the	primary	cilia	was	recently	highlighted	
by	 identification	 of	 a	 collection	 of	 genetic	 diseases	where	 genes	 involved	 in	 cilia	 growth	 or	
function	have	been	dysregulated	or	mutated.	These	rare	recessive	human	disorders	known	as	
ciliopathies	 –	 complex	 developmental	 syndromes	 that	 can	 involve	 cystic	 kidneys,	 obesity,	
mental	retardation,	blindness,	and	various	development	malformations	-	have	been	shown	to	
be	 caused	 by	 defects	 in	 proteins	 localized	 to	 cilia	 and	 ciliary	 basal	 bodies	 (Baker	 &	 Beales,	
2009).	 Primary	 cilia	 are	 now	 known	 to	 play	 important	 regulatory	 roles	 in	 development	 and	
tissue	 homeostasis.	 Recent	 studies	 by	 Berbari	 et	 al.	 (Berbari,	 O’Connor,	 Haycraft,	 &	 Yoder,	
2009)	have	shown	that	primary	cilia	are	involved	in	regulating	key	signalling	pathways	during	
development.	 Primary	 cilia	 have	 been	 shown	 to	 be	 essential	 for	 the	 proper	 function	 of	 the	
Sonic	Hedgehog	(Shh)	signalling	pathway,	the	canonical	Wnt/b-catenin	signalling	pathway	and	
the	PDGF	signalling	pathway	(Christensen	et	al.,	2007)	to	name	a	few	of	the	best	described.		
	
The	Hedgehog	signalling	pathway	plays	a	 fundamental	 role	 in	mammalian	development,	and	
particularly	 in	 tissue	 morphogenesis	 and	 differentiation.	 As	 well	 as	 playing	 developmental	
roles,	the	Hedgehog	pathway	is	also	involved	in	maintaining	adult	stem	cells	and	can	become	a	
driver	of	tumourigenesis	if	dysregulated.	During	Hedgehog	signalling	two	of	its	most	important	
proteins,	Smoothened	(SMO)	and	Patched	(PTCH),	have	been	shown	to	localise	to	the	primary	
cilium	 (Jynho	Kim	et	al.,	 2015).	Recently	 IFT	proteins	have	been	 shown	 to	drive	 this	primary	
cilium	Hedgehog	signalling	through	responses	to	Hedgehog	ligands	that	are	mediated	through	
receptors	found	on	the	primary	cilium	(He,	Agbu	and	Anderson,	2016).	 In	the	absence	of	the	
Sonic	 Hedgehog	 ligand	 (SHH),	 SMO	 is	 unable	 to	 locate	 to	 the	 primary	 cilium	 membrane.	
However,	when	the	SHH	ligand	is	present,	it	binds	PTCH	and	allows	SMO	translocation	to	the	
cilium	 and	 activation	 of	 the	 GLI	 transcription	 factors	 (Oro,	 2007).	 Interestingly,	 Hedgehog	
signalling	 has	 been	 shown	 to	 play	 major	 roles	 in	 endothelial	 cell	 biology	 from	 regulating	
HUVEC	 survival	 (Zhu	 et	 al.,	 2015),	 to	 mediating	 tumour	 associated	 angiogenesis	 and	
endothelial	dysfunction	leading	to	diabetic	neuropathy	(Chapouly	et	al.,	2016).		
	
As	 with	 the	 Hedgehog	 pathway,	 the	 Wnt	 signalling	 pathway	 is	 highly	 conserved	 through	
evolution	 and	 fundamental	 in	 development	 through	 control	 of	 tissue	 patterning	 and	 cell	
differentiation	 lineages	(Sineva	and	Pospelov,	2014).	The	Wnt	signalling	pathway	has	3	arms:	
the	 canonical	 Wnt	 pathway,	 the	 non-canonical	 planar	 cell	 polarity	 pathway,	 and	 the	 non-
canonical	Wnt/calcium	pathway.	The	planar	cell	polarity	pathway	has	the	most	evidence	for	an	
interaction	with	primary	cilia	through	Wnt	signalling	receptors	like	Frizzled,	and	other	proteins	
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being	located	on	the	ciliary	axoneme	and	at	the	ciliary	base	(Satir,	Pedersen	and	Christensen,	
2010).		
	
Activation	 of	 the	 PDGF	 signalling	 pathway	 plays	 important	 roles	 in	 angiogenesis-related	
functions	including	development,	wound	healing	and	tumour	angiogenesis	(Bodle	and	Loboa,	
2016).	 Similar	 to	 the	Wnt	 pathway,	 ligands	 and	 receptor	 for	 PDGF	 signalling	 localize	 at	 the	
primary	cilium.	In	fibroblasts,	it	has	been	shown	that	the	PDGF	receptor	PDGFa	localizes	at	the	
primary	cilium	during	growth,	and	activation	of	this	receptor	stimulates	downstream	signalling	
to	Akt	and	Mek1/2-Erk1/2	within	and	the	cilium	and	at	the	basal	body.	Fibroblasts	lacking	the	
essential	 IFT	protein	IFT88	(also	known	as	Tg737)	fail	to	grow	regular	cilia	and	lose	this	PDGF	
signalling	cascade	(Schneider	et	al.,	2005).		
	
An	 increasing	 number	 of	 developmental	 and	 homeostatic	 pathways	 are	 being	 linked	 to	 the	
structure	 and	 function	 of	 primary	 cilia.	 The	 extent	 of	 the	 importance	 of	 this	 cell	 organizing	
structure	is	still	unclear,	and	further	studies	are	likely	to	highlight	further	roles	of	the	primary	
cilium,	and	how	they	may	provide	targets	for	novel	therapies.		
	
	
1.7.2	Endothelial	cilia	and	their	role	in	sensing	blood	flow	
To	date	there	have	been	no	reports	of	endothelial	cells	bearing	motile	cilia,	but	primary	cilia	
have	 been	 reported	 on	 endothelial	 cells	 in	 the	 literature	 for	 more	 than	 40	 years	 (Mollo,	
Canese,	&	Bartoli,	1969).	Endothelial	cells	possess	cilia	that	have	the	9+0	microtubule	bundle	
arrangement	that	extend	from	the	basal	body,	and	are	therefore	morphologically	classified	as	
primary	 cilia	 (Egorova,	 van	 der	 Heiden,	 Poelmann,	 &	 Hierck,	 2012).	 Primary	 cilia	 found	 on	
endothelial	cells	are	typically	shorter	than	those	on	epithelial	cells,	 in	the	range	of	1	to	5µm,	
and	have	been	described	as	being	more	embedded	 in	 the	plasma	membrane	and	within	 the	
ciliary	pocket	(Basten	&	Giles,	2013).	The	cilium	typically	protrudes	from	the	luminal	or	apical	
side	of	the	cell	into	the	lumens	of	the	vessels,	although	sometimes	it	appears	to	protrude	from	
the	basal	 side	 into	 the	basement	membrane	and	underlying	extracellular	matrix	 (Egorova	et	
al.,	2012).		
	
Endothelial	 cells	within	 the	vascular	network	are	 in	direct	contact	with	blood	and	constantly	
exposed	to	flow.	They	are	able	to	sense	the	frictional	force	exerted	on	the	vessel	walls,	termed	
shear	 stress.	 Sensing	 of	 blood	 flow	 and	 pressure	 by	 endothelial	 cells	 is	 an	 important	
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physiological	response	that	controls	blood	vessel	diameter	and	patterning	(Jones,	le	Noble	and	
Eichmann,	 2006;	 Ando	 and	 Yamamoto,	 2013).	 The	 endothelial	 response	 to	 shear	 stress	 is	
necessary	 to	maintain	homeostasis	of	 the	 circulatory	 system,	while	 loss	of	 the	 response	 can	
lead	 to	 the	 development	 of	 vascular	 diseases	 such	 as	 hypertension,	 thrombosis,	 aneurysms	
and	atherosclerosis	(Ando	and	Yamamoto,	2013).	It	has	been	shown	that	a	sudden	increase	in	
sheer	 stress	 originating	 from	blood	 flow	may	 increase	 vessel	 diameter,	while	 a	 reduction	 in	
diameter	can	be	seen	from	the	 increased	pressure	within	the	blood	vessel	(Bolz	et	al.,	2000;	
Pyke	 and	Tschakovsky,	 2005).	 The	exact	mechanism	by	which	endothelial	 cells	 sense	 flow	 is	
undetermined,	but	many	hypotheses	have	been	gaining	experimental	support,	such	as	sensing	
flow	 through	 ion	 channels,	 G-proteins	 and	 their	 receptors;	 adhesion	 molecules,	 the	
cytoskeleton,	hemodynamic	drag	of	the	nucleus	caveolae;	and	primary	cilia	(Tkachenko	et	al.,	
2013)(Ando	and	Yamamoto,	2013).	These	findings	support	the	 idea	that	endothelial	cells	can	
sense	 local	 changes	 in	 flow	 and	 pressure,	 and	 also	 act	 upon	 this	 cue	 by	 communicating	 a	
response	to	the	surrounding	mural	cells	to	cause	significant	changes	in	vessel	morphology.		
	
Primary	 cilia	 have	 been	 identified	 in	 vivo	 on	 arteries	 and	 other	 blood	 vessels	 (Bystrevskaia,	
Antonov	and	Perov,	1987;	Haust,	1987)	and	have	been	reported	in	vitro	in	cultured	endothelial	
cells	(Iomini	et	al.,	2004;	Hierck	et	al.,	2008).	Early	studies	have	shown	that	endothelial	cells	in	
vitro	can	sense	mechanical	stimuli,	such	as	sheer	stress,	through	their	primary	cilium	(Hierck	et	
al.,	2008).	Flow-sensing	ion	channels	like	the	polycystin	family	(Pkd1	and	Pkd2)	localize	to	the	
ciliary	 membrane	 and	 are	 known	 to	 be	 able	 to	 mechanosense.	 Defects	 in	 either	 of	 these	
proteins	 leads	to	(ADPKD)	autosomal	dominant	polycystic	kidney	disease,	whereby	their	cells	
retain	 normal	 renal	 cilia	 but	 loss	 of	 flow	 recognition	 cause	 cysts	 to	 develop	 in	 the	 kidneys	
(Kotsis,	 Boehlke	 and	 Kuehn,	 2013).	 These	 ion	 channels	 are	 also	 found	 on	 endothelial	 cilia	
(AbouAlaiwi	et	al.,	2009,	2011),	and	interestingly	the	majority	of	ciliopathies	described	to	date	
all	have	a	vascular	phenotype.	In	endothelial	cells	isolated	from	mouse	models	which	lack	cilia	
(due	to	knock-out	of	Ift88,	also	known	as	Tg737),	and	from	polycystic	kidney	mice	(that	retain	
cilia	but	have	loss	of	polycystin1	and	polycystin2)	showed	reduced	or	no	response	to	fluid	flow	
induced	 sheer	 stress	 in	 vitro	 (Nauli	 et	 al.,	 2008).	 Similarly,	 removal	 of	 the	 primary	 cilium	 in	
MCDK	cells	abolishes	their	response	to	flow	(Praetorius	and	Spring,	2003).			
	
Very	 early	 flow	 sensing	 during	 vascular	 development,	 when	 forces	 are	 small,	 has	 also	 been	
linked	with	endothelial	primary	cilia	in	zebrafish	(Goetz	et	al.,	2014).	Studies	identified	primary	
cilia	 in	 the	 dorsal	 aorta	 of	 zebrafish	 bending	 under	 low	 levels	 of	 flow.	 They	 showed	 that	 a	
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number	 of	 zebrafish	 morphants	 (Zebrafish	 treated	 with	 a	 antisense	 oligonucleotide	 to	
temporarily	knockdown	a	gene	of	interest)	deficient	in	flow,	contractile	hearts,	or	the	Pkd2	ion	
channel	all	had	reduced	levels	of	endothelial	calcium	signalling	important	for	vasodilation,	but	
also	that	this	early	hemodynamic	response	to	flow	is	fundamental	in	downstream	angiogenesis	
and	 loss	of	 leads	 to	defects	 in	proper	angiogenic	 sprouting,	branching	and	 looping	 (Goetz	et	
al.,	 2014).	 	 In	 another	 zebrafish	 model,	 loss	 of	 proper	 cilia	 response	 through	 mutant	 IFT	
proteins,	 increased	 the	 chances	 of	 intracranial	 haemorrhage	 which	 could	 be	 completely	
rescued	 by	 endothelial	 specific	 re-expression	 of	 the	 IFT	 genes	 (Kallakuri	 et	 al.,	 2014).	
Interestingly,	this	research	also	linked	the	Hedgehog	signalling	pathway	with	vascular	integrity	
through	 Hedgehog	 inhibition	 resulting	 in	 increased	 intracranial	 haemorrhage	 and	 activation	
rescuing	of	the	phenotype	(Kallakuri	et	al.,	2014).		
	
	
1.7.3	Cilia	and	actin	cytoskeleton	
Cilia	 are	primarily	microtubule-based	 structures	but	 exciting	 recent	evidence	 is	 linking	actin-
related	activities	with	ciliogenesis	and	cilia	function.	The	exact	mechanisms	involved	in	actin-
linked	regulation	and	control	of	cilia	are	not	well-described.	In	most	cases	and	cell	types,	cells	
only	 ciliate	 while	 not	 actively	 proliferating.	 To	 induce	 ciliogenesis	 in	 cultured	 cells	 they	 are	
typically	taken	out	of	active	cycling	by	either	growth	to	a	high	confluence,	serum	starvation,	or	
a	 combination	 of	 both.	 However,	 recent	 evidence	 also	 suggest	 that	 other	 factors	 like	 cell	
shape,	spreading	and	extracellular	matrix	density	may	also	have	a	significant	influence	on	the	
cells	ability	to	ciliate	(Pitaval	et	al.,	2010).	In	most	cases	actin	polymerisation	has	been	shown	
to	 be	 an	 inhibitor	 of	 ciliogenesis,	 while	 destabilization	 of	 the	 actin	 cytoskeleton	 has	 the	
opposite	 effect	 and	 induces	 ciliogenesis.	 Controllers	 of	 actin	 cytoskeletal	 dynamics	 routinely	
show	 up	 as	 effectors	 of	 ciliogenesis.	 Large	 scale	 siRNA	 screens	 looking	 at	 genes	 involved	 in	
ciliogenesis	 have	 shown	 actin	 related	 genes	 to	 be	 both	 positive	 and	 negative	 regulators	 of	
ciliogenesis	(Kim	et	al.,	2010;	Wheway	et	al.,	2015).	Actin	branching	and	nucleation	have	been	
shown	 to	 decreases	 ciliogenesis,	 with	 components	 of	 the	 actin	 organizing	 complex,	 Arp2/3	
which	 is	known	to	control	actin	branching,	having	negative	effects	on	ciliogenesis	(Bershteyn	
et	al.,	2010).		
	
There	 are	 contradictory	 ideas	 as	 to	 how	 the	 actin	 cytoskeleton	 controls	 cilia	 formation	 and	
function,	 with	 bodies	 of	 evidence	 to	 support	 each.	 An	 intact	 and	 complete	 cytoskeletal	
network	 may	 be	 necessary	 for	 proper	 regulation	 of	 the	 shuttling	 of	 vesicles	 bound	 for	 the	
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ciliary	region	(basal	body	and	the	axoneme).		This	network	of	actin	fibres	may	slow	or	limit	the	
influx	 of	 vesicles	 in	 order	 to	precisely	 control	 the	 growth	 and	overall	 function	of	 the	 cilium.	
This	idea	is	supported	by	evidence	that	actin	polymerisation	or	disassembly	leads	to	elongated	
cilia	and	accumulation	of	vesicles	at	the	base	of	the	primary	cilium	(Kim	et	al.,	2010;	Jongshin	
Kim	et	al.,	 2015).	Another	mechanism	 involves	 the	 localization	of	disassembly	 factors	 to	 the	
base	of	the	cilium	by	the	actin	network	which	may	control	tubulin	acetylation	and	ultimately	
cilia	 length	 (Sánchez	 de	 Diego	 et	 al.,	 2014;	Malicki	 and	 Johnson,	 2016).	 The	 final	 proposed	
mechanism	involves	activation	of	the	transcriptional	coactivator	YAP/TAZ.	YAP/TAZ	activity	 is	
controlled	through	actin	cytoskeleton	remodelling	and	has	been	shown	to	control	ciliogenesis	
(Wada	 et	 al.,	 2011).	When	 YAP/TAZ	 is	 concentrated	 in	 the	 cytoplasm	 ciliogenesis	 occurs	 as	
normal,	while	nuclear	translocation	or	knockdown	of	YAP/TAZ	suppresses	ciliogenesis,	possibly	
through	 HDAC6	 recruitment	 which	 acts	 as	 a	 disassembly	 factor	 (Jongshin	 Kim	 et	 al.,	 2015).	
Additionally,	 actin	 remodelling	 factors	 LIMK2	 and	 TESK1	 also	 had	 an	 effect	 on	 ciliogeneis	
through	inhibiting	vesicular	trafficking	to	the	ciliary	base	by	controlling	expression	of	YAP/TAZ	
target	genes	(Jongshin	Kim	et	al.,	2015).		
	
	
1.7.3.1	Cilia	and	ROCK		
As	 described	 previously	 (section	 1.2.3-5),	 the	 Rho	 signalling	 pathway	 has	 a	major	 effect	 on	
actin	dynamics	and	the	cytoskeleton.	ROCK1	and	ROCK2	are	two	of	the	main	downstream	Rho	
effectors	and	therefore	have	many	substrates,	activation	of	which	causes	dynamic	changes	in	
actin	organization.		
	
Hyperactivation	of	RhoA	signalling	is	seen	in	some	ciliopathies.	TMEM216	is	a	transmembrane	
protein	 that	 localizes	 to	 the	 base	 of	 primary	 cilia	 and	 when	 mutated	 causes	 a	 number	 of	
ciliopathies	 (Valente	 et	 al.,	 2010).	 TMEM216	 mutant	 fibroblasts	 or	 knockdown	 results	 in	
defective	 ciliogenesis	 but	 also	hyperactivation	of	 RhoA	 signalling.	 	Mutant	 cells	 also	 showed	
mislocalisation	of	actin	cross	linking	proteins	and	stress	fibres	known	to	be	controlled	by	ROCK	
signalling	(Valente	et	al.,	2010).		
	
Another	report	showed	that	the	ciliopathy	protein	TMEM67,	mutated	as	the	cause	for	a	range	
of	 human	 ciliopathies,	 plays	 a	 role	 in	 non-canonical	Wnt	 (PCP)	 signalling	 and	 is	 required	 for	
actin	 cytoskeletal	 remodelling	 and	 Rho	 A	 activity	 (Dawe	 et	 al.,	 2009).	 Loss	 of	 TMEM67	
disrupted	signalling	through	Wnt5a	and	Ror2,	and	resulted	in	non-canonical	Wnt	(PCP)	defects	
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culminating	 in	 lung	 branching	 morphogenesis	 defects	 and	 aberrant	 stress	 fibre	 formation	
(Abdelhamed	et	al.,	2013).	Lung	branching	and	polarity	defects	were	rescued	by	stimulation	of	
Rho	A	signalling	by	calpeptin	(Abdelhamed	et	al.,	2015).		
	
It	is	therefore	evident	that	a	significant	link	between	ciliogenesis	and	Rho	signalling	exists.	As	
one	of	the	major	downstream	effectors	of	Rho	signalling,	the	Rho	kinases	(ROCK1	and	ROCK2)	
may	 play	 important	 regulatory	 roles	 in	 many	 of	 the	 implicated	 functions	 of	 primary	 cilia.	
Intriguingly,	 the	defects	seen	 in	stress	 fibre	 formation	and	 localization	 in	TMEM216-mutated	
patient	fibroblast	lines	further	link	ROCK	signalling	with	ciliogenesis	and	primary	cilia	function	
(Valente	et	al.,	2010).		
	
	
1.8	Aims	
The	Aims	of	 this	project	were	 to	understand	 the	detailed	molecular	mechanisms	of	 vascular	
lumen	 formation	 and,	 in	 particular,	 the	 role	 of	 Rho	GTPase	 signalling	 pathways.	 These	 have	
gained	increasing	recent	prominence	in	the	context	of	tubulogenesis.	To	provide	insights	into	
this	process,	 I	have	used	tissue	culture	and	 in	vivo	approaches	to	define	the	roles	of	Rac	and	
ROCK	signalling	during	vascular	lumen	formation.	Recent	work	has	suggested	that	primary	cilia	
are	involved	in	flow	recognition	and	development	of	blood	vessel	lumens.	I	have	therefore	also	
explored	links	between	the	regulation	of	cilia	growth	by	Rho	GTPases	and	potential	effects	on	
blood	vessel	lumens.	
	
	
1.8.1	Preliminary	work	leading	to	this	thesis	
Previous	work	by	the	Mavria	group	had	identified	DOCK4	as	a	regulator	of	lateral	branches	in	a	
RNAi	screen	using	the	angiogenesis	co-culture	assay.	Further	work	had	gone	on	to	show	that	
DOCK4	regulates	lateral	tubule	behaviour	through	its	activation	of	Rac1,	downstream	of	VEGF.	
This	 control	of	 lateral	 behaviour	was	 found	 to	be	 through	an	 interaction	of	DOCK4	with	 the	
Cdc42	 GEF,	 DOCK9,	 which	 controlled	 filopodia	 formation.	 Preliminary	 data	 suggested	 a	
potential	role	for	DOCK4	in	lumen	formation.		
	
The	 Rho	 associated	 kinases	 (ROCK1	 and	 ROCK2)	modulate	 RhoA	 activity	 to	mediate	 diverse	
effects	 on	 the	 actin	 cytoskeleton.	 Published	 work	 has	 suggested	 that	 ROCK	 signalling	 is	 an	
important	 mediator	 in	 a	 number	 of	 angiogenic	 processes.	 Development	 of	 a	 global	 ROCK2	
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genetic	 deletion	 mouse	 model	 prior	 to	 this	 study	 had	 shown	 that	 loss	 of	 ROCK2	 was	
embryonically	 lethal	 at	 E13.5,	 and	 that	 Rock2-/-	 embryos	 at	 this	 stage	 exhibited	 extensive	
haemorrhaging	and	pooling	of	blood	in	the	limb	buds.	
	
Recent	published	evidence	has	also	suggested	a	potential	role	for	primary	cilia	 in	endothelial	
cell	 biology	 and	 identified	 primary	 cilia	 within	 endothelial	 lumens.	 Primary	 cilia	 are	 already	
known	to	play	roles	 in	flow	sensing	and	calcium	signalling	 in	other	cell	types,	which	are	both	
important	 for	 lumen	formation.	A	reverse	genetic	siRNA	screen	 from	the	 Johnson	group	and	
other	workers	 has	 recently	 identified	 genes	 involved	 in	 control	 of	 the	 actin	 cytoskeleton	 as	
regulators	of	primary	cilia	 formation.	ROCK2	had	the	greatest	effect	on	ciliogenesis	 from	the	
entire	whole	genome	screen	carried	out	(Wheway	et	al.,	2015).		
	
The	objectives	of	the	project	were	as	follows:	
 
1)	Investigate	the	role	of	DOCK4	and	DOCK9	in	endothelial	lumen	formation	(Chapter	3)	
	
I	performed	assays	in	the	angiogenesis	co-culture	model,	with	knockdown	of	DOCK4	or	DOCK9	
to	determine	 the	effect	on	 lumen	 formation.	 Lumen	 formation	at	14	days	was	assessed	and	
compared	with	control	tubules	through	immunoflourescent	imaging	and	quantification.		
	
2)	Investigate	the	role	of	ROCK2	in	angiogenesis	and	lumen	formation	in	vivo	(Chapter	4)	
	
The	study	of	ROCK2	in	angiogenesis	employed	the	use	of	the	genetic	knockout	Rock2	-/-	mouse	
model	 available	 to	 the	 Mavria	 group.	 Studies	 using	 immunofluorescent	 and	
immunohistochemistry	microscopy	 techniques	 assessed	 the	 effect	 of	 ROCK2	 loss	 on	 in	 vivo	
developmental	angiogenesis	and	subsequent	lumen	formation.	
	
3)	Investigate	the	role	of	ROCK	signalling	in	endothelial	cilia	in	blood	vessels	(Chapter	5)	
	
The	 abundance	 and	 location	 of	 primary	 cilia	 were	 assessed	 in	 endothelial	 cells	 and	 tubules	
both	in	vitro	and	in	vivo.	The	effect	of	ROCK	signalling	on	cilia	formation	was	assessed	in	vitro	
by	pharmacological	approaches,	and	in	vivo	by	the	Rock2	-/-	knockout	mouse	model.	
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Chapter	2	
Materials	and	Methods	
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2.1	Cell	culture	basics	
2.1.1	Plate	coating	
Gelatin	coating	for	HDF	on	glass	bottom	plates:	2%	[w/v]	gelatin	solution	(Sigma	Aldrich-tissue	
culture	 grade)	 was	 diluted	 to	 0.1%	 with	 sterile	 PBS.	 Coated	 plates	 were	 kept	 at	 room	
temperature	 for	30	minutes	and	excess	gelatin	was	 rinsed	off	with	PBS.	Gelatin	coated	glass	
bottom	plates	were	used	for	confocal	and	live	imaging	of	co-cultures.		
	
Collagen	I	coating	for	HEK	293T	expansion	after	thawing	from	frozen.	T75	tissue	culture	flasks	
were	coated	with	filter	sterilized	50µg/ml	collagen-rat	tail	(BD	Bioscience)	diluted	from	3µg/ml	
stock	with	0.02M	acetic	acid	(made	from	17M	stock	acetic	acid).	6mls	was	added	to	each	flask	
and	left	for	1	hour	at	room	temperature	to	solidify	before	being	rinsed	three	times	with	sterile	
PBS.	Plates	were	used	immediately	or	stored	in	PBS	at	4	degrees	for	up	to	24	hours.	
	
2.1.2	Cell	lines		
Angio-tested	HDF	(Human	Dermal	Fibroblast	-	tested	to	perform	in	the	angiogenesis	co-culture	
assay)	 were	 obtained	 from	 TCS	 CellWorks	 (Buckingham,	 UK).	 HDFs	 purchased	 at	 passage	 8	
were	cultured	in	Dulbeccos’	Modified	Eagle’s	Medium	(DMEM)	with	10%	[v/v]	fetal	calf	serum	
(FCS,	 Biosera	 Ltd)	 supplemented	 with	 100mg/ml	 L-glutamine	 and	 100µg/ml	
penicillin/streptomycin	 (Sigma	 Aldrich).	 HDFs	 were	 thawed	 in	 the	 water	 bath	 at	 37°C	 and	
cultured	 in	 plastic	 tissue	 culture	 T75	 flasks	 in	 15ml	 media.	 HDFs	 were	 split	 1:5	 when	 they	
reached	90%	confluency.	HDF	cells	were	used	up	to	passage	12	for	co-culture	assays.	
	
Angiogenesis	tested	HUVEC	(Human	Umbilical	Vein	Endothelial	Cells	–	tested	to	perform	in	the	
angiogenesis	co-culture	assay)	were	also	obtained	from	TCS	CellWorks	(Buckingham,	UK)	and	
were	 cultured	 in	 Large	Vessel	 Endothelial	 Basal	Medium	 (LV)	 (TCS	CellWorks)	 supplemented	
with	 supplied	 antibiotics	 (1000X	 amphotericin	 B/gentamycin)	 and	 growth	 supplements	 (TCS	
Cellworks).	HUVEC	were	purchased	at	P1	before	being	thawed	into	T75	flasks	with	15ml	large	
vessel	endothelial	cell	basal	medium	as	per	supplier	 instructions.	After	approximately	2	days,	
when	 cells	 reached	no	more	 than	 85%	 confluency,	 they	were	harvested.	 Cells	were	washed	
once	with	sterile	pre-warmed	PBS	and	then	coated	with	1-2mls	of	trypsin	EDTA	0.25%	(Sigma	
Aldrich).	Flasks	were	gently	rocked	and	viewed	down	the	microscope.	When	90%	of	cells	had	
detached	 from	 the	 plastic,	 10mls	 of	 pre-warmed	 large	 vessel	 media	 was	 washed	 over	 the	
surface	of	 the	 cell	 layer	 to	 collect	 all	 suspended	 cells.	 Cells	were	 reseeded	at	 a	1:4	 ratio	 for	
expansion.	HUVEC	for	co-cultures	were	used	between	passage	1	and	4.		
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HCMEC	(Human	cerebral	microvascular	endothelial	cells)	 from	ATCC	were	cultured	 in	DMEM	
10%	FBS,	100mg/ml	L-glutamine,	100µg/ml	penicillin	and	100µg/ml	streptomycin.	Cells	were	
grown	to	confluency	before	splitting	at	a	ratio	of	1:4.	HCMEC	were	used	between	passage	30-
35	for	primary	ciliogenesis	assays.		
	
hTERT	RPE-1	(immortalized	human	retinal	pigment	epithelial	cells)	from	ATCC	were	cultured	in	
DMEM	10%	FBS,	100mg/ml	L-glutamine,	100µg/ml	penicillin	and	100µg/ml	streptomycin.	Cells	
were	grown	to	confluency	before	splitting	before	being	split	at	a	ratio	of	1:5.	hTERT-RPE1	cells	
were	used	for	the	ciliogeneis	assay	between	passage	28-35.		
	
HEK-293T	 (Human	 embryonic	 kidney	 cells)	 were	 cultured	 in	 DMEM	 10%	 FBS,	 100mg/ml	 L-
glutamine,	100µg/ml	penicillin	and	100µg/ml	streptomycin.	Cells	were	stored	at	passage	4	and	
brought	into	culture	in	collagen	I	coated	T75	tissue	culture	flasks.	Cells	were	harvested	when	
they	reached	90%	confluency	and	split	at	a	1:6	ratio	onto	plastic-bottomed	tissue	culture	flasks	
after	first	split.	Cell	were	used	until	passage	11.		
	
All	cells	were	cultured	in	5%	CO2	tissue	culture	incubators	at	37oC.		
	
2.1.3	Freezing	and	thawing	cells	
All	cell	 stocks	were	stored	at	 -196°C	 in	vapour	stage	 liquid	nitrogen	dewars.	Before	use	cells	
were	 stored	 on	 dry	 ice	 for	 transit	 and	 defrosted	 quickly	 in	 a	 37°C	water	 bath	 before	 being	
added	straight	to	warm	media.			
	
To	 prepare	 stocks	 for	 freezing,	 cells	 were	 harvested	 when	 actively	 proliferating	 at	 70-80%	
confluency.		Cells	were	washed	once	with	PBS	and	trypsinised	with	0.25%	trypsin	EDTA	and	re-
suspended	in	10ml	culture	medium.	Cells	were	counted	manually	with	a	hemocytometer	and	
pelleted	 by	 centrifugation	 in	 a	 bench	 top	 centrifuge	 (at	 300	 x	 g	 for	 4	 minutes,	 room	
temperature	 (20-22°C))	 the	 supernatant	 was	 discarded	 and	 the	 pellet	 was	 re-suspended	 in	
pre-chilled	freeze	medium	(90%	FBS,	10%	DMSO)	on	ice.	1ml	volumes	containing	between	0.5-
1x106	 (depending	on	 cell	 type)	were	 transferred	 to	1.5ml	 cryovials	 (Corning)	 and	 stored	at	 -
80°C	overnight	before	being	transferred	to	LN2	(-196°C)	for	long	term	storage.	
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2.1.4	Standard	solutions	
Standard	solutions	 Company	 Recipe	
DMEM	 (Dulbecco’s	 modified	 Eagles	
medium	
Sigma-Aldrich	 	
Freezing	medium	 	 90%	 FBS	 (Biosera	 Ltd)	 with	
10%	DMSO	(Invitrogen)	
LB	(Luria	broth)	 Sigma-aldrich	 20g	LB	powder	 in	1L	distilled	
water.	Autoclaved	
LVEM	 (Large	 vessel	 endothelial	
medium)	
TCS	cellworks	 Proprietary	preparation	
PBS	(phosphate	buffered	saline)	 Sigma-Aldrich	 	
4%	[w/v]	PFA	(paraformaldehyde)		 Sigma-Aldrich	 4	 grams	 of	 PFA	 powder	 in	
100ml	 PBS	 (heated	 to	 65	
degrees	to	dissolve)	
TE	(Tris	EDTA)	buffer	 	 1	ml	of	1	M	Tris-HCl	 (pH	8.0)	
and	 0.2	ml	 EDTA	 (0.5	M)	 up	
to	100ml	with	distilled	water.		
	
TBS	(Tris	buffer	saline,	pH8)	 	 50mM	Tris,	150mM	NACL	
TBST	(Tris	buffer	saline	Tween)		 	 TBS	 with	 0.1%	 Tween	 20	
(Sigma	Aldrich)	
0.25%	 trypsin	 EDTA	
(ethylenediaminetetraacetic	acid)	
Sigma-Aldrich	 	
Transfer	buffer	 	 25mM	 Tris,	 190mM	 glycine,	
20%		methanol	
Running	buffer	 Invitrogen	 10X	 solution	 dilutes	 with	
distilled	water	to	1X	
5X	siRNA	buffer	 Thermofisher	
Scientific	
Diluted	 to	 1X	 with	 RNAse-
free	 sterile	 water	 (Fisher	
Scientific)	
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Rac	Lysis	Buffer	 	 100mM	NaCl,	50mM	Tris-HCl	
pH7.4,	 10%	 glycerol,	 1%	 NP-
40	
5mM	 MgCl2,	 EDTA-free	
complete	 protease	 inhibitors	
(Roche),	1mM	DTT.			
PBX	 	 PBS	with	0.1%	 	 [v/v]	Triton-X	
100	
Mounting	 medium	 (ProLong	 Diamond	
Antifade	Mountant)	
Thermofisher	
scientific	
	
Bovine	serum	albumin	(powder)	 	 	
2%	[w/v]	gelatin	solution		 Sigma-Aldrich	 Diluted	to	0.1%	in	PBS	before	
use	
HUVEC	 optimised	 medium	
(Angiogenesis	growth	medium)	
TCS	cellworks		 	
Complete	PBS	(solutions	A	and	B)	 	 Solution	 A:	 10xPBS.	 20x	
Solution	 B:18mM	 CaCl2,	
70mM	 KCl,	 18mM	 MgCl2 
2740mM	NaCl.	Add	50mls	of	
A	 and	 25mls	 of	 B	 to	 425ml	
sterile	 water	 to	 prepare	
500mls.	Do	not	refrigerate.		
Table	2.1	Standard	solutions	used	throughout	this	thesis	
	
2.1.5	Bacterial	cell	culture		
DOCK9	 and	 DOCK4	 GIPZ	 shRNA	 clones	 for	 lentiviral	 knockdown	 were	 purchased	 from	
Dharmacon	and	 stored	at	 -80°C.	All	GIPZ	 shRNA	clones	were	 cultured	at	 37oC	 in	2xLB	broth	
(low	 salt)	 medium	 plus	 100µg/ml	 ampicillin.	 shRNA	 clones	 were	 grown	 according	 to	 the	
manufacturer’s	 protocols.	 In	 summary,	 bacterial	 stocks	 were	 defrosted	 and	 vortexed	 to	 re-
suspend	any	E.	coli	that	may	have	settled	to	the	bottom	of	the	tube.	A	10µl	inoculum	from	the	
glycerol	 stock	was	added	 to	3-5ml	of	2x	 LB	 (low	 salt)	plus	100µg/ml	ampicillin	 at	37oC,	with	
shaking,	overnight.	Overnight	 cultures	were	 then	added	 to	a	 larger	 volume	of	2xLB	at	1:500	
dilution	of	the	starter	culture.	Larger	volume	was	incubated	for	18-19hrs	with	fresh	antibiotics	
and	vigorous	shaking.	Cultures	were	then	pelleted	to	begin	plasmid	extraction.	
	 58	
2.1.5.1	DNA	plasmid	preparation		
Plasmid	DNA	was	extracted	using	an	“Invitrogen	Purelink	Midiprep	kit”.	0.2-1	μg	of	the	plasmid	
DNA	can	be	run	on	a	1%	agarose	gel.	pGIPZ	with	shRNA	is	11774	bp	in	size.	Plasmids	were	used	
to	prepare	lentiviral	vectors	for	shRNA	mediated	knockdown	(3.2.3).		
	
2.1.5.2	DOCK4/9	shRNA	sequences		
shRNA	constructs	were	from	Dharmachon	GE	life	sciences	and	were	used	to	make	lentiviral	
vectors	for	DOCK9	knockdown.	
DOCK9	shRNA3	(V3LHS_306026)	mature	antisense	“AACAAACAAGCTCTGTGCT”	
DOCK9	shRNA4	(V3LHS_306027)	mature	antisense	“TACTTGAGTTGTCACAGCT”	
DOCK4	shRNA1	mature	antisense		“CTCAGTATTTGCAGATATA“	
DOCK4	shRNA2	mature	antisense		“CGCAAGGTCTCTCAGTTAT”	
2.2	Cell	culture	techniques		
	
2.2.1	Production	of	Lentiviral	Vectors	in	293T	cells	
Virus	production	was	according	to	Tronolab	protocols.	On	day	1	(5pm)	2.5x106	HEK	293T	cells	
were	 plated	 in	 a	 10cm	 plate.	 On	 day	 2	 (5pm)	 calcium-phosphate	 precipitate	 was	 prepared	
(1ml/10cm	 plate)	 (transfer	 vector	 20µg,	 packaging	 plasmid	 15µg,	 Envelope	 plasmid	 6µg)	
vectors	were	added	to	0.5ml	of	ddH2O	and	50µgl	2.5M	CaCl2	before	adding	0.5mls	2xHBS	drop	
by	drop	to	the	solution	while	under	vortex	agitation.	The	precipitate	was	left	for	20	minutes	at	
room	 temperature	 then	 added	 dropwise	 to	 plates.	 The	 plates	 were	 mixed	 gently	 by	 tilting	
plate	from	side	to	side.	On	day	3	(9-10am)	media	 is	discarded	and	replaced	with	fresh	warm	
medium.	On	 day	 3	 (5pm)	Media	was	 collected	 and	 replaced	with	 fresh	 as	 before.	 Collected	
media	was	filtered	through	a	.45µm	filter	and	stored	at	4	oC	before	aliquoting	in	2ml	aliquots	
and	storing	at	 -80	 oC	 for	 long	 term	storage.	On	day	4	 (9-10am)	collection	step	was	 repeated	
and	 fresh	 media	 added.	 On	 day	 4	 (5pm)	 final	 media	 was	 collected,	 filtered	 and	 stored	 as	
before.	Plates	were	discarded.		
	
2.2.2	Virus	titre	assay	
Medium	 containing	 viral	 vectors	 from	 lentiviral	 production	was	 collected	 and	 used	 for	 viral	
titre	assays.	 7x104	HEK293T	were	 seeded	 in	24	well	plates	and	used	 to	 titre	 virus.	Virus	was	
added	neat	and	in	serial	dilutions	of	1:5,	1:10	and	1:50	in	DMEM	with	8µg/µl	polybrene	for	6	
hours	 or	 overnight.	 Virus	 was	 replaced	 with	 fresh	 DMEM	 supplemented	 with	 10%	 FBS	 and	
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grown	 for	 48	 hours	 before	 expression	 of	 GFP	 was	 assessed	 on	 the	 EVOS	 fluorescent	
microscope.	The	level	of	knockdown	was	assessed	by	western	blotting	for	proteins	of	interest	
(section	3.5.1).		
	
2.2.3	HUVEC	lentiviral	transduction	
5x105	HUVEC	were	seeded	into	T75	tissue	culture	dishes	for	transduction.	Virus	was	added	in	
the	 pre-determined	 dilution	 for	 the	 viral	 titre	 (section	 3.2.3)	 diluted	 in	 human	 large	 vessel	
endothelial	 cell	 medium	 with	 8µg/µl	 polybrene	 for	 6	 hours	 or	 overnight.	 Expression	 was	
assessed	with	GFP	expression	on	the	EVOS	microscope	and	by	western	blotting	for	proteins	of	
interest.		
	
2.2.4	HUVEC	cell	sorting	via	FACS	sort	
Transduced	HUVEC	were	trypsinised	and	collected	for	fluorescent	activated	cell	sorting.	1x106	
cell/ml	 were	 collected	 in	 LV	 medium	 and	 transferred	 to	 polystyrene	 cell	 sorter	 tubes	 for	
sorting.	The	LIMM	Cell	Sorting	Facility	sorted	the	cells	based	on	pre-determined	gates	based	
on	the	level	of	expression	of	GFP	and	knockdown	efficiency.	Sorted	HUVEC	were	placed	back	in	
culture	for	24	hours	or	used	directly	for	experimentation.		
	
2.2.5	HUVEC-HDF	coculture	assay	
2x104	 HDFs	 at	 passage	 8-11	 were	 plated	 on	 plastic	 or	 gelatin-coated	 glass-bottom	 24	 well	
plates	and	cultured	for	7	days	without	medium	change	until	grown	to	a	confluent	layer.	1x104	
HUVEC	were	then	seeded	onto	the	confluent	layer	of	HDFs	and	cultured	for	either	5	days	for	
sprouting	 assay	 or	 14-16	 days	 for	 the	 lumen	 assay.	 HDF-HUVEC	 culture	were	maintained	 in	
50:50	medium	 (LV:DMEM)	until	 day	 7	 before	 being	 changed	 to	 optimized	medium	 to	 aid	 in	
lumen	formation.	Media	was	refreshed	every	2	days.	Co-cultures	were	performed	with	HUVEC	
that	 had	 proteins	 of	 interest	 knocked	 down	 via	 siRNA	 or	 shRNA	 methods	 (sections	 3.1.4,	
3.2.4).	5-day	assays	were	washed	once	with	PBS	and	then	fixed	in	ice	cold	70%	ethanol	for	20	
minutes	for	IHC	staining	or	4%	PFA	for	immunoflourescent	staining.		
	
Angio-tested	HDFs	at	passage	8-11	were	plated	on	gelatin-coated,	24	well,	glass	bottom	plates,	
at	2x104	cells/well	and	allowed	to	grow	in	DMEM	10%	FBS	for	7	days	without	media	change.	
Angiotested	HUVEC	were	then	seeded	onto	confluent	HDFs	at	a	density	of	1x104	cells/well	 in	
50:50	media	(50%DMEM	10%FBS,	50%	Large	vessel	media	+	supplements	+	antibiotics).	After	7	
days,	 the	 culture	 media	 were	 changed	 to	 ‘Optimised’	 media	 (TCS	 Cellworks)	 and	 changed	
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every	 two	days	until	day	14-16.	Cultures	were	 then	 fixed	 in	4%	PFA	 for	20	minutes	at	 room	
temperature	 and	 stored	 in	 sterile	 complete	 PBS	 at	 4oC.	 Cultures	 were	 stained	 by	
immunofluorescence	for	analysis.		
	
2.2.6	In-vitro	ciliogenesis	assay	
Cells	to	be	studied	in	the	ciliogenesis	assays	were	grown	on	glass	cover	slips	for	imaging	in	24	
well	 tissue	 culture	 plastic	 plates.	 Cover	 slips	 were	 sterilized	 in	 70%	 ethanol	 before	 three	
washes	in	sterile	PBS.	Cells	were	seeded	at	70%	confluency	on	cover	slips	and	let	grown	for	24	
hours	 in	10%	DMEM.	Cells	were	 then	 serum	starved	 in	0.2%	FBS	DMEM	 for	48hours	before	
fixing	 with	 4%	 PFA.	 Inhibitor	 treatments	 were	 added	 during	 the	 48hours	 serum	 starvation	
period.		
	
2.2.7	Apical	membrane	initiation	site	assay	(AMIS	assay)	
HUVEC	were	seeded	on	glass	cover	slips	at	60%	confluency	for	the	apical	domain	assay	(AMIS).	
Cells	 were	 allowed	 to	 adhere	 for	 25	 minutes	 in	 the	 incubator	 before	 being	 fixed	 for	
immunoflourescent	imaging.		
	
2.3	Imaging	techniques		
2.3.1	Embryo	fixation	and	staining	(immunofluorescence)	
Embryos	were	harvested	at	E12.5	and	E13.5	for	analysis.	E12.5	and	E13.5	embryos	were	fixed	
in	 4%	 PFA	 at	 room	 temperature	 for	 30	 minutes	 and	 4oC	 for	 one	 hour.	 They	 were	
permeabilised	 in	 PBS/0.1%	 Triton	 X-100	 (PBX)	 for	 30	 minutes	 at	 room	 temperature	 before	
being	blocked	overnight	in	5%	BSA/PBX	at	4oC.	Primary	antibodies	were	incubated	overnight	at	
4oC	in	5%BSA/PBX.	Embryos	were	washed	3	x	30	minutes	in	1%	BSA-PBX	at	room	temperature.	
Secondary	antibody	was	incubated	in	5%	BSA-PBX	at	room	temperature	for	2	hours.	Embryos	
were	 washed	 3x30	 minutes	 in	 1%	 BSA-PBX	 at	 room	 temperature	 and	 incubated	 with	 DAPI	
(1:2000)	in	final	wash.		A	total	of	four	embryos	per	embryonic	day	were	analysed	with	5	fields	
per	embryo	quantified	for	characterisation	studies.			
	
2.3.2	Co-culture	fixation	and	immunofluorescence	staining		
Co-cultures	were	washed	once	with	complete	PBS	and	fixed	in	4%	PFA	for	20	minutes	at	room	
temperature.	Cultures	are	then	washed	twice	with	complete	PBS	and	stored	in	complete	PBS.	
Cultures	 were	 permeabilised	 in	 PBX	 (PBS	 0.1%	 Triton-X	 100)	 for	 20	 minutes	 at	 room	
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temperature	 before	 being	 blocked	 in	 PBX	 1%	BSA	 for	 20	minutes	 at	 room	 temperature	 and	
stored	in	PBS.		
	
All	primary	antibodies	were	incubated	in	PBX	1%	BSA	at	4oC	overnight.	Cultures	where	washed	
3x30	 minutes	 in	 PBX	 1%	 BSA.	 Primary	 antibody	 dilutions	 are	 listed	 in	 Table	 1.x.	 Secondary	
antibodies	were	incubated	for	2	hours	at	room	temp	in	PBX	1%	BSA	before	washing	in	in	PBX	
1%	BSA	3x30	minutes.	DAPI	was	added	in	the	final	was	at	a	dilution	of	1:2000.	For	phalloidin	
staining,	 cultures	were	 incubated	 for	1	hour	at	 room	temperature	 in	PBX	1%	BSA	at	a	1:200	
dilution.		
2.3.3	Cilia	assay	fixation	and	staining	
Ciliogenesis	assays	were	carried	out	using	glass	cover	slips	in	24	well	dishes.	Cover	slips	were	
washed	once	with	PBS	and	fixed	 in	4%PFA	for	15	minutes	at	room	temperature.	Monolayers	
were	permeabilised	 in	PBX	(PBS	0.1%	Triton-X100)	 for	20	minutes	before	blocking	 in	PBX	1%	
BSA	 for	 20	 minutes	 all	 at	 room	 temperature.	 Cover	 slips	 were	 then	 stained	 with	 primary	
antibodies	for	1	hour	at	room	temperature	in	PBX	1%BSA	before	3x5	minutes	washes	in	PBX.	
They	 were	 then	 stained	 for	 secondary	 antibodies	 in	 PBX	 1%	 BSA	 for	 1	 hour	 at	 room	
temperature	before	3x5	minutes	washes.	DAPI	nuclear	marker	was	added	in	the	final	wash.		
	
2.3.4	AMIS	assay	fixation	and	staining	
AMIS	assays	were	fixed	and	stained	as	above,	section	(2.3.3)	
	
2.3.5	Immunohistochemistry	staining	
Co-cultures	 were	 washed	 once	 with	 PBS	 and	 fixed	 in	 70%	 Ethanol	 for	 20	 minutes	 at	 room	
temperature.	 Cultures	 were	 stained	 using	 a	 commercially	 available	 kit	 from	 TCS	 Cellworks	
(Caltag	Med	systems)	based	on	binding	of	an	alkaline	phosphatase-coupled	anti-CD31	antibody	
linked	to	an	insoluble	chromogenic	substrate	that	stains	the	fixed	tubules	in	situ.		
	
2.3.5.1	Embryo	immunohistochemistry	
Embryos	 at	 E13.5	 were	 delivered	 to	 the	 pathology	 department	 after	 genotyping.	 Embryos	
were	embedded	in	paraffin	blocks	and	sectioned	prior	to	staining.		
	
2.3.6	Confocal	imaging	
All	 confocal	 imaging	 was	 carried	 out	 on	 a	 Nikon	 A1R-A1	 Confocal	 Microscope	 system	 with	
Nikon	“Elements”	software.		
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2.3.6.1	HUVEC-HDF	Co-culture	imaging	
Co-culture	imaging	was	carried	out	using	an	oil	immersion	x60,	x40,	or	x20	or	x10	lenses,	and	
galvano	scanning	head.	Z-stack	imaging	was	used	to	generate	3D	images	for	analysis.	Z-stacks	
of	15	µm	in	total	thickness	were	acquired	with	stacks	every	1.0	µm	at	1024px	resolution.	ND2	
z-stack	image	were	acquired	and	used	for	analysis.		
	
	
2.3.6.2	Wholemount	angiozone	embryo	imaging	
Imaging	of	E12.5	and	E13.5	embryos	were	taken	using	a	x40	oil	immersion	lens	and	a	galvano	
scanner	head.	Z-stack	images	were	used	to	generate	3D	images	and	acquired	in	the	angiozone.		
Z-stacks	 of	 15-30	 µm	 in	 total	 thickness	 were	 acquired	 with	 stacks	 every	 1.0	 µm	 at	 1024px	
resolution.	
	
2.3.6.3	Cilia	imaging	
Monolayers	of	ciliated	cells	were	imaged	using	x20	or	x40	(oil	immersion)	lenses	and	a	galvano	
scanner	 head.	 Z-stacks	 of	 5µm	 total	 thickness	 were	 acquired	 with	 stacks	 every	 0.5µm	 at	
1024px	resolution.		
	
2.3.6.4	AMIS	imaging	
Spreading	 cells	were	 imaged	 using	 x20	 or	 x40	 (oil	 immersion)	 lenses	 and	 a	 galvano	 scanner	
head.	 Z-stacks	 of	 5µm	 total	 thickness	 were	 acquired	 with	 stacks	 every	 0.5µm	 at	 1024px	
resolution	and	used	for	quantification.		
	
2.3.7	Bright	field	imaging	of	Immunohistochemistry	stained	sections	
Phase	 contrast	 images	 of	 tube	 formation	 in	 the	 organotypic	 sprouting	 assay	 was	 acquired	
using	a	Nikon	light	microscope	(x4	and	x10	images)	or	an	Olympus	CKX41	inverted	microscope	
(x40	objective).		
	
Lumen	 and	 cilia	measurements	 in	 the	 embryo	 immunohistochemistry	 sections	were	 carried	
out	using	a	Nikon	Axiovision	brightfield	microscope	(x4,	x16,	x40	and	x100	lenses).	Full	method	
is	described	in	sections	3.4.5	and	3.4.6.	
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2.3.8	Live	imaging	
Low	magnification,	 long	term,	 time	 lapse	 imaging	was	carried	out	using	a	 Incucyte	Zoom	 live	
imaging	system.	Images	of	co-culture	were	taken	every	2	hours	in	phase	and	GFP	channels	and	
combined	to	make	time	lapse	movies	using	the	Incucyte	Zoom	software.		
	
High	magnification	 live	cell	 imaging	of	eGFP-expressing	cells	and	 tissues	was	performed	on	a	
Nikon	A1R-A1	Confocal	Microscope	system	with	a	heated	chamber	and	C02	supply.		
	
Incucyte	 proliferation	 assays	 were	 performed	 by	 seeding	 GFP	 expressing	 HUVEC	 (Non-S,	
DOCK9	shRNA	3	and	4)	in	24	well	plates	at	20-30%	confluency	in	triplicate.	Cells	were	imaged	
in	phase	and	GFP	channels	at	x10	magnification	and	the	increase	in	confluency	was	calculated	
using	the	Incucyte	Zoom	software.		
	
2.3.9	Phalloidin	staining	of	cells		
Cells	 to	be	 stained	 for	 F-actin	 visualisation	were	 incubated	 in	 a	1:200	dilution	of	Alexa	 Fluor	
633	 phalloidin	 in	 PBX	 (PBS	 0.1%	 Triton-X	 100)	 for	 1	 hour	 at	 room	 temperature.	Wells	 were	
washed	3	times	with	PBX	and	used	for	imaging	immediately.		
	
	
	
	
	
	
Antibody	 Species	
	 	
Supplier	 Dilution	
CD31	(PECAM1)	Sc	31045	 Goat	 Santa	Cruz	 1:100	
VE-cadherin	Sc-6458	 Goat	 Santa	Cruz	 1:100	
h-Podocalyxin	Af-1658	 Goat	 R	+	D	systems	 1:200	
Endomucin	Sc-65495	 Rat	 Santa	Cruz	 1:100	
Podocalyxin	 (mouse)	
AF1556	
Goat	 R	+	D	systems	 1:100	
Collagen	IV	Ab	6586	 Rabbit	 Abcam	 1:200	
ARL13B	17711-1-AP	 Rabbit	 Proteintech	 1:1000	
DOCK9		 Rabbit	 Proteintech	 1:50	
Focal	 adhesion	 kinase	
(FAK)	ab40794	
Goat	 Abcam	 1:200	
Table	2.2	List	of	primary	antibodies	used	for	immunofluorescence	
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Antibody	 Species	
	 	
Supplier	 Dilution	
Alexa	Fluor	488	 Donkey	anti	rat	
IgG	
Invitrogen	 1:1000	
Alexa	Fluor	488	 Donkey	anti	rabbit	IgG	 Invitrogen	 1:1000	
Alexa	Fluor	594	 Goat	 anti	
rabbit	
Invitrogen	 1:1000	
Alexa	Fluor	594	 Donkey	anti	rat	 Invitrogen	 1:1000	
Alexa	Fluor	594	 Donkey	anti	goat	 Invitrogen	 1:1000	
Alexa	Fluor	633	 Goat	Anti	rabbit	 Invitrogen	 1:1000	
Alexa	Fluor	647	 Donkey	anti	goat	 Invitrogen	 1:1000	
	 	 	 	
DAPI	 	 Sigma-Aldrich	 1:2000	
Alexa	Fluor	633	
Phalloidin		
	 Invitrogen	 1:200	
Table	2.3	List	of	secondary	antibodies	used	for	immunofluorescence	
	
2.4	Image	analysis	
All	immunoflourescent	image	analysis	was	carried	out	using	Volocity	analysis	software	(Perkin	
Elmer).	 Confocal	 Z	 stack	 rendering	 of	 images	 (Nikon	ND2)	was	 carried	 out	 using	Volocity	 3D	
analysis	software	version	6.2.	“xyz”	 imaging	mode	was	used	to	quantify	embryo,	cilia	and	co-
culture	z-stacks.	3D	opacity	imaging	mode	was	used	to	view	3D	reconstructions	of	Z	stacks.		
	
2.4.1	HUVEC-HDF	Co-culture	lumen	measure	
Co-culture	assay	lumens	were	measured	in	“xyz”	mode	while	scrolling	through	multiple	plains	
of	 generated	 z-stacks	 (15µm	 deep).	 The	 line	 drawing	 tool	 was	 used	 to	 quantify	 length	 of	
lumens	 vs	 length	 of	 total	 tubules.	 Tubules	 less	 than	 150µm	 in	 length,	 considered	 to	 be	
“growing	 tips”	 were	 not	 measured	 in	 lumen	 quantifications.	 Lumenised	 lengths	 were	
compared	with	total	length	of	tubule	within	entire	Z-stack	image	to	get	percentage	lumenised	
length	values.		
	
2.4.2	HUVEC-HDF	nuclei	per	length	counts	
Nuclei	per	length	measures	were	carried	out	on	z-stack	sections	from	lumen	measures	above	
using	velocity	 imaging	software.	Total	 length	of	 tubule	was	measured	and	 intact	nuclei	along	
the	total	length	was	counted.		
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2.4.3	Cilia	analysis	(ciliogenesis	assay)	
Monolayers	of	cilia	were	imaged	at	x20	and	x40	times,	and	multiple	planes	taken	to	generate	a	
Z-stack	 reconstruction.	 Image	 analysis	was	 carried	out	with	 the	 line	measuring	 and	 counting	
tool	 in	 Volocity	 software.	 All	 cilia	 within	 the	 x20	 images	 were	 counted	 and	 cilia	 length	
measured	and	compared	between	treatments.		
	
2.4.4	Lumen	and	filopodia	measuring	via	immunofluorescence	(Embryo	analysis)	
Images	of	E12.5	and	E13.5	embryo	“angiozone”	at	x40	magnification	were	taken	and	used	to	
create	 3D	 Z-stack	 images	 for	 analysis	 (15-30µm	 deep).	 Filopodia	 were	 measured	 in	 z-stack	
images	by	 scrolling	 through	each	 Z-stack	 and	 counting	 filopodia	on	 all	 vessels.	 Lumens	were	
measured	 using	 the	 line	 drawing	 and	measuring	 tool.	 Podocalyxin	 staining	 and	 presence	 of	
circulating	 blood	 cells	 were	 used	 to	 quantify	 total	 lumen	 percentage	 and	measured	 against	
total	vessel	length.	Tip	cells	were	counted	as	cells	with	a	single	nucleus,	sprouting	from	a	vessel	
wall,	with	abundant	filopodia.		
	
2.4.5	Cilia	count	in	the	embryo	immunohistochemistry	sections	
Transverse	 sections	 at	 the	 level	 of	 the	 interventricular	 foramen	 of	 Monro	 were	 taken	 for	
analysis	of	blood	vessel	cilia.	Cilia	were	counted	as	(red)	staining	for	ARL13B	within	the	blood	
vessels	stained	for	endomucin	(brown).	Counts	were	done	using	the	manual	count	tool	in	the	
Axiovision	software	from	images	taken	at	x100	magnification.	All	lumenised	vessels	within	the	
parenchyma	were	imaged	and	cilia	counted.		
	
2.4.6	Lumen	measure	in	the	embryo	immunohistochemistry	sections	
Transverse	 sections	 at	 the	 level	 of	 the	 interventricular	 foramen	 of	 Monro	 were	 taken	 for	
analysis	 of	 blood	 vessel	 lumens.	 Lumens	 were	 identified	 by	 endomucin	 staining	 and	 radius	
measured	 manually	 using	 Axiovision	 software	 circle	 tool	 at	 x40	 and	 x100	 magnification.	 All	
lumens	within	the	parenchymal	tissue	were	measured	for	each	section.		
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2.5	Biochemical	techniques		
2.5.1	Western	blotting	analysis		
	
2.5.1.1	Protein	quantification	by	BCA	protein	assay	
Proteins	 were	 quantified	 by	 the	 BCA	 (bicinchoninic	 acid)	 method	 (Smith	 et	 al.,	 1985).	 This	
method	 combines	 the	biuret	 reaction	with	 the	 violet-coloured	 complex	 formation	of	 copper	
ions	by	bicinchoninic	acid.	A	standard	curve	of	BSA	ranging	 from	25µg	–	2mg	of	protein	was	
prepared	 and	 used	 to	 quantify	 unknown	 samples.	 Protein	 standards	 and	 unknown	 samples	
were	 pipetted	 in	 triplicate	 into	 a	 96	 well	 plate.	 BCA	 reagent	 was	 added	 to	 each	 well	 and	
allowed	 to	 react	 for	 30	 minutes	 at	 37oC.	 Protein	 concentration	 was	 then	 measured	 on	 a	
spectrophotometer	at	562nm	wavelength	and	was	calculated	on	Microsoft	Excel.		
2.5.1.2	SDS-PAGE	
To	 identify	 proteins	 of	 interest	 quantified	 protein	 samples	 were	 analysed	 using	 Sodium	
Dodecyl	Sulphate	Polyacrylamide	Gel	Electrophoresis	(SDS-PAGE).	Quantified	proteins	(3.5.1.1)	
were	resuspended	in	4X	loading	buffer	(NuPage,	Invitrogen)	with	50mM	DTT	and	heated	at	70	
oC	 for	 10	minutes	 before	 loading.	 To	 identify	 proteins	 of	 larger	 than	 100kDa,	 3-8%	 precast	
acrylamide	gels	were	used	(Invitrogen).	Electrophoresis	was	performed	at	150V	for	1.5	hours	
in	 1X	 Tris-Acetate	 SDS	 Running	 Buffer	 (NuPAGE)	 with	 added	 NuPAGE	 antioxidant	 (1:500	
NuPage,	Invitrogen).	5-10µl	of	protein	standard	ladder	(Dual	colour	marker,	Biorad	10-250kDa)	
was	loaded	to	compare	proteins.		
	
2.5.1.3	Western	blotting	and	detection	
After	 completion	of	 SDS-PAGE	electrophoresis	 the	 gels	were	 transferred	 to	 50ml	 of	 transfer	
buffer	 for	 equilibration.	 Gels	 were	 then	 transferred	 to	 PVDF	 membrane	 (pre-activated	 in	
methanol	 for	 10	 seconds)	 and	 sandwiched	 between	 4	 sheets	 of	 Whatman	 paper	 and	 4	
sponges.	 The	 sandwich	 was	 then	 placed	 in	 a	 transfer	 rig	 prefilled	 with	 1x	 transfer	 buffer	
(3.1.4).	Transfer	was	at	1A	for	2hours	at	4oC	or	0.1A	at	4oC	overnight.		
	
Enhanced	chemiluminescence	(ECL)	methods	were	used	to	visualize	membranes.	Membranes	
were	first	blocked	in	5%	milk	powder	in	TBS	for	1hour	at	room	temperature.	Primary	antibody	
was	 added	 in	 TBST	1%	BSA	overnight	 at	 4oC.	After	 three	5	minute	washes	 in	 TBST,	 at	 room	
temperature,	 secondary	antibody	 (horseradish	peroxidase	enzyme	conjugated)	was	added	 in	
5%	milk	powder	for	2	hours	at	room	temp.	Primary	and	secondary	antibodies	are	listed	in	table	
2.4.	Membranes	were	 then	given	three	5	minute	washes	 in	TBST	before	adding	ECL	solution	
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(Amersham	ECL	solutions	A	and	B,	1:1	ratio)	 for	1	minute	at	room	temperature.	Membranes	
were	exposed	on	X-ray	film	(Amersham	Hyperfilm)	and	band	intensities	analysed	using	Image	J	
software.		
	
2.5.1.4	Stripping	and	reprobing		
PVDF	membranes	were	stripped	and	reprobed	for	a	different	antibody	or	loading	controls.	To	
strip	membranes,	 they	were	washed	 in	 ultrapure	water	 for	 10	minutes	 at	 room	 temp,	 then	
0.5M	sodium	hydroxide	for	10	minutes	and	finally	ultrapure	water	for	10	minutes.	Membranes	
were	then	re-blocked	in	5%	milk	powder	and	probed	with	primary	antibodies.		
	
	
Primary	antibody	 Company	 Dilution/	concentration	
Rabbit	DOCK9	A300-531A	 Bethyl	 1:1000	
Mouse	DOCK4	Ab	85723	 Abcam	 1:1000	
Mouse	anti	GAPDH	 Sigma	-Aldrich	 1:1000	
Rabbit	anti	GAPDH	 Abcam	 1:1000	
Goat	 anti	 VE-cadherin	 sc-
6458	
Santa	Cruz	 1:1000	
Secondary	antibody	 Company	 Dilution/	concentration	
Sheep	Anti-mouse	IgG	HRP	 Amersham	 1:10000	
Donkey	 Anti-Rabbit	 IgG	
HRP	
Amersham	 1:10000	
Donkey	Anti-Goat	HRP		 Abcam	 1:10000	
Table	2.4	List	of	antibodies	used	in	this	thesis	for	immunoblot	assays	
	
	
2.6	Statistical	methods	
Normal	distribution	of	data	was	assessed	before	parametric	 test	were	carried	out.	Statistical	
significance	was	determined	using	the	two	tailed	student	T-test	on	Microsoft	Excel	assuming	a	
two-tailed	distribution	with	unequal	variance	between	sample	means.	All	error	bars	in	primary	
data	represent	S.E.M.	for	3	or	more	biological	replicates.		
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Chapter	3	
Rac	GEF	DOCK4	and	Cdc42	GEF	DOCK9	
Control	Tubule	Lumen	Formation	
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3.1	Introduction		
Blood	 vessel	 growth	 from	 pre-existing	 vessels	 largely	 takes	 place	 through	 the	 process	 of	
sprouting	angiogenesis.	During	sprouting	angiogenesis	 tip	cells	sprout	 from	a	vessel	wall	and	
migrate	towards	growth	factors	and	other	cells	in	the	surrounding	microenvironment.	Tip	cells	
have	abundant	actin-rich	 filopodial	protrusions	 that	 sense	 the	extracellular	environment	and	
allow	 response	 to	 directional	 ques.	 The	 actin	 cytoskeleton	 controls	 several	 fundamental	
endothelial	cell	functions	during	angiogenesis;	including	migration,	spreading	and	cell	division.	
Cell	motility	and	intricate	changes	in	cell	shape	are	particularly	important	during	sprouting	and	
also	during	the	later	stages	of	alignment,	elongation	and	lumen	formation.	The	Rho	family	of	
small	 GTPases	 cycle	 between	 active,	 GTP-bound	 forms	 and	 inactive,	 GDP-bound	 forms	 to	
transmit	 signals	 from	 growth	 factors	 receptors,	 and	 are	 known	 to	 play	 major	 roles	 in	
controlling	and	modulating	 the	actin	cytoskeleton	 (Hall,	1998).	Guanine	nucleotide	exchange	
factors,	 or	 GEFs,	 catalyse	 the	 exchange	 of	 GDP	 for	 GTP	 thus	 activating	 the	 GTPases,	 while	
GTPase	activating	proteins,	or	GAPs,	 increase	the	 intrinsic	hydrolysis	 rate	of	 the	GTPase	thus	
inactivating	 it	 (Kather	 and	 Kroll,	 2013).	 In	 previous	 work,	 described	 in	 “Preliminary	 work	
leading	 to	 this	 thesis”,	 it	 had	 been	 shown	 that	 knockdown	 of	 the	 Rac1	 GEF	 DOCK4	 in	
endothelial	 cells	 led	 to	 disruption	 of	 VEGF-driven	 filopodia	 in	 developing	 tubules	 in	 an	
organotypic	 angiogenesis	 assay,	 and	 that	 VEGF	 stimulated	 formation	 of	 a	 complex	 between	
DOCK4	 and	 the	 Cdc42	 GEF	 DOCK9.	 DOCK9	 knockdown	 blocked	 filopodia	 formation.	
Preliminary	work	had	also	shown	that	DOCK4	knockdown	may	impact	on	lumen	formation	in	
the	 assay.	 This	 Chapter	 aims	 to	 further	 investigate	 the	 role	 of	 DOCK4	 and	 DOCK9	 in	 lumen	
formation,	and	assess	how	cytoskeletal	changes	early	in	tubule	morphogenesis	can	affect	later	
stages	of	lumen	formation.		
	
	
3.2	Optimisation	of	the	organotypic	coculture	assay	to	model	angiogenesis	in	vitro		
To	study	the	roles	of	DOCK4	and	DOCK9	in	angiogenesis,	we	used	an	in	vitro	co-culture	model	
that	 recapitulates	 distinct	 stages	 of	 tubule	 formation.	 This	 model	 involves	 the	 coculture	 of	
human	dermal	fibroblasts	(HDF)	with	primary	human	umbilical	vein	endothelial	cells	(HUVEC);	
endothelial	 cells	 are	 seeded	 onto	 a	 confluent	 layer	 of	 HDF	 that	 have	 grown	 for	 seven	 days	
(Figure	3.1).	The	HDF	produce	a	natural	3D	environment	 including	matrix	and	growth	factors	
that	 enables	 the	 development	 of	 capillary-like	 tubules	 as	 shown	 in	 Figure	 3.2	 and	 reported	
previously	 (Bishop	 et	 al.,	 1999;	 Donovan	 et	 al.,	 2001;	Mavria	 et	 al,	 2006).	 	 HUVEC	may	 be	
marked	with	EGFP	by	means	of	 lentiviral	transduction	followed	by	FACS	sorting	(Mavria	et	al	
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2006;	 Hetheridge	 et	 al,	 2011),	 so	 that	 different	 stages	 of	 tubule	 morphogenesis	 can	 be	
monitored	 by	 live	 cell	 imaging	 or	 by	 timelapse	microscopy	 (Figure	 3.3).	 At	 the	 start	 of	 the	
project,	 the	 number	 of	 cells	 was	 varied	 for	 optimal	 tubule	 formation	 which	 was	 seen	 with	
1x104	 HUVEC	 and	 2.0x104	 HDF	 (Figure	 3.2),	 and	 therefore	 these	 cell	 numbers	were	 used	 in	
subsequent	experiments.		
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Figure	3.1	Organotypic	angiogenesis	assay	and	overview	of	stages	leading	to	tube	formation	
(A)	Coculture	assay	setup	schematic.	2x104	 fibroblasts	are	plated	and	 let	grow	to	confluence	
for	seven	days	after	which	time	1x104	HUVEC,	unmodified,	marked	with	EGFP,	or	transduced	
with	 lentiviruses	harbouring	shRNAs	and	EGFP	are	 seeded	onto	 the	 fibroblasts.	 (B)	Stages	of	
tubule	 formation	 observed	 in	 the	 coculture	 Sprouting	 tubules	 can	 be	 observed	 5	 days	 after	
seeding	and	quiescent	tubules	at	11	days	(Abraham	et	al,	2009).	The	cocultures	are	analysed	
for	lumen	formation	14	days	after	seeding	of	HUVEC	onto	the	fibroblasts.		
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Figure	3.2	Tubule	growth	in	the	HUVEC-HDF	coculture	assay	at	5	days	
2x104	fibroblasts	were	plated	and	let	grow	to	confluence	for	seven	days	after	which	time	1x104	
HUVEC	were	seeded	and	let	grow	for	5	days	after	which	they	were	fixed	with	4%	PFA.	Cultures	
were	 stained	 using	 IHC	 for	 the	 endothelial	 marker	 CD31	 to	 visualise	 developing	 tubules	
(chapter	 2	 section	 2.3.5).	 Arrows	 point	 to	 tip	 cells	 (blue)	 and	 developing	 sprouts	 (red).	
Magnification	X10.		
	
	
	
	
X10
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Figure	3.3	Still	images	from	time-lapse	movies	depicting	stages	of	tubule	growth	
2x104	fibroblasts	are	plated	and	let	grow	to	confluence	for	seven	days	after	which	time	1x104	
EGFP-HUVEC	are	seeded	and	 imaged	using	the	 Incucyte	 live	cell	 imaging	system.	GFP	 images	
were	taken	every	2	hours	for	14	days.	Shown	are	still	images	at	day	0	(A),	day	2	(B),	and	day	8	
(C).	Arrows	indicate	cells	moving	towards	each	other	into	clusters.	Scale	bar	=	350µm.		
A
B
C
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3.3	Analysis	of	lumen	formation	in	the	coculture	assay		
As	 HUVEC	 develop	 tubules	 in	 the	 coculture	 assay,	 they	 go	 through	 distinct	 stages	 of	
morphogenesis.	 Early	 after	 seeding,	 HUVEC	may	 aggregate	 into	 clusters	 (Figure	 3.3A),	while	
single	 cells	 start	 to	 migrate	 along	 the	 fibroblast	 tracts	 towards	 other	 HUVEC	 (Hetheridge,	
Mavria	and	Mellor,	2011).	Clusters	 form	(Figure	3.3B)	and	being	to	 remodel	dynamically	and	
sprout	 for	approximately	8	days	 (Figure	3.3C)	by	which	stage	 they	are	still	 immature	and	do	
not	 form	 lumens.	 In	order	 to	 form	 lumens,	 stalk	endothelial	 cells	behind	 the	 leading	 tip	 cell	
must	downregulate	their	 response	to	angiogenic	growth	factors	and	establish	 lateral	cell-cell	
adhesions	 (Strilić	et	al.,	 2010;	Blanco	and	Gerhardt,	 2013;	Hayashi	et	al.,	 2013).	 To	promote	
the	development	of	lumens	in	the	coculture	assay	media	were	changed	at	day	7	to	optimised	
media	 that	 contain	 a	 lower	 concentration	 of	 growth	 factors	 (personal	 communication;	 Tim	
Almond	 TCS	 Cell	Works)	 and	 the	 tubules	were	monitored	 up	 to	 18	 days	 after	 seeding	 onto	
confluent	fibroblasts.	High	power	confocal	 imaging	on	day	11	show	that	the	endothelial	cells	
take	 on	 an	 elongated	 shape	 and	 align	 next	 to	 each	 other	 in	 elaborate	 branched	 networks	
(Figure	 3.4)	 while	 lumens	 start	 to	 form	 at	 sites	 of	 opposing	 cell-cell	 adhesion	 (Figure	 3.4).	
Moreover,	 the	 cells	 are	 joined	 by	 mature	 adherens	 junctions	 (Figure	 3.5)	 as	 shown	 by	
continuous	distribution	of	vascular	endothelial	(VE)	cadherin	(Abraham	et	al.,	2009).	Formation	
of	 an	 apical	membrane	was	 also	 observed	 at	 this	 stage,	marked	by	 expression	of	 the	 apical	
marker	podocalyxin,	which	later	localises	at	the	apical	surface	of	a	developed	lumen	(Strilić	et	
al.,	2009).	By	observing	the	tubules	at	different	stages	beyond	day	11,	it	was	determined	that	
14	day-old	cocultures	show	the	greatest	abundance	of	lumens	as	marked	by	apical	podocalyxin	
localisation	 (Figure	 3.6),	 and	 therefore	 the	 assays	 were	 routinely	 taken	 to	 this	 stage.	 For	
quantification,	 tubules	 showing	apical	podocalyxin	 staining	were	compared	with	 total	 tubule	
length,	and	around	40%	of	tubules	were	lumenised	in	the	assay	at	day	14.		
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Figure	3.4	Onset	of	lumen	formation	in	mature	tubules	in	the	coculture	assay	
2x104	fibroblasts	are	plated	and	let	grow	to	confluence	for	seven	days	after	which	time	1x104	
EGFP-HUVEC	are	seeded	onto	the	fibroblasts.	The	cocultures	were	fixed	on	day	11,	nuclei	were	
marked	 with	 DAPI	 (blue)	 and	 tubules	 were	 imaged	 using	 confocal	 microscopy.	 White	
arrowheads	point	to	elongated	and	juxtaposed	endothelial	cells	lining	the	developing	lumens.	
x40	confocal	images	with	oil-immersion	lens.	Scale	bar	50µm.	
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Figure	3.5	VE-cadherin	and	podocalyxin	localization	in	mature	tubules	in	the	coculture	assay	
2x104	fibroblasts	are	plated	and	let	grow	to	confluence	for	seven	days	after	which	time	1x104	
HUVEC	 are	 seeded	 onto	 the	 fibroblasts.	 The	 cocultures	 were	 fixed	 on	 day	 11,	 nuclei	 were	
marked	 with	 DAPI	 (blue)	 and	 tubules	 were	 imaged	 using	 confocal	 microscopy.	 Adherens	
junctions	were	marked	with	VE-cadherin	(green),	apical	membrane	with	podocalyxin	(red)	and	
nuclei	 with	 DAPI	 (blue).	 The	 tubules	 were	 imaged	 by	 confocal	 microscopy.	 Note	 the	
displacement	 of	 VE-cadherin	 at	 the	 site	 of	 lumen	 formation	 and	 the	 staining	 of	 the	 site	 of	
displacement	with	podocalyxin.	Scale	bar	=	15	µm.		
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Figure	3.6	Lumen	formation	in	the	coculture	assay	
2x104	fibroblasts	are	plated	and	let	grow	to	confluence	for	seven	days	after	which	time	1x104	
HUVEC	 are	 seeded	 onto	 the	 fibroblasts.	 The	 cocultures	 were	 fixed	 on	 day	 14,	 nuclei	 were	
marked	with	DAPI	(blue)	and	tubules	were	imaged	using	confocal	microscopy.	Three	stages	of	
lumen	opening	can	be	seen	using	podocalyxin	staining	(red).	Apical	localization	of	podocalyxin	
can	 be	 seen	 between	 elongated	 endothelial	 cells;	 collagen	 IV	 marks	 basement	 membrane	
(green).	Arrows	point	to	apical	podocalyxin	and	opening	leading	to	formation	of	the	lumen	(L).	
Scale	bar	15µm.	
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3.4	DOCK4	is	necessary	for	lumen	formation	in	the	coculture	assay	
In	order	to	assess	the	role	of	DOCK4	in	lumen	formation,	primary	HUVEC	were	transduced	with	
lentiviruses	 harbouring	 DOCK4	 shRNAs.	 This	 is	 because,	 unlike	 siRNA	 knockdown	 which	 is	
transient,	 lentiviral	shRNAs	achieve	 long-term,	stable	knockdown.	This	 is	required	 in	order	to	
assess	the	degree	of	lumen	formation	at	14	days	after	seeding	HUVEC	onto	the	fibroblasts.		In	
addition	to	shRNAs	the	lentiviruses	also	express	EGFP,	which	allows	FACS	sorting	of	transduced	
cells	 for	 live	 cell	 imaging.	 Initial	 experiments	 therefore	 assessed	 the	 degree	 of	 correlation	
between	the	level	of	EGFP	expression	and	knockdown	efficiency.	Cells	expressing	high	and	low	
EGFP	levels	were	sorted,	and	the	level	of	knockdown	in	those	populations	was	determined	by	
western	blotting.	Analysis	showed	that	higher	levels	of	knockdown	occurred	in	cells	expressing	
higher	EGFP	levels,	compared	to	cells	expressing	lower	EGFP	levels.	Two	different	shRNAs	that	
target	 different	 sequences	 within	 the	 same	 gene	 are	 routinely	 used	 in	 experiments	 to	
eliminate	 the	 possibility	 that	 the	 observed	 phenotypes	 are	 due	 to	 off-target	 effects.	
Accordingly,	HUVEC	were	transduced	with	two	different	lentiviral	DOCK4	shRNAs	(shRNA1	and	
shRNA2)	or	negative	control	shRNA,	and	were	seeded	onto	confluent	HDFs	(cell	sorting	gates	
in	appendix).	The	cocultures	were	fixed	at	14	days	after	seeding	HUVEC	onto	HDF	and	stained	
for	podocalyxin.	Multiple	Z-stack	 images	were	acquired	as	described	 in	Methods	 (Chapter	2,	
Section	 2.3.6.1)	 in	 order	 to	 image	 the	 three-dimensional	 lumens	 forming	 over	 multiple	
confocal	planes.	Single	Z-plane	 images	from	a	3D	Z-stack	showed	that	tubules	 lacking	DOCK4	
elongated	 but	 became	 thin	 and	 failed	 to	 acquire	 sufficient	 lateral	 adhesions	 (Figure	 3.7A).		
There	were	no	changes	in	the	expression	level	of	VE-cadherin	which	is	an	important	molecule	
in	 EC-EC	 adhesion	 and	early	 lumen	 formation	 (Figure	3.7	B).	 To	 further	 assess	 the	extent	of	
lateral	adhesions	and	loss	of	thickening	within	the	DOCK4	knockdown	tubules,	a	measurement	
of	nuclei	per	tubule	length	was	taken	in	control	and	DOCK4	shRNA	tubules.	Consistent	with	the	
long	 thin	 elongated	 tubules	 that	 lack	 lumens	 seen	 in	 the	 DOCK4	 knockdown	 (Figure	 3.9),	
DOCK4	tubules	showed	less	nuclei	per	length	of	tubule	when	compared	to	the	thicker	control	
tubules	 (Figure	 3.8).	 Quantification	 of	 lumenised	 length	 showed	 that	 there	 was	 a	 marked	
decrease	 in	 lumenised	 length	 with	 DOCK4	 knockdown	 by	 both	 shRNA1	 and	 shRNA2	 when	
compared	with	control	tubules	(Figure	3.10).			
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Figure	3.7	The	effect	of	DOCK4	knockdown	on	tubule	lateral	adhesions		
(A)	 2x104	 fibroblasts	 are	 plated	 and	 let	 grow	 to	 confluence	 for	 seven	 days	 after	which	 time	
1x104	 HUVEC	 transduced	with	 non-silencing	 control	 shRNA	or	DOCK4	 shRNA	 2	were	 seeded	
onto	 the	 fibroblasts.	 Cultures	were	 then	 fixed	 and	 stained	 as	 before	 for	 immunoflourescent	
imaging.	EGFP	HUVEC	(green),	VE-cadherin	(red)	DAPI	(blue).	Note	loss	of	lateral	adhesions	in	
DOCK4	shRNA2	tubules.	Similar	effects	were	observed	with	an	additional	DOCK4	shRNA.	Scale	
bar	 =	 25µm.	 (B)	 Western	 blot	 of	 the	 junctional	 protein	 VE-cadherin	 assessed	 after	 DOCK4	
knockdown	and	normalised	to	GAPDH	levels.		
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Figure	3.8	DOCK4	knockdown	controls	endothelial	cell	numbers	in	tubules	
2x104	fibroblasts	are	plated	and	let	grow	to	confluence	for	seven	days	after	which	time	1x104	
HUVEC	transduced	with	negative	control	shRNA	or	DOCK4	shRNA	1	or	shRNA	2	were	seeded	
onto	 the	 fibroblasts.	 Tubule	 length	 was	 assessed	 by	 measuring	 length	 of	 GFP	 expressing	
tubules	 and	 counting	 DAPI	 stained	 nuclei	 within.	 Bar	 chart	 shows	 quantification	 of	
nuclei/1000µm	 length	 for	 control,	 DOCK4	 shRNA1	 and	 DOCK4	 shRNA2.	 Quantifications	 are	
from	multiple	images	(control	n=16	images,	DOCK4	shRNA1	n=16,	DOCK4	shRNA2	n=18)	from	
two	independent	experiments,	each	set	up	in	triplicate.	Significance	was	calculated	using	a	two	
tailed	student	T-test.	p	value	for	Dock4	shRNA1	=0.0057.	**	=	p<0.01.	
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Figure	3.9	DOCK4	knockdown	inhibits	lumen	formation	in	the	coculture	assay	
2x104	fibroblasts	are	plated	and	let	grow	to	confluence	for	seven	days	after	which	time	1x104	
HUVEC	transduced	with	non-silencing	control	shRNA	or	DOCK4	shRNA	1	were	seeded	onto	the	
fibroblasts.	 The	 cocultures	 were	 fixed	 on	 day	 14,	 nuclei	 were	marked	with	 DAPI	 (blue)	 and	
tubules	were	imaged	using	confocal	microscopy.	Apical	localization	of	podocalyxin	can	be	seen	
between	elongated	endothelial	cells	surrounding	lumens	(L);	collagen	IV	marks	the	basement	
membrane.	Scale	bar	14µm	
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Figure	3.10	Quantification	of	the	effect	of	DOCK4	knockdown	on	lumen	formation	
Bar	 chart	 shows	 quantification	 of	 percentage	 of	 tubules	 with	 lumens	 compared	 with	 total	
tubule	length.	Lumen	formation	was	assessed	by	podocalyxin	staining	and	confocal	imaging	of	
mature	 tubules	 at	 14	days	 after	 seeding	HUVEC	onto	 fibroblasts.	Quantifications	 are	 from	2	
independent	experiments	with	negative	control	n=3,	shRNA1	n=3	and	shRNA2	n=3.	5	 images	
were	quantified/well.	Scale	bar	=	14µm.	Significance	was	calculated	using	a	two	tailed	student	
T-test.	**	=	p<0.01,	***=p<0.001.		
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3.5	Generation	of	lentiviral	shRNAs	for	DOCK9	knockdown	studies		
In	 the	 preliminary	 work	 leading	 to	 this	 thesis,	 DOCK4	 was	 found	 to	 interact	 with	 DOCK9,	
therefore	 I	 set	out	 to	 investigate	 the	effects	of	DOCK9	on	 tubule	 formation	 in	 the	 coculture	
system	and	whether	knockdown	affects	lumen	formation.	In	order	to	assess	lumen	formation	
at	 14	 days	 after	 seeding	 HUVEC	 onto	 fibroblasts,	 long-term	 stable	 DOCK9	 knockdown	 was	
necessary.	 Multiple	 shRNA	 vectors	 that	 also	 expressed	 EGFP	 from	 Open	 Biosystems	 were	
grown	and	packaged	into	lentiviral	vectors	as	described	in	Methods	(Chapter	2,	Section	2.2.2-
2.2.3).	Primary	HUVEC	were	infected	with	multiple	shRNA	constructs	via	lentiviral	transduction	
and	were	 then	 fluorescence-activated	 cell	 sorted	based	on	 EGFP	 fluorescence.	 Total	 protein	
from	cell	 lysates	of	 sorted	cells	was	 then	quantified	and	 run	on	a	western	blotting.	The	 two	
DOCK9	shRNAs,	shRNA3	and	shRNA4,	gave	the	best	knockdown	assessed	by	western	blotting	
and	were	used	in	experiments	(Figure	3.11	A).	DOCK9	protein	levels	were	compared	against	a	
non-silencing	negative	control	shRNA	and	gave	values	of	95.2%	knockdown	for	DOCK9	shRNA3	
and	97.1%	knockdown	for	shRNA4	(Figure	3.11	B).		
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Figure	3.11	Stable	knockdown	of	DOCK9	by	means	of	lentiviral	transduction		
(A)	 Lysate	 was	 made	 with	 HUVEC	 transduced	 with	 non-silencing	 control	 shRNA	 or	 DOCK9	
shRNA	3	or	shRNA	4	10	days	after	transfection.	Levels	of	the	Cdc42	GEF	DOCK9	were	assessed	
by	 western	 blotting	 where	 expression	 of	 DOCK9	 in	 the	 knockdown	 samples	 (shRNA3	 and	
shRNA4)	was	compared	with	DOCK9	levels	 in	the	negative	control	sample	(non-silencing).	(B)	
Values	 shown	 are	 expressed	 as	 a	 percentage	 of	 control	 expression,	 normalised	 against	 the	
housekeeping	gene	GAPDH.		
	
	
	
	
	
	
	
	
DO
CK
9 s
hR
NA
3
DO
CK
9 s
hR
NA
4
No
n-
sil
en
cin
g s
hR
NA
DOCK9
GAPDH
shRNA Knockdown
DOCK9 shRNA3 95.2%
DOCK9 shRNA4 97.1%
0
20
40
60
80
100
120
No
n-
sil
en
cin
g
sh
RN
A3
sh
RN
A4
%
 D
O
C
K
9 
pr
ot
ei
n 
ex
pr
es
si
on
A
B
	 85	
3.6	Analysis	of	the	effect	of	DOCK9	knockdown	on	endothelial	cell	shape	and	proliferation	
Since	 Cdc42	 is	 known	 to	 control	 spreading	 and	 proliferation	 (Barry	 et	 al.,	 2015),	 first	 I	
examined	 whether	 DOCK9	 knockdown	 affects	 endothelial	 cell	 shape	 and	 proliferation.	 Cell	
spreading	was	analysed	 in	control	 cells	and	DOCK9	knockdown	cells	by	 seeding	onto	culture	
dishes	 and	 imaged	 by	 phase	 contrast	 imaging	 (Figure	 3.12	 A).	 No	 significant	 difference	 in	
spreading	area	was	found	between	control	shRNAs	and	DOCK9	shRNA	knockdown	cells	(Figure	
3.12	A).	 To	 account	 for	 any	 similarities	 in	 area	between	 spreading	 cells	 and	 elongated	 cells,	
circularity	 measurements	 were	 also	 carried	 out	 using	 ImageJ	 software.	 No	 significant	
difference	was	found	between	the	circularity	of	control	shRNAs	and	DOCK9	shRNA	knockdown	
cells,	suggesting	that	spreading	and	cell	shape	changes	are	not	under	control	of	DOCK9	(Figure	
3.12	C).	Cdc42	has	also	been	shown	to	play	a	role	in	proliferation	in	many	cell	types	(Boe	et	al.,	
2012;	Melendez	et	al.,	2013).	Any	potential	effect	on	proliferation	might	result	 in	differences	
in	cell	number	in	the	co-culture	assay	and	ultimately	affect	lumen	quantification	results.	Two	
methods	were	used	to	assess	any	potential	differences	in	proliferation	due	to	loss	of	DOCK9.	
The	Ki-67	protein	 is	commonly	used	as	a	proliferation	marker	and	known	to	be	expressed	 in	
the	nucleus	of	 cells	 in	 interphase	 and	 in	mitotic	 chromosomes,	 but	 not	 during	G0	 (Scholzen	
and	Gerdes,	2000).	Quantification	of	Ki67	positive	nuclei	 showed	no	 significant	difference	 in	
proliferation	between	empty	 vector,	 non-silencing	 control	 and	DOCK9	 shRNA3	or	 shRNA4	 in	
HUVEC	 24	 hours	 after	 seeding	 (Figure	 3.13	 A).	 Proliferation	 was	 also	 assessed	 using	 a	 live	
imaging	 microscope	 (Incucyte),	 capable	 of	 time-lapse	 imaging	 EGFP-HUVEC	 during	
proliferation	 over	 the	 course	 of	 three	 days	 (Described	 in	 Chapter	 2	 section	 2.3.8).	 This	
experiment	 considers	 if	 there	were	any	differences	 in	 cycling	 speeds	of	 cells	 lacking	DOCK9.	
Similarly,	 results	 showed	 that	 there	 were	 no	 proliferation	 differences	 in	 control	 or	 DOCK9	
knockdown	 cells	 when	 grown	 to	 confluence	 over	 three	 days,	 shown	 as	 an	 increase	 in	 GFP	
fluorescence	over	time	(Figure	3.13	B).		
	
Knockdown	of	DOCK9	did	not	affect	VE-cadherin	localisation	in	HUVEC	growing	as	a	monolayer	
or	in	the	coculture	assay	(Figure	3.13	C).	DOCK9	knockdown	did	not	have	an	effect	on	overall	
VE-cadherin	 levels	 assessed	 by	 western	 blotting.	 (Figure	 3.13	 C).	 These	 results	 suggest	 that	
DOCK9	is	dispensable	for	VE-cadherin	expression	and	localisation.		
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Figure	3.12	DOCK9	knockdown	does	not	affect	HUVEC	spreading	or	bipolarity	
1x104	HUVEC	transduced	with	non-silencing	control	shRNA	or	DOCK9	shRNA	3	or	shRNA4	were	
seeded	onto	glass	cover	slips	in	24	well	dishes	and	let	adhere	overnight	before	fixing	with	PFA	
and	Imaging	with	ImageJ.	(A)	Representative	images	of	cells	spreading	and	circularity	in	control	
and	DOCK9	shRNA3	and	DOCK9	shRNA4.	Scale	bar	=	200um.	(B)	Spreading	area	was	measured	
and	 compared	 to	 control	 non-silencing	 shRNA.	 (C)	 Circularity	 was	 measured	 using	 ImageJ	
where	a	value	of	1	represents	a	perfect	circle	(round	cell).	Significance	was	calculated	using	a	
two	 tailed	 student	 T-test.	 EV,	 empty	 vector;	 Non-S,	 non-silencing;	 ns,	 non-significant;	 a.u.	
(arbitrary	units).		
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Figure	3.13	DOCK9	does	not	control	endothelial	cell	proliferation	or	VE-cadherin	expression	
(A)	1x104	HUVEC	 transduced	with	non-silencing	and	EV	control	 shRNA	or	DOCK9	shRNA	3	or	
shRNA4	were	seeded	onto	glass	cover	slips	in	24	well	dishes	and	let	adhere	overnight	before	
fixing	 with	 PFA.	 Proliferation	 was	 assessed	 by	 means	 of	 Ki-67	 staining.	 Bar	 chart	 shows	
percentage	of	cell	nuclei	positive	for	Ki-67.	Ns,	non-significant.	(B)	Increase	in	confluence	over	
3	days	as	measured	by	EGFP	fluorescence	on	the	Incucyte	live	imaging	system.	No	significant	
difference	was	 found	between	proliferation	 rates	 as	measured	by	 increasing	 confluence.	 (C)	
VE-Cadherin	 after	 DOCK9	 knockdown	western	 blot.	 Significance	 was	 calculated	 using	 a	 two	
tailed	student	T-test.	EV,	empty	vector;	Non-S,	non-silencing;	ns,	non-significant.		
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3.7	DOCK9	knockdown	inhibits	lumen	formation	in	the	coculture	assay	
To	investigate	the	role	DOCK9	plays	in	lumen	formation,	the	previously	optimized	lumen	assay	
was	 employed.	 Primary	 HUVEC	 were	 transduced	 with	 lentiviruses	 harboring	 non-silencing	
control	and	DOCK9	shRNAs	as	described	 in	 section	3.5	above.	Cocultures	were	grown	 for	14	
days	 and	 stained	 for	 immunofluorescence	 microscopy.	 Lumen	 formation	 was	 assessed	 by	
podocalyxin	 localization	 at	 apical	 sites	 as	 before.	 Tubules	 lacking	 DOCK9	 had	 a	 long	 thin	
morphology	 and	 less	 branching	when	 compared	with	 control	 tubules.	 This	 result	 suggests	 a	
role	for	DOCK9	in	branching	of	developing	tubules	but	no	role	in	tip	dynamics.		When	stained	
for	 podocalyxin	 control,	 tubules	 showed	 strong	 and	 defined	 stain	 for	 podocalyxin	 at	 lateral	
sites	between	elongated	cells	(Figure	3.14).	There	was	a	twofold	decrease	in	lumen	formation	
in	 tubules	 lacking	 DOCK9	with	 both	 shRNAs	 tested	 (Figure	 3.15).	 These	 results	 suggest	 that	
DOCK9	 is	 dispensable	 for	 tubule	 elongation	 but	 necessary	 for	 lumen.	 Studies	 on	 the	 role	 of	
DOCK4	 in	 lumen	 formation	 had	 shown	 an	 association	 between	 a	 defect	 in	 lumen	 formation	
and	 lateral	 adhesions	 with	 DOCK4	 knockout	 (Abraham	 et	 al.,	 2015).	 However,	 when	 the	
formation	of	lateral	adhesions	was	assessed	with	DOCK9	knockdown	by	measuring	the	number	
of	nuclei	per	unit	length,	no	differences	were	seen	between	control	tubules	and	tubules	with	
DOCK9	(Figure	3.16).	This	suggests	that	in	addition	to	cytoskeletal	rearmaments	evidenced	by	
the	 control	 of	 filopodial	 protrusions	 regulated	 by	 DOCK4	 and	 DOCK9,	 DOCK4	 may	 play	
additional	roles	in	the	control	of	lateral	cell-cell	contacts,	which	are	not	shared	by	DOCK9.		
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Figure	3.14	EGFP-HUVEC	forming	tubules	in	the	coculture		
2x104	fibroblasts	are	plated	and	let	grow	to	confluence	for	seven	days	after	which	time	1x104	
HUVEC	 transduced	 with	 non-silencing	 control	 shRNA	 or	 shRNA	 4	 were	 seeded	 onto	 the	
fibroblasts.	 The	 cocultures	 were	 fixed	 on	 day	 14,	 nuclei	 were	marked	with	 DAPI	 (blue)	 and	
tubules	were	imaged	using	confocal	microscopy.	Apical	localization	of	podocalyxin	can	be	seen	
between	 elongated	 endothelial	 cells	 surrounding	 lumens	 (L);	 collagen	 IV	 marks	 basement	
membrane.	Scale	bar	16µm.		
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Figure	3.15	DOCK9	controls	lumen	formation	in	the	coculture	assay	
2x104	 fibroblasts	are	plated	and	grown	to	confluency	 for	 seven	days,	after	which	 time	1x104	
HUVEC	 transduced	 with	 non-silencing	 control	 shRNA,	 or	 DOCK9	 shRNA	 3	 or	 shRNA	 4	 were	
seeded	onto	 the	 fibroblasts.	The	cocultures	were	 fixed	on	day	14,	and	 lumen	 formation	was	
assessed	 by	 podocalyxin	 staining	 and	 confocal	 imaging	 of	 mature	 tubules.	 Bar	 chart	 shows	
quantification	 of	 percentage	 of	 tubules	 with	 lumens	 compared	 with	 total	 tubule	 length.		
Quantifications	 are	 from	 4	 independent	 experiments,	 n=number	 of	 images,	 (Non-silencing	
n=12,	shRNA3	n=12	and	shRNA4	n=12).	Significance	was	calculated	using	a	two	tailed	student	
T-test.	***	=	p<0.001.	Non-S,	non-silencing.		
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Figure	3.16	DOCK9	knockdown	does	not	affect	endothelial	density	in	tubules		
2x104	 fibroblasts	 are	plated	 and	 grown	 to	 confluency	 for	 seven	days	 after	which	 time	1x104	
HUVEC	 transduced	 with	 non-silencing	 control	 shRNA	 or	 DOCK9	 shRNA	 3	 or	 shRNA	 4	 were	
seeded	 onto	 the	 fibroblasts.	 Tubule	 length	 was	 assessed	 by	 measuring	 length	 of	 GFP	
expressing	tubules	and	counting	DAPI	stained	nuclei	within.	Bar	chart	shows	quantification	of	
nuclei/1000µm	length	for	Non-silencing,	DOCK9	shRNA3	and	DOCK9	shRNA4.	Quantifications	
are	 from	multiple	 images	 (Non-silencing	n=16	 images,	DOCK9	 shRNA3	n=16,	DOCK9	 shRNA4	
n=18)	from	two	independent	experiments,	each	set	up	in	triplicate.	Significance	was	calculated	
using	a	two	tailed	student	T-test.	Non-S,	non-silencing,	ns,	non-significant.		
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Figure	3.17	Validation	of	the	DOCK9	antibody	in	HUVEC		
1x104	 HUVEC	 transduced	 with	 non-silencing	 control	 shRNA	 or	 DOCK9	 shRNA4	 were	 seeded	
onto	glass	cover	slips	in	24	well	dishes	and	let	adhere	overnight	before	fixing	with	70%	ethanol	
after.	(A)	Representative	immunofluorescence	images	of	HUVEC	stained	with	DOCK9	antibody.	
Scale	bar	=	62µm.	(B)	Bar	chart	shows	corrected	total	cell	fluorescence	(CTCF)	and	integrated	
density	 (IntDen)	measured	 using	 the	 ImageJ	 software.	 N=	 number	 of	 cells	 quantified	 (Non-
silencing	=	40,	DOCK9	 shRNA4	=	42)	 from	5	 images	per	 condition.	Dashed	 lines	 indicate	 cell	
boundaries.	Significance	was	calculated	using	a	two	tailed	student	T-test.	**	=	p<0.01.		
	
	
	
	
	
Non-silencing DOCK9 shRNA4
D
O
C
K
9
0
10
20
30
40
50
60
70
80
90
100
Non - silencing DOCK9 shRNA4A
ve
ra
ge
 D
O
C
K
9 
flo
ur
es
ce
nc
e 
in
te
ns
ity
 (%
)
CTCF IntDen
D
A
P
I
A
B
**
	 93	
3.8	DOCK9	localises	with	the	apical	surface	in	spreading	HUVEC	in	vitro	
To	 investigate	 the	 localisation	 of	 DOCK9	 in	 endothelial	 cells	 by	 immunofluorescence	
microscopy,	 staining	with	 a	newly	 available	 antibody	 (Proteintech)	was	optimized	 in	HUVEC.	
DOCK9	was	 knocked	down	using	 lentiviral	 shRNAs	 against	DOCK9	 in	HUVEC	and	 knockdown	
efficiency	was	confirmed	using	western	blotting.	Cells	were	then	seeded	for	24	hours	before	
trying	 two	 different	 fixation	 methods,	 4%	 PFA	 and	 70%	 ethanol.	 Immunofluorescence	 was	
then	carried	out	 to	 look	at	 levels	of	DOCK9	 in	cells	with	shRNA	compared	with	non-silencing	
negative	control	virus.	70%	ethanol	fixation	was	the	only	method	that	resulted	in	a	decreased	
whole	cell	intensity	for	DOCK9	stain	in	shRNA4	knockdown	cells	compared	with	control	(Figure	
3.17).	These	results	were	consistent	with	levels	of	knockdown	seen	by	western	blotting	(Figure	
3.11).		
	
As	shown	 in	section	3.4,	DOCK4	tubules	 failed	to	acquire	sufficient	 lateral	adhesions	to	 form	
lumens	as	evident	by	the	nuclei	per	unit	length	measures.	However,	DOCK9	tubules	showed	no	
difference	 in	 nuclei	 per	 length	 measures	 when	 compared	 with	 control.	 To	 investigate	 the	
potential	 mechanism	 by	 which	 DOCK9	 is	 controlling	 lumen	 formation	 and	 podocalyxin	
localisation	in	tubules,	the	localisation	of	podocalyxin	to	the	apical	surface	during	polarisation	
was	assessed.		
	
In	endothelial	cells,	as	with	many	other	cells	types,	acquisition	of	polarity	plays	a	major	role	in	
many	 of	 their	 functions.	 Acquiring	 apical-basal	 (luminal-abluminal)	 polarity	 is	 one	 of	 the	
necessary	steps	 in	order	to	form	vascular	 lumens	(Iruela-Arispe	and	Davis,	2009).	Galvagni	et	
al.	showed	that	during	the	early	stages	of	spreading	in	vitro,	endothelial	cells	display	an	F-actin	
rich	domain	on	 their	 apical	 surface	which	 is	 found	 to	be	enriched	 for	many	proteins	usually	
found	 on	 the	 apical	 surface.	 Consequently,	 they	 called	 this	 site	 of	 accumulation	 of	 apical	
proteins	in	spreading	cells	in	2D	culture	apical	membrane	insertion	site	(AMIS)	(Galvagni	et	al.,	
2012).	 Recent	 research	 has	 also	 shown	 that	 the	 transport	 and	 accumulation	 of	 important	
apical	 proteins	 at	 this	 AMIS	 is	 a	 process	 that	mimics	 stages	 prior	 to	 lumen	 formation	when	
HUVEC	again	accumulate	apical	proteins	at	the	newly	developing	lumen	(Richards,	Hetheridge	
and	Mellor,	2015).		
	
During	 spreading,	endothelial	 cells	 form	this	apical	domain	which	can	be	seen	by	 staining	of	
actin	filaments	(phalloidin).	Importantly,	podocalyxin	can	be	seen	to	localize	at	the	AMIS	along	
with	the	endothelial	junctional	protein	VE-cadherin	(Figure	3.18).	After	optimization	of	staining	
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with	the	DOCK9,	I	investigated	the	localisation	of	DOCK9	during	this	process	and	found	it	was	
concentrated	 at	 the	 apical	 surface,	 as	 previously	 reported	 for	 other	 apical	 proteins	 (Figure	
3.19).		
	
To	 elucidate	 a	 potential	 role	 of	 DOCK9	 in	 localisation	 of	 proteins	 to	 the	 apical	 membrane,	
siRNA	 knockdown	was	 carried	 out	 on	HUVEC,	 and	 cells	 lacking	 DOCK9	were	 seeded	 for	 the	
AMIS	 assay.	 Knockdown	 of	 DOCK9	 did	 not	 affect	 localisation	 of	 podocalyxin	 to	 the	 apical	
membrane	suggesting	it	may	regulate	a	different	process	in	lumen	formation	(Figure	3.20).		
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Figure	3.18	Apical	proteins	localise	to	the	AMIS	domain	during	early	spreading	in	HUVEC	
1x104	 HUVEC	 were	 seeded	 onto	 glass	 cover	 slips	 in	 24	 well	 dishes	 and	 let	 spread	 for	 25	
minutes	 before	 fixing.	 (A)	 Cells	 were	 stained	 for	 apical	 proteins	 and	 imaged	 by	 confocal	
microscopy	to	generate	Z-stacked	images.	Zoomed	area;	Phalloidin	(red),	VE-cadherin	(green),	
DAPI	(blue).	(B)	Phalloidin	(red),	podocalyxin	(green),	DAPI	(blue).	Scale	bar	=	12um		
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Figure	3.19	DOCK9	localises	with	the	AMIS	apical	domain	in	spreading	HUVEC	
1x104	 HUVEC	 were	 seeded	 onto	 glass	 cover	 slips	 in	 24	 well	 dishes	 and	 let	 spread	 for	 25	
minutes	 before	 fixing.	 Cells	 were	 stained	 for	 apical	 proteins	 and	 imaged	 by	 confocal	
microscopy	to	generate	Z-stacked	images.	Phalloidin	(red),	DOCK9	(green),	DAPI	(blue).	Dashed	
line	indicates	cell	boundary.	Scale	bar	=	31µm	
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Figure	3.20	DOCK9	knockdown	does	not	affect	apical	localisation	of	podocalyxin			
HUVEC	transduced	with	control	(Non-silencing)	and	DOCK9	siRNA	were	seeded	on	glass	slides	
and	 let	 spread	 for	 25	 minutes	 before	 fixing.	 Cells	 were	 stained	 for	 the	 apical	 protein	
podocalyxin	 and	 imaged	 by	 confocal	 microscopy	 to	 generate	 Z-stacked	 images.	 Bar	 chart	
shows	quantification	of	the	localization	of	podocalyxin	to	the	apical	domain	(AMIS)	in	control	
(Non-silencing)	and	DOCK9	siRNA.		
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3.9	Conclusions	
Vascular	 lumen	 formation	 is	a	 vital	 step	 in	order	 to	 confer	 functionality	 to	developing	blood	
vessels.	 	The	process	of	tube	formation	in	other	cell	types	has	been	well	studied	to	date	and	
diverse	mechanisms	have	been	described,	for	example	in	epithelial	cells	multiple	mechanisms	
exist	 based	on	 the	 size,	 location,	 and	 function	of	 the	 resulting	 lumen	 to	 be	 formed	 (section	
1.5.2)	 (see	 reviews	 (Chung	 and	Andrew,	 2008;	 Sigurbjörnsdóttir,	Mathew	and	 Leptin,	 2014).	
However,	 endothelial	 lumen	 formation	 remains	 to	 be	 fully	 understood	 since	 conflicting	 and	
contradictory	 theories	 exist.	 Blood	 vessel	 lumens	 have	 been	 shown	 to	 form	 via	 two	 key	
mechanisms	 (Iruela-Arispe	 and	 Davis,	 2009):	 expansion	 of	 an	 intracellular	 vacuoles	 within	
endothelial	 cells	 to	 form	 seamless	 lumens	 (Kamei,	W	 Brian	 Saunders,	 et	 al.,	 2006);	 or	 cord	
hollowing,	 whereby	 a	 lumen	 forms	 by	 opposing	 endothelial	 cells	 with	 lateral	 adhesions	
followed	by	re-distribution	of	the	cell	junctions	to	the	edge	of	the	newly	formed	tube	(Strilić	et	
al.,	2009;	Pelton	et	al.,	2014).	Both	of	these	mechanisms	demand	an	intricate	control	of	actin	
dynamics	 and	 cell	 shape.	 A	 third	 key	 mechanism	 describes	 the	 expansion	 of	 blood	 vessel	
lumens	in	response	to	blood	flow	by	inverse	blebbing,	(Gebala	et	al.,	2016)	which	also	involves	
intricate	in	cytoskeletal	dynamics	and	actomyosin	contraction.		
	
Rho	 GTPases	 are	 known	 to	 be	 involved	 in	 many	 cellular	 functions	 including	 controlling	 the	
actin	 cytoskeleton	 and	 cell	 shape	 changes.	 Guanine	 nucleotide	 exchange	 factors	 (GEFs)	 and	
GTPase	 activating	 proteins	 (GAPs)	 which	 activate	 and	 deactivate	 GTPases,	 respectively,	 can	
provide	 another	 level	 of	 control	 based	 on	 their	 expression	 patterns	 by	 regulating	 activity	 in	
context-specific	 situations	 and	 also	 in	 a	 spacio-temporal	 manner	 (Kather	 and	 Kroll,	 2013).	
Therefore,	the	importance	of	understanding	the	role	of	individual	GEFs	during	angiogenesis	is	
imperative,	 as	 they	 may	 result	 in	 very	 specific	 targetable	 molecules	 in	 situations	 where	
angiogenesis	is	deregulated.			
	
In	this	chapter	I	have	demonstrated	that:	(i)	lumens	form	in	the	co-culture	assay	via	lateral	cell-
cell	 adhesions	 and	 cord	 hollowing;	 (ii)	 DOCK4	 and	 DOCK9	 play	 vital	 roles	 in	 early	 tubule	
morphogenesis	and	actin	rearrangement,	and	both	are	necessary	for	lumen	formation;	(iii)	the	
Cdc42	 GEF,	 DOCK9,	 localises	 with	 the	 apical	 surface	 of	 spreading	 HUVEC	 in	 vitro.	 The	 co-
culture	assay	is	an	ideal	method	to	visualise	the	effect	of	loss	of	GEFs	such	as	DOCK4	or	DOCK9	
on	tubule	morphogenesis	as	 it	provides	the	opportunity	to	investigate	many	stages	of	tubule	
growth.	 As	 seen	 using	 CD31	 IHC	 staining,	 endothelial	 cells	 went	 through	multiple	 stages	 of	
angiogenic	growth	and	tubule	morphogenesis	as	previous	described	(Figure	3.1)	 (Hetheridge,	
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Mavria	 and	 Mellor,	 2011).	 Tubules	 then	 rearrange	 further	 and	 endothelial	 cells	 acquire	
lumenal-ablumenal	 polarity	 at	 sites	 of	 cell-cell	 adhesions.	 This	 is	 consistent	 with	 previously	
described	 mechanisms	 and	 podocalyxin	 staining	 patterns	 seen	 in	 vivo	 (Strilić	 et	 al.,	 2009;	
Robbins	and	Beitel,	2016).		
	
DOCK9	is	a	GEF	for	the	Rho	GTPase	Cdc42,	which	is	known	to	regulate	many	cellular	functions	
related	to	actin	dynamics	and	filopodia	formation	(Krugmann	et	al.,	2001;	Meller	et	al.,	2004).	
Activation	 of	 Cdc42	 can	 be	 achieved	 by	 a	 number	 of	 exchange	 factors	 in	 diverse	 signalling	
pathways.	As	a	driver	of	so	many	important	and	distinct	cellular	functions,	the	specificity	of	its	
action	is	achieved	through	the	spatial	abundance	of	GEFs	in	distinct	regions	of	the	cell	and	also	
through	competition	between	GEFs	and	GAPs	at	difference	sites.		
	
When	DOCK9	was	knocked	down	in	the	coculture	assay,	the	result	was	a	two-fold	decrease	in	
lumenisation	seen	when	compared	with	control	tubules	(Figure	3.15).	However,	nuclei/	length	
measurements	showed	no	difference	in	lateral	adhesions	or	abundance	of	endothelial	cells,	as	
seen	with	DOCK4	knockdown.		
	
Polarisation	and	acquisition	of	apical-basal	(luminal-abluminal)	identity	are	essential	during	the	
early	stages	of	tubule	growth.	Defects	in	apical	luminal	identity	could	result	in	defects	in	tubule	
rearrangement	during	lumen	formation.	Interestingly,	activation	of	Cdc42	by	DOCK9	at	the	cell	
membrane	 has	 previously	 been	 shown	 to	 have	 lateral	 influences	 on	 cells,	 for	 example	 the	
control	 of	 dendrite	 outgrowth	 in	 rat	 hippocampal	 neurons	 (Kuramoto,	 Negishi	 and	 Katoh,	
2009).	I	have	shown	that	DOCK9	localises	with	the	apical	surface	of	polarising	endothelial	cells	
in	the	AMIS	assay,	along	with	a	range	of	other	important	apical	proteins	in	vitro	(Figure	3.18,	
3.17).	 Loss	 of	 DOCK9	 at	 this	 stage	 did	 not	 affect	 polarisation	 of	 cells	 or	 expression	 of	
podocalyxin	at	the	AMIS.		
	
These	 results	 show	 that	 DOCK9,	 like	 DOCK4	 controls	 lumen	 formation.	 While	 both	 control	
cytoskeletal	rearrangements	thus	regulating	a	yet	unidentified	site	in	the	formation	of	a	tube,	
such	 as	 establishment	 of	 a	 curvature	 for	 example,	 DOCK4	 also	 regulates	 lateral	 cell-cell	
contacts,	a	function	that	is	not	shared	by	DOCK9	according	to	the	data	presented	in	this	thesis.	
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Chapter	4	
The	role	of	ROCK2	in	Sprouting	and	
Lumen	Formation	in	vivo	
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4.1	Introduction	
The	Rho	associated	coiled-coil-containing	protein	serine/threonine	kinases	of	which	there	are	
two	 isoforms,	 ROCK1	 and	 ROCK2,	 are	 highly	 conserved	 serine	 threonine	 kinases	 that	 are	
involved	in	signalling	cascades	that	control	actin	dynamics	down	stream	of	RhoA/C	signalling.	
Rho	 kinase	 signalling	 has	 been	 implicated	 in	 different	 aspects	 of	 angiogenesis	 and	 lumen	
formation	 (Bryan	 et	 al.,	 2010;	 M.	 Kim	 et	 al.,	 2015).	 The	 exact	 role	 of	 ROCK	 signalling	 in	
endothelial	cell	biology	is	not	completely	understood	with	multiple	and	conflicting	roles	having	
been	 reported	 in	 the	 literature	 potentially	 due	 to	 the	 use	 of	 different	 assays	 and	 model	
systems	and	the	lack	of	studies	in	ROCK	knockout	mouse	models.	ROCK	plays	important	roles	
in	 cardiovascular	 disease	 and	 endothelial	 dysfunction	with	 a	 function	 in	 smooth	muscle	 cell	
contraction	and	vasodilation	of	blood	vessels	(Yao	et	al.,	2010).	This	is	supported	by	the	use	of	
ROCK	 inhibitors	 for	 the	 treatment	of	 cardiovascular	 disease.	 Small	molecule	ROCK	 inhibitors	
against	 ROCK	 are	 currently	 being	 tested	 in	 clinical	 trials	 and	 used	 to	 treat	 many	 vascular	
diseases	 looking	 at	 their	 effect	 on	 hypercontraction	 of	 vascular	 smooth	 muscle	 cells	 and	
endothelial	dysfunction	(Lin	et	al.,	2007;	Surma,	Wei	and	Shi,	2011).	Some	of	these	trials	have	
shown	promising	results	for	example	the	use	of	Fasudil	in	acute	ischemic	stroke	(Shibuya	et	al.,	
2005)	 and	 Y27632	 in	 vasospasm	 (Disli	 et	 al.,	 2009),	 however	 it	 is	 not	 known	whether	 their	
effects	are	solely	due	to	inhibition	of	ROCK.	A	number	of	new	more	potent	and	selective	ROCK	
inhibitors	have	been	developed	however	their	effects	on	angiogenesis	are	yet	unknown.	For	a	
better	understanding	of	 the	effects	of	 targeting	ROCK	 in	disease,	 it	 is	necessary	 to	elucidate	
the	 fundamental	 roles	 of	 ROCK	 in	 endothelial	 cells	 and	 for	 this	 purpose	 the	 use	 of	 in-vivo	
models	can	offer	the	best	 insights.	 In	this	chapter	 I	 investigate	the	role	of	the	ROCK2	 in	new	
blood	vessel	formation	and	lumen	formation	 in-vivo	using	a	Rock2	knockout	mouse	model.	A	
better	 understanding	 of	 ROCK	 signalling	 in	 the	 vasculature	 may	 influence	 the	 way	 we	
administer	 therapeutic	 agents	 aimed	 to	 inhibit	 ROCK	 and	 improve	 the	 outcome	 of	 these	
treatments.		
	
	
4.2	Loss	of	global	ROCK2	is	embryonically	lethal	at	E13.5	
Earlier	work	by	Thumkeo	and	colleagues	(Thumkeo	et	al.,	2003)	had	identified	that	global	loss	
of	 the	mouse	Rho	associated	kinase	2	gene	 (Rock2)	was	embryonically	 lethal,	with	 less	 than	
10%	 of	 Rock2-/-	 embryos	 surviving	 beyond	 E13.5	 while	 surviving	 mice	 were	 born	 runts	 but	
subsequently	 developed	 normally	 and	were	 fertile.	 Embryonic	 lethality	 was	 associated	with	
placental	dysfunction	and	intrauterine	growth	retardation	before	foetal	death	(Thumkeo	et	al.,	
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2003).	The	architecture	of	the	endothelium-free	placental	labyrinth	layer	of	the	Rock2	-/-	mice	
was	disrupted	with	extensive	thrombus	formation	forming	throughout.	These	findings	helped	
elucidate	a	 role	 for	ROCK2	 in	 inhibiting	blood	coagulation	and	maintaining	blood	 flow.	 Later	
work	by	the	same	group	had	led	to	the	discovery	that	loss	of	Rock1	was	less	severe	than	Rock2	
but	Rock1-/-	embryos	experienced	failure	of	eyelid	closure	and	closure	of	the	ventral	body	wall	
leading	 to	omphalocele	with	 intestine	and	 liver	protruding	outside	 the	abdomen	 (Shimizu	et	
al.,	2005).	These	defects	were	as	a	results	of	loss	of	organisation	of	actomyosin	bundles	at	the	
eye	and	the	umbilical	ring.	Most	Rock1-/-	mice	died	as	a	result	of	cannibalisation	by	the	mother	
soon	after	birth.		
	
Work	employing	a	new	Rock2	knockout	line	generated	more	recently	in	the	late	Christopher	J	
Marshall’s	 laboratory	at	 the	 Institute	of	Cancer	Research	and	described	 in	 ‘Preliminary	work	
leading	to	this	thesis’	had	also	 identified	that	 loss	of	Rock2	globally	was	 lethal	after	E13.5.	 In	
order	to	investigate	a	potential	involvement	of	placental	defects	in	the	embryonic	lethality	of	
Rock2	knockout	embryos,	the	Rock2	null	preimplantation	embryos	were	transferred	to	a	wild	
type	mother	 and	 their	 development	 compared	 that	 of	 the	Rock2	 null	 embryos	 in	 the	Rock2	
heterozygous	background.	It	was	found	that	the	embryonic	lethality	could	not	be	rescued	with	
the	wild	type	uterus	(McCarthy	et	al,	unpublished	data).	
	
Rock2-/-	 embryos	 showed	 disorganised	 vasculature	 as	 observed	 macroscopically	 with	
haemorrhages	 in	the	head,	neck	and	trunk	region	and	occasionally	pooled	blood	in	the	paws	
and	 feet	 (Figure	 4.1),	 in	 addition	 to	 omphalocele	 as	 observed	 previously	 (Thumkeo	 et	 al.,	
2003).	 Rock2	 knockout	 embryos	 also	 appeared	 paler	 when	 compared	 with	 wild	 type	
littermates	 (Figure	 4.1).	 Sections	 taken	 from	 the	 Interventricular	 foramen	 of	 Monro	 (the	
channel	 between	 the	 lateral	 ventricles	 and	 the	 third	 ventricle)	 high	 expression	 of	 ROCK2	 in	
blood	 vessels	 and	 confirmed	 complete	 loss	 of	 expression	 of	 ROCK2	 in	 the	 knockout	 mice	
(Figure	 4.2	 A,	 B).	 The	 apparent	 haemorrhages	 in	 the	 Rock2	 knockout	 embryos	 suggested	
improper	 blood	 flow	 and	 perfusion,	 potentially	 resulting	 from	 defects	 in	 blood	 vessel	
organisation	and/or	potential	heart	defects,	which	prompted	further	investigation	of	the	role	
of	ROCK2	in	angiogenesis	during	development.	
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Figure	4.1	Morphology	of	embryos	with	global	Rock2	deletion	at	E13.5 
Whole	mount	bright	field	images	of	Rock2	+/+	(wild	type)	and	Rock2	-/-	(knockout)	littermates	at	
embryonic	 day	 13.5.	 (A)	 Images	 show	 smaller	 size	 and	 hutched	 posture	 of	 E13.5	 Rock2-/-	
littermates.	Scale	bar	=	2mm	(B)	Image	of	Rock2	-/-	embryo	showing	incomplete	closing	(arrow)	
of	the	abdominal	wall	(omphalocele)	and	exhibiting	haemorrhages	in	the	head	and	neck	area	
(arrowhead).	Note	that	blood	vessels	appear	disorganised.	Scale	bar	=	1mm.	Images	taken	by	
Dr	Afshan	McCarthy,	ICR.		
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Figure	4.2	ROCK2	staining	of	sections	from	wild	type	and	Rock2	knockout	embryos. 
Transverse	 (horizontal)	 sections	 taken	 at	 the	 level	 of	 the	 interventricular	 foramen	of	Monro	
stained	 for	 ROCK2	 expression	 in	 embryos	 at	 E13.5.	 (A)	 Immunohistochemical	 staining	 for	
ROCK2	expression	in	the	brain	parenchyma	of	wild	type	embryos	(Rock2+/+),	and	loss	of	ROCK2	
expression	 in	Rock2	knockout	embryos	 (Rock2-/-).	 Scale	bar	=	10	µm	(B)	Dashed	box	zoomed	
region	from	(A)	showing	strong	ROCK2	expression	and	normal	development	of	blood	vessels	in	
brain	connective	tissue	surrounding	the	parenchyma.	Scale	bar	=100µm.	BV	=	blood	vessel.		
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4.3	Characterising	of	embryonic	brain	blood	vessels	E12.5	vs	E13.5	
As	significant	haemorrhaging	was	seen	in	the	head	and	neck	regions	of	the	ROCK2-/-	embryos	
and	 high	 expression	 of	 ROCK2	 in	 the	 vasculature,	 this	 led	 me	 to	 investigate	 blood	 vessel	
morphology	 and	 blood	 vessel	 lumen	 integrity	 at	 this	 developmental	 stage.	 Previously,	most	
studies	 of	 in	 vivo	 developmental	 angiogenesis	 relied	 on	 dissection	 of	 the	 retina	 or	 the	
hindbrain	 for	 staining	 and	 quantification	 of	 angiogenic	 functions.	 The	 disadvantage	 of	 using	
these	areas	is	the	extensive	dissection	needed	and	the	flat-mounting	required	for	imaging.	This	
results	 in	 loss	 of	 3D	 tissue	 structure	 and	 collapse	 of	 lumens.	 To	 investigate	 if	 there	 were	
vascular	abnormalities	prior	to	lethality	at	E13.5	I	characterised	a	previously	described	area	of	
developmental	angiogenesis	in	the	brain	(Lim	et	al.,	2010)	termed	the	angiozone	from	hereon.	
A	network	of	angiogenic	vessel	growth	branching	off	the	carotid	artery	was	selected	as	it	was	
in	 close	 proximity	 to	 the	 brain	 region	 showing	 haemorrhages	 and	 imaged	 with	 ease	 in	 the	
wholemount	embryos	(Figure	4.3	A).	The	advantage	of	imaging	the	angiozone	is	that	embryos	
can	be	stained	and	imaged	wholemount	without	the	need	for	dissection	and	importantly,	the	
blood	vessels	remain	intact	with	perfused	lumens.		
	
Wild	type	embryos	at	two	embryonic	stages	prior	to	lethality	were	chosen	for	characterisation,	
E12.5	 and	 E13.5	 (Figure	 4.3	 B).	 Angiogenic	 functions	 between	 the	 two	 developmental	 days	
were	quantified	and	compared.		Analysis	indicated	angiogenic	growth	in	the	brain	at	this	stage	
of	 development.	 There	 were	 significant	 increases	 in	 the	 total	 number	 of	 filopodia,	 vessel	
length	and	lumenised	length	between	E12.5	and	E13.5	(Table	4.1).		
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Figure	4.2	Sprouting	and	lumen	formation	at	E12.5	and	E13.5	in	wild	type	embryos 
Whole	mount	 confocal	 imaging	of	 immunofluorescent	 staining	of	 E12.5	 and	 E13.5	wild	 type	
mouse	embryos.	(A)	Left	hand	image,	whole	mount	tile	imaging	of	a	E13.5	embryo	stained	for	
endomucin	(green)	(the	image	was	assembled	from	XYZ	images	using	Volocity	software,	Perkin	
Elmer).	 Scale	bar	=	1mm.	Right	hand	 image	 shows	 the	position	of	 the	5	areas	quantified	 for	
analysis.	(B)	Endomucin	(green)	and	podocalyxin	(red)	staining	of	angiozone	for	analysis.	White	
arrows	point	to	filopodia,	stars	mark	blood	vessel	lumens.	Scale	bar	=	62µm		
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Counts	per	40x	
image	
E12.5	 E13.5	 p	value	
Filopodia 
47.4 (+/- 
3.19) 
69.2 (+/- 
3.05) 
1.60E-05 
Tip cells 
0.95 (+/- 
0.184) 
1.2 (+/- 
0.186) 
0.347 
Filopodia per tip cell 
5.2(+/-
0.36) 
6.8(+/-
0.35) 
0.003 
Branch points 
14.3 (+/-
1.4) 
17.7 (+/-
1.6) 
0.115 
Lateral filopodia per 
length 
0.051 0.059 0.326 
Total vessel length 
(µm) 
872.3 1080.9 0.003 
Total lumenised 
length (µm) 
283.1 568.6 2.10E-05 
Lumenised length 
(% total) 
34.4 52.9 0.003 
	
Table	4.1.	Angiogenic	growth	and	lumen	formation	at	embryonic	days	E12.5	and	E13.5	
Measures	of	 angiogeneic	 functions	at	embryonic	days	12.5	and	13.5	 in	 the	wild	 type	mouse	
embryo.	 Confocal	 images	 in	 the	 angiozone	 were	 analysed	 for	 angiogenic	 functions.	 Values	
represent	measurements	within	a	30µm	z-stack	image	for	each	image.	n=number	of	Z-stacks:	
E12.5	 n=20,	 E13.5	 n=20;	 4	 embryos	 per	 embryonic	 day,	 5	 images	 per	 angiozone.	 p	 values	
calculated	from	student	T	tests.	
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4.4	ROCK2	controls	endothelial	cell	filopodia	formation	and	vascular	integrity		
To	 investigate	 the	 influence	 of	 ROCK2	 on	 actin	 dynamics	 I	 determined	 the	 abundance	 of	
filopodia	on	the	developing	vessels	within	the	angiozone	 in	knockout	embryos	and	wild	type	
littermate	 controls.	 Filopodia	 are	 actin-rich	 structures	 that	 sense	 the	 external	 environment	
during	 endothelial	 tip	migration	 and	 sprouting	 (Mattila	 and	 Lappalainen,	 2008).	 As	with	 the	
angiozone	 characterisation,	 3D	 Z-stack	 reconstructions	 of	 areas	 within	 the	 angiozone	 were	
generated	using	confocal	microscopy	and	filopodia	in	each	image	counted	by	scrolling	through	
the	 entire	 z-stack.	 Characterisation	 of	 the	 blood	 vessels	 closer	 to	 the	 skin	 in	 the	 angiozone	
showed	 increased	 endothelial	 filopodia	 in	 the	 Rock2-/-	 mice	 compared	 with	 the	 wild	 type	
littermate	controls	(Figure	4.3).	ROCK	is	a	known	kinase	for	LIMK	1	and	2	and	also	controls	MLC	
2	phosphorylation	(Maekawa	et	al.,	1999)	which	 in	turn	phosphorylate	the	actin	binding	and	
severing	 protein	 cofilin	 (Ohashi	 et	 al.,	 2000),	 and	 controls	 actomyosin	 contractility	
respectively.	 It	 is	therefore	expected	that	 loss	of	ROCK	activity	may	lead	to	an	abundance	of,	
and	slower	turnover	or	defective	retraction	of	actin	based	filopodia.		
	
Evidence	of	defects	in	vascular	integrity	were	also	seen	in	the	angiozone	with	blood	cells	found	
outside	 the	blood	vessels	 in	 the	Rock2-/-	embryos	only	 (Figure	4.4).	 These	observations	were	
consistent	with	points	of	haemorrhage	identified	through	earlier	macroscopic	observations	in	
the	E13.5	Rock2-/-	embryos.		
	
Embryo	sections	at	the	level	of	the	heart	stained	for	endomucin	by	immunohistochemistry	also	
showed	increased	filopodial-like	structures	supporting	further	the	idea	that	in	the	absence	of	
ROCK2	endothelial	 cells	are	defective	 in	 turning	over	or	 retracting	 filopodial	protrusions	and	
consequently	 the	 vasculature	 of	 the	 Rock2-/-	 embryos	 retains	 a	 sprouting	 phenotype	 when	
compared	with	wild	type	controls	(Figure	4.5).		
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Figure	4.3	Increased	filopodial	sprouting	in	cerebral	blood	vessel	in	Rock2	knockout	embryos	
Filopodial	 protrusions	 were	 assessed	 by	 wholemount	 confocal	 imaging	 of	 the	 angiozone	 in	
E13.5	Rock2+/+	and	Rock2-/-	mouse	embryos	stained	for	endomucin.	(A)	Representative	images	
of	 filopodia	 in	Rock2+/+	 versus	Rock2-/-	 embryos.	 Scale	bar	=	15µm.	 (B)	Bar	 chart	of	 filopodia	
counts	 of	 E13.5	 Rock2+/+	 versus	 Rock2-/-,	 n=15	 images	 (Z-stacks)	 from	 embryos	 from	 each	
genotype	 Rock2-/-	 versus	 Rock2+/+	 littermate	 controls.	 Statistical	 significance	 was	 calculated	
using	a	two	tailed	student	T-test.	*	=	p<0.05.	
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Figure	4.4	Altered	vascular	integrity	in	cerebral	blood	vessel	in	Rock2	knockout	embryos	
Representative	images	of	blood	vessels	in	Rock2+/+	versus	Rock2-/-	embryos	show	blood	cells	
outside	the	vasculature	in	Rock2-/-	embryos	only.	Scale	bar	=	15µm.		
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Figure	4.5	Rock2	knockout	embryos	show	increased	filopodia	formation	in	developing	blood	
vessels	at	the	heart	level	 
Transverse	sections	taken	at	the	 level	of	the	heart	stained	for	vascular	marker	endomucin	 in	
embryos	 at	 E13.5.	 Immunohistochemical	 staining	 for	 endomucin	 in	 the	major	 vessels	 at	 the	
heart	 level	 in	Rock2	 -/-	and	Rock2	+/+.	Note	the	prominent	 filopodial	 like	structures	 in	nascent	
blood	 vessels	 stained	 for	 endomucin	 (white	 arrows).	 Dashed	 box;	 zoomed	 region	 of	 hyper-
filopodia	 phenotype.	 Note	 increased	 sprouting	 in	 the	 vessels	 around	 the	 aorta	 and	 spinal	
column	in	the	Rock2-/-	embryo.	A=	Aorta,	S=spinal	column.	Scale	bar	=	30µm.		
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4.5	ROCK2	controls	the	morphology	of	the	major	vessels	during	development	
To	 further	determine	 the	effect	of	 loss	of	Rock2	 in	blood	vessel	development,	 sections	 from	
the	heart	were	stained	for	endomucin	and	CD31	to	assess	any	effect	on	major	blood	vessels.	
These	blood	vessels	differ	 significantly	 from	vessels	 in	 the	parenchyma	as	 they	experience	a	
much	 greater	 flow	 rate	 and	 pressure	 and	 must	 withstand	 greater	 forces.	 They	 are	 also	
encompassed	within	numerous	levels	of	mural	cells	which	are	known	to	play	important	roles	in	
vasodilation	and	vasoconstriction.	
	
Sections	taken	at	the	level	of	the	heart	confirmed	loss	of	ROCK2	expression	in	the	Rock2-/-	mice	
(Figure	4.6).	As	with	the	haemorrhaging	seen	in	the	neck	and	head,	it	was	immediately	evident	
that	 there	 was	 significant	 haemorrhage	 in	 the	 pericardial	 cavity	 of	 majority	 of	 the	 Rock2-/-	
animals,	with	blood	cells	found	outside	the	vascular	network	and	heart	and	within	the	cavity	
itself	(Figure	4.6	A-B).	High	levels	of	ROCK2	expression	are	seen	in	the	heart	and	especially	in	
the	epicardium	outer	layer	of	the	heart	wall	(Figure	4.6	A-B).	Intriguingly,	the	epicardium	layer	
in	the	Rock2-/-	mice	is	seen	to	be	fractured	and	discontinuous	which	may	be	contributing	to	the	
haemorrhaging	and	leaking	of	blood	cells	seen	around	the	heart	and	in	the	pericardial	cavity.		
	
To	 assess	 the	 effect	 of	 loss	 of	Rock2	 on	 the	major	 blood	 vessels,	 analysis	 of	 the	 aorta	was	
carried	 out.	 Aortas	were	measured	 for	 diameter,	 area	 and	 circularity	 in	 both	wild	 type	 and	
Rock2	knockout	embryos.	Rock2	knock-out	aortas	showed	increased	aortic	area	and	abnormal	
circularity	 when	 compared	 with	 wild	 type	 (Figure	 4.7A-B).	 Increased	 aortic	 diameter	 is	
associated	with	aortic	abnormalities,	aneurisms	and	cardiovascular	degeneration	as	a	result	of	
old	age	(Daugherty	and	Cassis,	2004).	Staining	also	showed	inconsistent	mural	cell	coverage	of	
the	aorta	 (Figure	4.7A)	with	 some	areas	of	 the	aorta	 completely	 lacking	mural	 cell	 coverage	
and	other	areas	showing	increased	mural	cell	layers	surrounding	the	vessel.			
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Figure	4.6	Rock2	controls	vascular	integrity	in	the	heart	
Transverse	sections	taken	at	the	level	of	the	heart	stained	for	ROCK2	expression	in	embryos	at	
E13.5.	 (A)	 Immunohistochemical	 staining	 for	 ROCK2	 expression	 in	 the	 major	 vessels	 of	 the	
heart	 in	 ROCK2	 -/-	 and	 ROCK2	 +/+.	 The	 heart	 and	 the	 major	 vessels	 show	 strong	 ROCK2	
expression.	 Black	 arrow	 shows	 blood	 cells	 found	 outside	 the	 heart	 chambers.	 Scale	 bar	 =	
100µm.	(B)	Zoomed	inserts	from	(A)	showing	heart	High	levels	of	ROCK2	expression	in	Rock2+/+	
sections.	Black	arrow	indicated	blood	cells	outside	heart	chambers.	Scale	bar	50µm.		
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Figure	4.7	Loss	of	Rock2	affects	aortic	diameter	and	expansion	
Transverse	section	taken	at	the	level	of	the	heart	showing	the	descending	aorta	stained	for	the	
mural	cell	marker	NG2.	(A)	Representative	images	of	the	aorta	of	wild	type	and	Rock2	-/-	E13.5	
embryos.	 (B)	 Bar	 graphs	 of	 aorta	 area	 and	 circularity	 (n=number	 of	 embryos	 Rock2+/+;	 n=4,	
Rock2-/-;	n=4).	Significance	was	calculated	using	a	two	tailed	equal	variance	student	T-test.	*	=	
p<0.05.	Scale	bar	=	100µm.		
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4.6	ROCK2	controls	blood	vessel	diameter	and	lumen	density	during	angiogenic	development	
Filopodia	 are	 associated	with	 active	 and	 dynamic	 endothelial	 cell	 tips	 cells	 during	 sprouting	
angiogenesis.	 However,	 in	 order	 to	mature	 and	 form	 functional	 lumens	 capable	 of	 carrying	
blood,	endothelial	cells	must	downregulate	sprouting	activity.	Given	that	filopodial	protrusions	
persisted	in	the	Rock2	knockout	embryos	this	led	me	to	assess	any	potential	effects	on	lumen	
formation.	For	this	purpose,	I	chose	to	look	at	blood	vessel	lumens	in	the	brain	parenchyma	by	
immunohistochemistry	 as	 this	 provides	 a	 large	 amount	 of	 lumens	 for	 study	 and	 multiple	
sections	for	different	anti	body	staining.	Sections	at	the	foramen	of	Monro	were	sectioned	and	
stained	 by	 immunohistochemistry	 for	 endothelial	 blood	 vessel	 marker	 CD31.	 Transverse	
sections	at	 the	 level	of	 the	 interventricular	 foramen	of	Monro	were	 taken	and	blood	vessels	
within	the	entire	parenchyma	of	both	hemispheres	were	measured	(Figure	4.8).	There	were	no	
differences	 in	 the	 overall	 numbers	 of	 vessels	 in	 the	 Rock2-/-	 mice	 compared	 to	 wild	 type	
controls	 (Figure	 4.9),	 however,	 Rock2-/-	 embryos	 showed	 reduced	 numbers	 of	 blood	 vessels	
with	open	lumens	when	compared	with	wild	type	littermate	controls	(Figure	4.9).	On	further	
investigation,	the	lumens	that	persisted	in	the	Rock2-/-	embryos	were	of	larger	calibre	(Figure	
4.9).	Given	that	Rock2	loss	is	global	in	these	mice,	effects	on	blood	vessel	size	and	stability	may	
have	due	to	loss	of	Rock2	in	other	cell	types,	such	as	pericytes.	To	assess	any	possible	effect	of	
Rock2	 loss	 on	mural	 cell	 coverage,	NG2	 staining	was	 carried	 out	 on	 the	 same	 vessels	which	
showed	no	differences	in	blood	vessel	mural	cell	coverage	between	Rock2	knockout	mice	and	
wild	type	controls	(Figure	4.10).	
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Figure	4.8	Rock2	controls	blood	vessel	diameter	in	the	parenchyma	during	development	
Transverse	 sections	 were	 taken	 at	 the	 level	 of	 the	 interventricular	 foramen	 of	 Monro	 and	
stained	 for	 blood	 vessel	 marker	 CD31.	 Images	 show	 representative	 images	 of	 lobes	 of	 the	
parenchyma	 from	 sections	 stained	 for	 CD31.	 Zoomed	 box	 inserts	 shows	 high	magnification	
example	of	perfused	blood	vessel	lumens	within	the	parenchyma.	Scale	bar	=	50µm		
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Figure	4.9	Rock2	controls	lumen	opening	and	lumen	dynamics	during	development			
Transverse	 sections	 taken	at	 the	 level	 of	 the	 interventricular	 foramen	of	Monro,	 stained	 for	
blood	vessels	marker	CD31	were	used	to	measure	lumens	between	Rock2	+/+	and	Rock2-/-.	Bar	
charts	 show	 total	 vessel	 count,	 total	 lumen	 counts	 and	 total	 lumen	 diameters.	 Asterisk	
indicates	significant	values	assessed	by	T	Test	with	paired	values.	n=	3	embryos	per	genotype	
(Rock2	 +/+,	 Rock2	 -/-	 littermate	 controls).	 Statistical	 significance	of	 pair-wise	 comparisons	was	
calculated	using	a	two-tailed	student	T-test.	*	=	p<0.05,	***=p<0.001.		
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Figure	4.10	Mural	cell	coverage	is	not	affected	in	Rock2-/-	parenchymal	vessels			
Transverse	sections	taken	at	the	level	of	the	interventricular	foramen	of	Monro	and	stained	for	
mural	cell	marker	NG2.	Representative	images	of	NG2	coverage	in	vessels	of	the	parenchyma	
in	Rock2-/-	and	Rock2	+/+	littermate	controls.		
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4.7	Conclusions		
Rho	 signalling	 through	 the	 Rho	 kinases	 results	 in	 diverse	 changes	 in	 the	 organisation	 of	 the	
actin	 cytoskeleton	 that	 controls	 shape	 and	movement	 of	 all	 cells.	 Precise	 regulation	 of	 the	
actin	cytoskeleton	is	essential	for	endothelial	cells	as	they	adopt	intricate	morphologies	during	
migration,	 sprouting	 and	 the	 process	 of	 lumen	 formation.	 Rho	 Kinases	 (ROCKs)	 act	
downstream	of	Rho	and	convert	its	kinase	activity	into	multiple	different	actin-related	outputs	
including	 the	 regulation	 of	MLC,	 stress	 fibre	 formation	 and	 contractility	 (Riento	 and	 Ridley,	
2003).		
	
There	 is	 growing	 evidence	 that	 Rho/ROCK	 plays	 an	 important	 pathophysiological	 role	 in	
cardiovascular	 disease.	 Increased	 ROCK	 activity	 has	 been	 shown	 to	 play	 roles	 in	 vascular	
smooth	 muscle	 cell	 contraction,	 endothelial	 dysfunction,	 recruitment	 of	 inflammatory	 cells	
and	 in	vascular	 remodelling	which	are	hallmarks	of	a	 range	of	vascular	diseases	(Surma,	Wei	
and	 Shi,	 2011).	 Those	 phenotypes	 are	 also	 commonly	 followed	 by	 extensive	
neovascularization,	 a	 process	 of	 new	 growth	 in	 damaged	 areas	 to	 overcome	 blockage	 or	
restriction	of	blood	flow.	A	range	of	small	molecule	inhibitors	that	target	ROCKs	are	available,	
and	 early	 results	 have	 shown	 positive	 effects	 in	 treating	 some	 of	 the	 features	 of	 vascular	
diseases	including	vaso-hyper	constriction,	hypertension	and	artery	stiffness	(Shimokawa	and	
Rashid,	2007;	Surma,	Wei	and	Shi,	2011;	Shi	and	Wei,	2013).	To	 fully	understand	 the	 lasting	
effect	 of	 these	 inhibitors	 on	 vascular	 diseases,	 it	 is	 important	 to	 study	 ROCK	 signalling	 in	
healthy	 endothelial	 cells.	 As	 neovascularization	 is	 such	 an	 important	 process	 following	 a	
number	 of	 these	 vascular	 diseases,	 it	 is	 imperative	 to	 understand	 the	 fundamental	 role	 of	
ROCKs	in	endothelial	cell	biology	and	ultimately	in	angiogenesis.		
	
In	 this	 chapter	 I	 have	 investigated	 the	 role	 of	 ROCK2	 in	 angiogenesis	 and	 blood	 vessel	
development	in	the	mouse	embryo.	In	previous	Rock2	genetic	deletion	studies,	10%	of	ROCK2	
KO	mice	 survived	and	were	born	as	 runts	 (Thumkeo	et	al.,	 2003).	 Interestingly	 the	 surviving	
animals	 reported	 in	 those	 studies	 showed	 similar	 phenotypes	 to	 the	Rock2-/-	 knockout	mice	
analysed	in	my	own	work,	with	pooled	blood	in	the	paws	that	was	due	to	a	significant	dilation	
of	 vessels	 eventually	 leading	 to	 haemorrhages	 at	 E13.5	 and	 defects	 in	 limb	 development	
(Thumkeo	 et	 al.,	 2003).	 Macroscopic	 observation	 of	 the	 mice	 in	 our	 study	 revealed	 that	
embryonic	 lethality	 beyond	 E13.5	 was	 accompanied	 with	 improper	 closing	 of	 the	 abdomen	
(omphalocele),	 disorganized	 blood	 vessels	 and	 haemorrhages	 in	 the	 head	 and	 neck	 region.	
Immunoflourescent	analysis	showed	the	superficial	blood	vessels	near	the	developing	eye	and	
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ear	are	highly	angiogenic	and	that	there	was	a	considerable	degree	of	 lumenisation	of	blood	
vessels	in	this	area	at	this	stage	of	development	(Figure	4.2,	Table	4.1).	Rock2	knockout	mice	
showed	hyper-filopodial	protrusions	in	the	angiozone	at	E13.5	(Figure	4.3).	These	results	show		
that	Rock2	is	required	for	endothelial	cell	quiescence	and	they	are	in	agreement		with	previous	
studies	using	 tissue	culture	organotypic	assays	 (Abraham	et	al.,	2009)	which	had	shown	that	
ROCK2	knockdown	stimulates	sprouting.		
	
Lumen	 length	measures	using	podocalyxin	at	 the	angiozone	 in	 the	Rock2-/-	mice	would	have	
been	an	interesting	readout,	however,	due	to	the	limited	number	of	Rock2-/-	embryos	available	
from	 the	 breedings,	 immunohistochemical	 analysis	 of	 sectioned	 embryos	 provided	 the	 best	
use	of	available	embryos	as	multiple	sections	can	be	stained	with	different	antibodies.	When	
the	 vessels	 of	 the	 brain	 parenchyma	 were	 analysed	 for	 vessel	 lumen	 size	 using	
immunohistochemistry,	Rock2	knock-out	mice	showed	a	significant	decrease	in	the	abundance	
of	blood	vessels	with	open	 lumens.	On	 the	other	hand,	 the	overall	 number	of	blood	vessels	
within	the	parenchyma	remained	the	same	but	a	significant	decrease	in	perfused	lumens	was	
observed.	These	experiments	show	that	ROCK2	is	necessary	for	the	formation	of	blood	vessel	
lumens	from	nascent	blood	vessels.	 Interestingly,	the	persisting	 lumens	were	shown	to	be	of	
somewhat	 larger	 lumen	 diameter	 when	 compared	 the	 wild	 type	 littermates	 at	 the	 same	
developmental	stage.	This	may	suggest	that	perfused	ROCK2	knock-out	lumens	are	attempting	
to	 compensate	 for	 lack	 of	 overall	 perfused	 vessels	 by	 expanding	 to	 meet	 the	 oxygen	 and	
nutrient	demands	during	this	rapid	embryonic	growth.		
	
One	limit	of	using	the	global	Rock2	knockout	is	that	loss	of	Rock2	is	seen	in	all	cell	types	and	it	
is	not	endothelial	specific.	This	must	be	taken	under	consideration	when	assessing	the	effect	of	
loss	of	Rock2.	These	results	show	that	there	are	no	changes	in	pericyte	coverage	(Figure	4.10)	
of	 the	 parenchymal	 vessels	 but	 we	 cannot	 exclude	 the	 possibility	 that	 other	 cell	 type	 may	
influence	angiogenesis.	For	example,	the	apparent	changes	in	smooth	muscle	cells	are	likely	to	
account	for	changes	in	diameter	and	shape	observed	in	aortas	of	Rock2	null	mice	(Figure	4.7)		
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Chapter	5	
The	role	of	Rho-associated	kinases	in	
Cilia	Formation	in	Endothelial	Cells	
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5.1	Introduction	
Primary	 cilia	 are	 cellular	 organelles	 that	 are	 composed	 of	microtubules	 that	 play	 a	 role	 in	 a	
huge	 range	 of	 mechanosensation,	 chemosensation,	 and	 signal	 transduction	 pathways.	
Endothelial	 cilia	 have	 been	 implicated	 in	 flow	 sensing	 in	 blood	 vessels	 and	 vascular	
remodelling	 in	 the	 zebrafish	 (Goetz	et	 al.,	 2014).	 They	 have	 also	 been	 identified	 in	 areas	 of	
disturbed	flow	in	vasculature	linked	with	atherosclerosis,	but	their	exact	role	in	blood	vessels	is	
not	 fully	 understood	 (Van	 der	 Heiden	 et	 al.,	 2008).	 Although	 primary	 cilia	 are	 mainly	
microtubule-based	 structures,	 the	 actin	 cytoskeleton	 and	 its	 regulation	 seems	 to	 play	 an	
important	role	on	ciliogenesis	and	cilia	maintenance.	Effectors	of	actin	cytoskeletal	dynamics	
have	also	been	shown	to	have	profound	effects	on	cilia	and	their	 function.	As	an	effector	of	
actin	 dynamics,	 Rho-associated	 kinase	 (ROCK1	 and	 2)	 signalling	 has	 recently	 been	 shown	 to	
have	a	significant	 influence	on	ciliogenesis.	This	pathway	has	also	been	previously	 implicated	
in	many	aspects	of	angiogenesis	and	lumen	formation	(Bryan	et	al.,	2010;	M.	Kim	et	al.,	2015).	
In	 this	 chapter	 I	 investigate	 what	 effect	 the	 Rho-associated	 kinases	 have	 on	 ciliogenesis	 in	
endothelial	cells	and	retinal	pigment	epithelial	cells	(RPE)	in	vitro	and	in	vivo.		
	
	
5.2	Cultured	human	vascular	endothelial	cells	ciliate	in	the	organotypic	angiogenesis	assay	
To	 characterise	 the	 role	 of	 ROCK	 signalling	within	 endothelial	 primary	 cilia,	 the	 presence	 of	
primary	 cilia	 on	 endothelial	 cells	 in	 vitro	was	 investigated.	 	 Primary	 human	 umbilical	 vein	
endothelial	cells	 (HUVEC)	were	first	tested	 in	culture.	To	 identify	cilia,	HUVEC	were	grown	to	
high	 confluence	 in	 monolayers	 (Iomini	 et	 al.,	 2004)	 where	 they	 take	 on	 the	 expected	
cobblestone-like	 appearance	 associated	 with	 ciliogenesis.	 After	 reaching	 cobblestone	
confluence,	HUVEC	were	serum	starved	to	halt	proliferation	and	induce	ciliogenesis	(Geerts	et	
al.,	 2011).	To	 identify	primary	cilia	on	HUVEC,	an	antibody	against	 the	 small	GTPase	ARL13B	
was	used.	ARL13B	is	a	prenylated	cytoplasmic	protein	that	localizes	to	the	ciliary	membrane	of	
primary	 cilia	 during	 and	 after	 ciliogenesis	 and	 known	 to	 be	 involved	 in	 cilia	 maintenance	
(Larkins	et	al.,	2011).	When	probed	by	 immunofluorescence	 for	ARL13B,	HUVEC	showed	 the	
positive	 localized	 staining	 characteristic	 for	 cilia	 on	 a	 small	 number	 (<1%)	 of	 cultured	
cobblestone	 HUVEC	 (Figure	 5.1	 A).	 The	 distribution	 of	 primary	 cilia	 was	 investigated	 in	 the	
HDF-HUVEC	 co-culture	 assay,	 for	 which	 tubes	 with	 lumens	 can	 be	 observed	 as	 shown	 in	
Chapter	3	(Figure	3.6).	Investigation	of	the	presence	of	cilia	at	two	stages	of	the	model	system	
was	analysed,	prior	to	and	post	lumen	formation.	At	day	7	after	seeding	HUVEC	onto	confluent	
fibroblasts,	 HUVEC	 show	 an	 elongated	 phenotype	 and	 form	 tubules	 although	 they	 are	 still	
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proliferating.	Staining	for	ARL13B	at	this	time	point	did	not	detect	cilia	on	tubules,	potentially	
due	to	the	proliferative	state	of	the	endothelial	cells	(not	shown).	In	contrast,	at	day	14	when	
lumens	formed	in	the	assay	as	visualized	by	podocalyxin	staining,	short	cilia	(~1-2µm)	could	be	
detected	 on	 a	 proportion	 of	 HUVEC	 (Figure	 5.1	 B).	 Interestingly,	 all	 cilia	 appeared	 on	 the	
luminal	site	of	the	tubes,	consistent	with	the	proposed	function	of	cilia	in	sensing	flow	in	the	
luminal	site.	Fibroblasts	in	the	assay	showed	longer	cilia	(~5µm)	throughout	(Figure	5.1	B).		
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Figure	5.1	Cilia	identification	on	endothelial	cells	growing	in	a	monolayer	and	in	the	HUVEC-
HDF	coculture	model	
(A)	 Confluent	 HUVEC	 in	 monocultures	 were	 serum	 starved	 for	 24	 hrs,	 and	 then	 fixed	 and	
stained	 for	cilia	marker	ARL13B	and	DAPI.	Scale	bar	=	12µm.	(B)	HUVEC-HDF	coculture	assay	
stained	for	cilia	marker	ARL13B	and	luminal	marker	podocalyxin	14	days	after	seeding	HUVEC	
onto	 HDFs.	 White	 arrows	 indicate	 positive	 ARL13B	 cilia	 staining	 on	 HUVEC,	 yellow	 arrow	
indicates	positive	ARL13B	staining	on	HDF	cells;	L,	lumens.	Scale	bar	=	59µm.		
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5.3	Microvascular	endothelial	cells	assemble	primary	cilia	during	brain	development	
To	assess	endothelial	cilia	 in	a	more	physiological	environment	 I	 looked	at	 the	abundance	of	
primary	 cilia	 in	 the	 vasculature	 of	 developing	 mouse	 embryos.	 As	 described	 in	 chapter	 4	
section	4.2,	an	area	has	been	identified	termed	the	angiozone	that	can	be	stained	and	imaged	
for	angiogenic	blood	vessels	during	brain	development.	This	region	shows	intact	blood	vessel	
lumens	in	a	plexus	of	blood	vessels	that	sprout	from	the	carotid	artery.	As	previously	shown,	
this	 is	 a	 suitable	 area	 for	 imaging	 lumens	 as	 embryos	 can	 be	 stained	 wholemount,	 for	
endothelial	markers,	without	the	need	for	dissection.	This	retains	the	3D	environment	in	which	
the	 lumens	 are	developing,	which	 also	provides	 a	model	 system	 to	 visualize	 vascular	 cilia	 in	
vivo.	Embryos	were	harvested	and	stained	at	embryonic	day	13.5	(E13.5).	As	shown	in	chapter	
4	section	4.2,	both	developing	and	established	blood	vessels	can	be	seen	at	this	developmental	
stage	in	the	angiozone	area.	ARL13B	positive	cells	can	also	be	seen	within	vessels	walls	of	open	
lumens	and	perfused	vessels	 (Figure	5.2A	and	B).	 Similar	 to	 the	 in	 vitro	 angiogenesis	model,	
the	 surrounding	 stromal	 cell	 population	 show	prominent	ARL13B	positive	 cilia	 (Figure	 5.2A).	
Similarly,	as	with	 the	co-culture	model,	 the	majority	of	primary	cilia	 face	the	apical	 (luminal)	
side	of	the	vessel.		
	
Transverse	sections	at	the	level	of	the	interventricular	foramen	of	Monro,	an	area	previously	
discussed	 in	 chapter	 4	 section	 4.5,	 were	 also	 stained	 for	 the	 cilia	 marker	 ARL13B	 and	
endothelial	 marker	 endomucin	 (Figure	 5.3)	 by	 immunohistochemistry,	 since	 those	 embryos	
were	 fixed	 and	 embedded	 in	 paraffin.	 Blood	 vessels	 within	 the	 parenchyma	 identified	 with	
endomucin	showed	positive	staining	 for	ARL13B	which	 identified	endothelial	cell	cilia	 (Figure	
5.3).	Cilia	were	observed	on	the	luminal	side	of	these	blood	vessels	shown	in	Figure	5.3.		
	
Interestingly,	primary	cilia	were	not	observed	 in	 larger,	more	established	vessels	such	as	 the	
aorta,	pulmonary	vein	and	the	pulmonary	artery	(Figure	5.4)	consistent	with	the	idea	that	high	
levels	of	shear	stress	generated	by	blood	flow	disassemble	primary	cilia	in	vascular	endothelial	
cells	(Iomini	et	al.,	2004).		
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Figure	5.2	Endothelial	cilia	identification	in	the	angiozone	of	developing	embryos	
Angiozone	vascular	staining	in	the	E13.5	mouse	embryo.	Immunofluorescence	staining	of	the	
angiozone	for	blood	vessel	marker	endomucin	(green),	cilia	marker	ARL13B	(red)	and	nuclear	
marker	 DAPI	 (blue).	 (A)	 XY	 compression	 of	 angiozone	 showing	 total	 cilia.	 (B)	 Single	 Z-plane	
showing	ARL13B	staining	in	blood	vessel.	White	arrow	in	the	zoomed	image	points	to	a	cilium	
in	the	blood	vessel;	L,	lumen.	Scale	bar	=	37µm.		
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Figure	5.3	Endothelial	cilia	identification	in	vessels	at	the	foramen	of	Monro	
Immunohistochemical	staining	of	the	brain	parenchyma	at	the	level	of	the	foramen	of	Monro.	
(A)	Transverse	section	stained	for	the	endothelial	marker	endomucin	(brown),	the	cilia	marker	
ARL13B	(red),	and	Haematoxylin	(Htx)	and	Eosin.	Scale	bar	=	100µm.	(B)	Section	stained	as	in	
(A)	 visualised	 at	 x40	magnification	 allows	 detection	 of	 ARL13B	 positive	 endothelial	 cell	 cilia.	
Note	cilia	(in	red	circles)	protruding	into	the	lumen.	L,	Lumen;	Scale	bar	=	10	µm.		
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Figure	5.4	Lack	of	primary	cilia	in	the	developing	aorta	visualised	at	the	heart	level		
Image	 shows	histology	of	 the	developing	aorta	of	a	E13.5	embryo	 from	a	 transverse	 section	
taken	 at	 the	 level	 of	 the	 heart,	 stained	 for	 endomucin	 (brown)	 and	 ARL13B	 (red)	 by	
immunohistochemistry.	 Note	 the	 absence	 of	 primary	 cilia	 within	 this	 part	 of	 the	 aorta;	 L,	
lumen.	Scale	bar	=	10	µm	
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5.4	Investigating	the	role	of	ROCK	in	ciliogenesis	using	an	in	vitro	ciliogenesis	assay	
To	 analyse	 the	 role	 of	 ROCK	 signalling	 in	 endothelial	 cilia,	 an	 in	 vitro	 cilia	 growth	 assay	was	
employed	(Chapter	2	section	2.2.6).	This	assay	yields	monolayers	of	ciliated	cells	 that	can	be	
routinely	 treated	with	 inhibitors	 and	 then	 stained	 for	 immunofluorescence	 visualization	 and	
quantification	 of	 cilia.	 Primary	HUVECs	were	 first	 tested	 in	 the	 cilia	 growth	 assay.	 However,	
HUVEC	in	vitro	produced	low	and	variable	numbers	of	cilia	in	vitro	(approximately	1%),	which	
was	unsuitable	for	quantification	(Figure	5.1	A).		
	
Since	only	a	small	proportion	of	HUVEC	ciliated	 in	monoculture,	and	 in	the	cocultures	only	a	
fraction	 of	 tubules	 developed	 lumens,	 alternative	 endothelial	 cell	 lines	 were	 acquired	 and	
tested.	Human	cerebral	microvascular	endothelial	cells	(HCMECs)	and	mouse	brain	endothelial	
cells	 (bEnd3)	 were	 tested	 in	 the	 assay.	 Again,	 only	 a	 small	 proportion	 of	 HCMECS	 (<2%)	
ciliated.	 The	 cells	 were	 assessed	 in	 the	 in	 vitro	 ciliogenesis	 assay	 and	 both	 cell	 types	 were	
stained	for	the	cilia	marker	ARL13B	and	imaged	using	confocal	microscopy.	bEnd3	cells	showed	
small	 perinuclear	 dots	 positive	 for	 ARL13B	 in	 areas	 expected	 to	 display	 primary	 cilia	 at	 this	
stage	(Figure	5.5).	HCMEC	were	heterogeneous	in	their	morphology,	while	a	small	percentage	
of	 cells	 (approximately	 1%)	 showed	 positive	 staining	 for	 ARL13B	 (Figure	 5.5).	 Overall,	 even	
when	 grown	 at	 higher	 confluency’s	 and	 using	 different	 serum	 starvation	 conditions,	 the	
cultured	primary	endothelial	cells	and	cell	 lines	showed	to	small	a	proportion	of	ciliated	cells	
for	routine	quantification.		
	
Human	retinal	pigment	epithelial	cells	(hTERT-RPE1)	are	commonly	used	to	study	cilia	in	vitro	
as	they	readily	ciliate	under	appropriate	conditions,	and	their	cilia	are	of	a	length	suitable	for	
measuring	and	quantification	(Rambhatla	et	al.,	2002).	RPE1	cells	were	grown	as	described	in	
chapter	2	section	2.2.6,	and	in	the	assay	yielded	monolayers	of	ciliated	cells	with	greater	than	
90%	 of	 all	 cells	 extending	 a	 cilium	 (Figure	 5.6).	 Cilia	 ranging	 in	 length	 from	 2-5	 µm	 were	
observed.	This	cell	line	was	used	for	ciliogenesis	signalling	experiments	from	hereon.		
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Figure	5.5	bEnd3	and	HCMEC	ciliate	under	serum	starvation	in	culture	
bEnd3	 and	 HCMEC	 cells	 were	 seeded	 at	 70	 %	 confluency	 in	 10%	 FBS	 DMEM	 for	 24	 hours	
before	being	serum	starved	(0.2%FBS)	to	initiate	ciliogenesis	for	48	hours	prior	to	fixation.	(A)	
Mouse	 bEnd3	 cells	 ciliating	 under	 serum	 starvation.	 (B)	 Human	 cerebral	microvascular	 cells	
ciliating	 under	 serum	 starvation.	 ARL13B	 (red),	 DAPI	 (blue).	 Zoomed	 insets	 shows	 individual	
ARL13B	stained	cilia.	Scale	bar	=	31µm.		
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Figure	5.6	hTERT-RPE1	cells	ciliate	readily	under	serum	starvation	in	culture	
hTERT-RPE1	 cells	 were	 seeded	 at	 70%	 confluence	 in	 10%	 FBS	 DMEM	 for	 24hr	 before	 being	
serum	starved	(0.2%)	for	48	hours	prior	to	fixation.	 Image	shows	ciliated	hTERT-RPE1	cells	 in	
cilia	 growth	 assay,	 ARL13B	 (yellow),	 DAPI	 (blue).	 Zoomed	 inset	 shows	 individual	 ARL13B-
stained	primary	cilia.		Scale	bar	=	31µm.		
	
	
	
	
	
	
	
	
	
	
	
	
ARL13B    DAPI
	 133	
5.5	Rho	kinase	(ROCK1/2)	controls	cilia	length	and	density		
Actin	plays	important	roles	in	cilia	maintenance:	for	example,	actin	branching	activity	inhibits	
ciliogenesis	(Malicki	and	Johnson,	2016).	To	study	the	role	of	the	ROCK	pathway	in	ciliogenesis,	
I	 used	 the	 cilia	 growth	assay	and	 treated	 the	 cultures	with	 the	 commercially	 available	ROCK	
inhibitor	 Y27632	 (Tocris).	 The	 treatment	 with	 Y27632	 was	 optimised	 and	 showed	 that	
treatment	on	day	2,	after	the	start	of	serum	starvation,	gave	the	highest	 level	of	ciliogenesis	
and	 two	 previously	 optimised	 doses	 of	 10uM	 and	 50uM	 were	 selected.	 The	 actin-binding	
protein	 cofilin,	 involved	 in	depolymerising	actin,	 is	downstream	of	ROCK	 through	LIM	kinase	
phosphorylation,	and	has	been	shown	to	enhance	cilia	 formation	(Jongshin	Kim	et	al.,	2015).	
Y27632-treated	cells	stained	with	the	actin	marker	phalloidin	showed	a	typical	ROCK	inhibition	
phenotype	 (Figure	 5.8)	 with	 loss	 of	 stress	 fibres.	 Furthermore,	 treatment	 with	 increasing	
concentrations	 of	 Y27632	 gave	 a	 significant	 increase	 in	 length	 of	 cilia	 when	 compared	with	
untreated	 cells	 (Figure	 5.9).	 Y27632	 treatment	 at	 10µM	 gave	 a	 20%	 increase	 in	 cilia	 length	
compared	with	control,	while	treatment	with	50µM	Y27632	gave	mild	levels	of	cytotoxicity	in	
some	cells	but	resulted	in	a	50%	increase	in	cilia	length	(Figure	5.10	A).	However,	there	was	a	
corresponding	 decrease	 in	 the	 number	 of	 ciliated	 cells	 with	 both	 concentrations	 of	 Y27632	
(Figure	5.10	B).	Treatment	of	cells	with	50µM	Y27632	gave	a	14%	decrease	in	the	number	of	
cells	ciliated	when	compared	with	control	(Figure	5.10	B).		
	
Downstream	 of	 ROCK	 signalling,	 multiple	 effector	 proteins	 influence	 the	 actin	 cytoskeleton	
through	direct	effects	on	actin	filaments	(Figure	5.7).	Blebbistatin	 inhibits	the	ATPase	activity	
of	 non-muscle	 myosin	 IIa	 (Amano	 et	 al.,	 1996).	 Blebbistatin	 binds	 myosin	 II	 and	 blocks	 its	
ATPase	activity	function	thereby	blocking	the	effects	of	MLC2	phosphorylation	downstream	of	
Rho	signalling.	Treatment	of	hTERT-RPE1	cells	with	the	previously	optimised	amount	of	10µM	
Blebbistatin	in	the	ciliogenesis	assay	(Figure	5.11)	resulted	in	significant	increases	in	cilia	length	
compared	with	control	(Figure	5.12).	LIM	kinase	(LIMK)	is	activated	upon	ROCK	activation	and	
phosphorylates	cofilin	that	in	turn	inhibits	its	actin	severing	ability	(Figure	5.7).	This	results	in	
stabilization	of	 F-actin	 filaments.	 	 Treatment	of	hTERT-RPE1	 cells	with	a	 LIM	kinase	 inhibitor	
(BMS5;	 SYN	 kinase	 (Scott	 et	 al.,	 2010))	 in	 the	 ciliogenesis	 assay	 (Figure	 5.11)	 resulted	 in	
increased	cilia	length	(Figure	5.12A).	Consistent	with	results	seen	in	treatment	of	hTERT-RPE1	
cells	 with	 Y27632,	 cells	 exhibited	 less	 cilia	 when	 treated	 with	 downstream	 ROCK	 inhibitors	
Blebbistatin	and	Lim	kinase	inhibitors	(5.12B)	
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To	 further	 determine	 the	 effect	 of	 actin	 polymerisation	 on	 cilia	 growth,	 I	 investigated	 the	
effects	 of	 treatment	 with	 an	 actin	 depolymerisation	 agent	 for	 its	 effect	 on	 ciliogenesis.	
Latrunculin	 B	 (Lat	 B),	 an	 actin	 depolymerising	 agent	 that	 sequesters	 G-actin	 and	 therefore	
prevents	F-actin	assembly	(McLaughlin,	Morton	and	Ayscough,	2000)	was	used	in	these	assays.	
In	our	published	 study	we	optimised	 Lat	B	 concentrations	 for	blocking	actin	driven	 filopodia	
protrusions	without	affecting	cell	viability	(Abraham	et	al.,	2015).	Treatment	of	ciliating	hTERT-
RPE	cells	with	0.01μg/ml	Lat	B	in	the	ciliogenesis	assay	(Figure	5.11)	resulted	in	an	increase	in	
cilia	length	(Figure	5.12A)	and	decrease	in	overall	cilia	numbers	(5.12B)	
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Figure	5.7	Rho/ROCK	pathway	and	inhibitors		
The	 Rho/ROCK	 signalling	 pathway	 indicating	 the	 sites	 of	 inhibitor	 activity.	 Y27632	 (ROCK	
inhibitor)	inhibits	both	isoforms	of	ROCK	(ROCK1/ROCK2)	by	competing	with	ATP	for	binding	to	
the	catalytic	site.	The	lim	kinase	inhibitor,	BMS5	inhibits	lim	kinase	1	and	lim	kinase	2	equally.	
Blebbistatin	inhibits	the	ATPase	activity	of	class	II	myosins.	Latrunculin	B	binds	to	G-actin	and	
prevents	 F-actin	 assembly	 by	 reducing	 the	 pool	 of	 monomeric	 actin	 available	 for	 filament	
growth.		
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Figure	5.8	Y27632	causes	loss	of	stress	fibres	in	hTERT-RPE1	cells	in	the	in	vitro	ciliogenesis	
assay	
7x104	hTERT-RPE1	cells	were	plated	 in	24	well	plates	and	 let	grow	for	24	hours	before	being	
treatment	with	Y27632	 in	reduced	serum	media	(0.2%	FBS	DMEM)	to	 initiate	ciliogenesis	 for	
48	hours.	Phalloidin	stain	shows	loss	of	stress	fibres	 in	cells	treated	with	Y27632.	Scale	bar	=	
31µm.		
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Figure	5.9	Effect	of	treatment	of	hTERT-RPE1	cells	with	the	ROCK	inhibitor	Y27632		
7x104	hTERT-RPE1	cells	were	plated	in	24	well	plates	and	allowed	to	grow	for	24	hours	before	
being	treated	with	Y27632	 in	reduced	serum	media	 (0.2%	FBS	DMEM)	to	 initiate	ciliogenesis	
for	 48	 hours.	 Representative	 images	 of	 ARL13B-stained	 cilia	 are	 shown	 for	 control,	 Y27632	
10µM	and	Y27632	50µM.	Zoomed	insets	show	individual	ciliated	cells.	Scale	bar	=	31µm.		
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Figure	5.10	Treatment	with	the	ROCK	inhibitor	Y27632	increases	ciliary	length	and	reduces	
the	number	of	ciliated	hTERT-RPE1	cells	
7x104	hTERT-RPE1	cells	were	plated	in	24	well	plates	and	allowed	to	grow	for	24	hours	before	
being	treated	with	Y27632	 in	reduced	serum	media	 (0.2%	FBS	DMEM)	to	 initiate	ciliogenesis	
for	48	hours.	 (A)	Bar	 chart	 shows	average	cilia	 length	 in	 cells	within	a	20x	microscopic	 field.	
Error	bars	represent	S.E.M;	N=number	of	fields	(control,	17;	Y27632	10µM,	18;	Y27632	50µM,	
19);	from	four	independent	experiments;	at	least	100	cells	were	counted	per	condition	in	each	
experiment.	(B)	Bar	chart	shows	percentage	ciliated	cells	within	a	20x	microscopic	field;	Error	
bars	 represent	 S.E.M;	N=number	 of	 fields	 (control,	 17;	 Y	 10µM,	18;	 Y	 50µM,	19);	 from	 four	
independent	 experiments;	 minimum	 of	 100	 cells	 were	 counted	 per	 condition	 in	 each	
experiment.	Significance	was	calculated	using	a	two	tailed	student	T-test.	**,	p<0.01.		
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Figure	5.11	Treatment	with	LIM	kinase	inhibitors,	blebbistatin,	or	the	actin	depolymerising	
agent,	latrunculin	B	increases	ciliary	length	in	hTERT-RPE1	cells	
7x104	hTERT-RPE1	cells	were	plated	in	24	well	plates	and	allowed	to	grow	for	24	hours	before	
being	 treated	 with	 either	 (blebbistatin	 10µM,	 LIM	 kinase	 inhibitor	 10µM,	 or	 latrunculuin	 B	
(0.01µg/µl)	 in	 reduced	 serum	media	 (0.2%	 FBS	 DMEM)	 to	 initiate	 ciliogenesis	 for	 48	 hours.	
Representative	 images	of	ARL13B-stained	cilia	are	shown	for	control,	Blebbistatin	10µM,	LIM	
kinase	inhibitor	10µM	and	latrunculin	B	0.01µg/µl.	Scale	bar	=	15µm.		
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Figure	5.12	Treatment	with	LIM	kinase	inhibitors,	blebbistatin	or	the	actin	depolymerising	
agent,	latrunculin	B	increases	ciliary	length	in	hTERT-RPE	cells	
7x104	hTERT-RPE1	cells	were	plated	onto	24	well	plates	on	glass	cover	slips	and	allowed	grow	
for	24	hours	before	being	treated	with	LIMK	inhibitor	(5µM,10µM)	or	latrunculin	B	(0.01µg/µl)	
or	Blebbistatin	(10µM)	in	reduced	serum	media	(0.2%	FBS	DMEM)	to	initiate	ciliogenesis	for	48	
hours.	(A)	Bar	charts	show	average	cilia	length	in	cells	treated	with	inhibitors	within	a	x20	field.	
Lim	Kinase	inhibitor:	N=number	of	fields	(control,	12;	LIM	kinase	inhibitor	5µM,	15;	LIM	kinase	
inhibitor	10µM,	15)	 from	three	 independent	experiments;	at	 least	50	cells	were	counted	per	
condition	 in	 each	 experiment.	 Latrunculin	 B	 at	 0.01µg/µl:	 within	 a	 field	 of	 view	 from	 three	
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independent	experiments.	N=number	of	fields	(control,	10;	Lat	B	0.01µg,	10);	at	least	50	cells	
were	 counted	 per	 condition	 in	 each	 experiment.	 Blebbistatin	 10µM:	 N=number	 of	 fields	
(control,	12;	Blebbistatin	10µM,	12)	from	four	independent	experiments;	at	least	50	cells	were	
counted	 per	 condition	 in	 each	 experiment.	 Significance	 was	 calculated	 using	 a	 two	 tailed	
student	 T-test.	 ***=p<0.001.	 *=p<0.05.	 Error	 bars	 represent	 S.E.M.	 (B)	 Bar	 charts	 show	
percentage	 ciliated	 cells	 within	 a	 20x	 microscopic	 field;	 Lim	 Kinase	 inhibitor:	 N=number	 of	
fields	 (control,	 12;	 LIM	 kinase	 inhibitor	 5µM,	15;	 LIM	 kinase	 inhibitor	 10µM,	15)	 from	 three	
independent	 experiments;	 at	 least	 50	 cells	were	 counted	 per	 condition	 in	 each	 experiment.	
Latrunculin	 B	 at	 0.01µg/µl:	 within	 a	 field	 of	 view	 from	 three	 independent	 experiments.	
N=number	of	fields	(control,	10;	Lat	B	0.01µg,	10);	at	least	50	cells	were	counted	per	condition	
in	 each	experiment.	 Blebbistatin	 10µM:	N=number	of	 fields	 (control,	 12;	Blebbistatin	10µM,	
12)	from	four	independent	experiments;	at	 least	50	cells	were	counted	per	condition	in	each	
experiment.	 Significance	 was	 calculated	 using	 a	 two	 tailed	 student	 T-test.	 ***=p<0.001.	
*=p<0.05.	Error	bars	represent	S.E.M.	
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5.6	Inhibition	of	components	of	the	ROCK	pathway	in	Rock2	-/-	MEFs		
Chemical	inhibitor	may	act	on	multiple	targets.	In	order	to	verify	the	differences	in	cilia	length	
and	abundance	observed	with	Y27632	 treatment	was	due	 to	 inhibition	of	ROCK,	 I	 sought	 to	
assess	 ciliogenesis	 in	mouse	embryonic	 fibroblasts	 (MEFs)	 isolated	 from	 the	Rock2	 knockout	
mice.	First,	wild-type	MEFs	were	cultured	in	the	in	vitro	ciliogenesis	assay	to	see	if	the	effect	of	
treatment	with	Y27632	on	ciliogenesis	held	 for	 this	cell	 type.	Wild-type	MEFs	exhibit	smaller	
cilia	(~2-3µm)	than	RPE1	cells	but	ciliate	sufficiently	to	be	quantified.	Indeed,	wild-type	MEFs	
treated	with	 Y27632	 exhibited	 the	 same	 phenotype	 as	 seen	 before	with	 an	 increase	 in	 cilia	
length	 (Figure	5.13	A).	 The	proportion	of	 ciliated	 cells	was	also	decreased,	 as	observed	with	
the	hTERT-RPE1	cells	(Figure	5.13	B).	MEFs	were	then	isolated	from	the	null	and	wild-type	mice	
and	ciliogenesis	was	assessed	in	cilia	growth	assay.		Wild-type	and	Rock2	-/-	MEFs	were	seeded	
and	 allowed	 to	 grow	 48	 hours	 as	 before	 without	 the	 use	 of	 inhibitors.	 Cilia	 length	
quantifications	 showed	 that	 Rock2-/-	 MEFs	 exhibited	 longer	 cilia	 when	 compared	 with	 wild-
type	 MEFs	 (Figure	 5.14),	 consistent	 with	 results	 seen	 with	 the	 ROCK	 inhibitor.	 They	 also	
showed	a	decreased	number	of	total	ciliated	cells	when	compared	with	wild	type	MEFs.	
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Figure	5.13	Effect	of	ROCK	pathway	inhibitors	on	wild-type	mouse	embryonic	fibroblasts	
(MEFs)		
5x104	wild	type	MEFs	were	plated	onto	24	well	plates	and	let	grow	for	24	hours	before	being	
treatment	with	Y27632	in	reduced	serum	media	(0.2%	FBS	DMEM)	to	initiate	ciliogenesis,	for	
48	hours.	(A)	Bar	chart	shows	average	cilia	length	in	cells	within	a	microscopic	field.	Error	bars	
represent	S.E.M;	N=number	of	fields	(control,	20;	10µM	Y27632,	17;	50µM	Y27632,	10)	from	
three	 independent	 experiments;	 at	 least	 50	 cells	 were	 counted	 per	 condition	 in	 each	
experiment.	 (B)	 Bar	 chart	 shows	 percentage	 ciliated	 cells	 per	 field	 of	 view	 with	 Y27632	
treatment;	Error	bars	represent	S.E.M;	N=number	of	fields;	(control,	20	fields;	Y27632	10µM,	
17;	 Y27632	 50µM,	 10)	 from	 three	 independent	 experiments;	 minimum	 of	 100	 cells	 were	
counted	 per	 condition	 in	 each	 experiment.	 Significance	 was	 calculated	 using	 a	 two	 tailed	
student	T-test.	**	=	p<0.01.		
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Figure	5.14	Isolated	Rock2	-/-	mouse	embryonic	fibroblasts	(MEFs)	have	increased	ciliary	
length	and	fewer	ciliated	cells	compared	with	wild-type	MEFs		
5x104	mouse	embryonic	 fibroblasts	 (MEFs)	 isolated	 from	Rock2	 -/-	 embryos	cells	were	plated	
onto	24	well	plates	and	allowed	to	grow	for	24	hours	before	being	grown	 in	 reduced	serum	
media	(0.2%	FBS	DMEM)	to	initiate	ciliogenesis	for	48	hours.	(A)	Bar	chart	shows	average	cilia	
length	 in	cells	within	microscopic	 field.	Error	bars	 represent	S.E.M;	N=number	of	 fields;	 (WT,	
20;	 Rock2	 -/-,	 20);	 from	 three	 independent	 experiments;	 at	 least	 50	 cells	 were	 counted	 per	
genotype	 in	each	experiment.	 (B)	Bar	chart	 shows	percentage	ciliated	cells	per	 field	of	view.	
Error	bars	represent	S.E.M;	N=number	of	fields;	(WT,	20;	Rock2	-/-,	20)	from	three	independent	
experiments.	Significance	was	calculated	using	a	two	tailed	student	T-test.	**	=	p<0.01.		
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5.7	ROCK2	controls	endothelial	ciliogenesis	and	orientation	in	blood	vessels		
The	 in	vitro	experiments	using	chemical	inhibitors	and	analyses	of	cilia	length	and	abundance	
in	RPEs	 and	MEFs	 showed	 that	ROCK2	 controls	 ciliogenesis	 in	 cell	 culture	 since	 inhibition	or	
loss	of	Rock2	results	in	decreased	ciliary	abundance	and	deregulated	ciliary	length.	It	was	then	
of	 interest	 to	 assess	 whether	 ROCK	 inhibition	 affected	 ciliogenesis	 in	 endothelial	 cells	 and	
whether	this	correlated	with	the	observed	vascular	phenotypes	of	the	ROCK2	knockout.		
	
To	investigate	whether	ROCK2	controls	ciliogenesis	in	endothelial	cells	in	blood	vessels	in	vivo,	
I	measured	the	abundance	of	cilia	 in	the	blood	vessels	of	 the	brain	parenchyma	of	wild	type	
and	Rock2-/-	mouse	embryos	at	E13.5	(Chapter	4	section	4.2)	where	I	had	found	that	cilia	are	
abundant	in	blood	vessels	(Figure	5.3).	Rock2-/-	and	wild	type	littermate	controls	at	E13.5	were	
fixed,	sectioned	and	stained	for	the	cilia	marker	ARL13B.	Cilia	were	counted	within	endothelial	
stained	vessels	throughout	the	parenchyma	of	the	entire	brain	section	from	each	slide	(Figure	
5.15).	Given	the	defects	observed	in	the	regulation	of	cilia	length	and	abundance	in	cell	culture	
with	 ROCK	 inhibition	 in	 order	 to	 assess	 whether	 in	 the	 absence	 of	 Rock2	 there	 were	 any	
changes	 in	 primary	 cilia	 location	 in	 the	blood	 vessels,	 cilia	were	 classified	 according	 to	 their	
location	 in	 relation	 to	 the	 vessel	wall	 and	 orientation	 as	 luminal	 (protruding	 into	 the	 vessel	
lumen),	 internal	 (within	 the	 vessel	 wall)	 or	 external	 (protruding	 outside	 the	 vessel	 wall)	 as	
(Figure	 5.16A).	 The	 Rock2	 knockout	 embryos	 showed	 reduced	 overall	 cilia	 numbers	
(approximately	 20%	 less	 cilia)	 in	 the	 blood	 vessels	 of	 the	 developing	 brain	when	 compared	
with	the	wild-type	embryos	(Figure	5.16B).	When	location	of	cilia	was	taken	into	consideration,	
Rock2	-/-	embryos	had	fewer	cilia	in	the	internal	and	luminal	compartments	(29.6%)	compared	
with	Rock2	+/+	embryos	(42.1%),	and	an	increase	in	the	percentage	of	external	cilia	form	57.9%	
in	wild	type	to	70.4%	in	Rock2	knockout	embryos	(Figure	5.16B).	
	
Although	 cilia	 counts	 were	 reduced	 in	 the	 Rock2-/-	 embryos	 when	 compared	 with	 Rock2+/+,	
accurate	 measurement	 of	 their	 length	 was	 not	 feasible	 through	 sectioned	 IHC	 slides.	 To	
address	 this,	 HCMECs	 (human	 cerebral	 microvascular	 endothelial	 cells)	 were	 treated	 with	
Y27632	in	culture	and	the	small	number	of	cells	that	ciliated	were	measured.	Indeed,	inhibition	
of	ROCK	using	Y27632	resulted	in	an	increase	in	ciliary	length	in	the	HCMEC	(Figure	5.17).	
	
	
	
	
	 147	
	
Figure	5.15	Endothelial	cell	cilia	of	the	vasculature	of	the	E13.5	Rock2	-/-	mice	
Transverse	 sections	 taken	 at	 the	 level	 of	 the	 interventricular	 foramen	 of	 Monro	 of	 E13.5	
embryos	were	stained	for	endomucin,	ARL13B	and	Htx-eosin.	Representative	images	of	section	
at	the	interventricular	foramen	of	Monro	level	stained	for	Endomucin	and	ARL13B,	H&E	stain	
with	endomucin	 (brown)	 and	ARL13B	 (red)	 in	Rock2+/+	 and	Rock2-/-.	 Zoomed	 inset	of	 vessels	
stained	for	endomucin	and	ARL13B.	Scale	bar	=	100µm.	
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Figure	5.16	Endothelial	cell	cilia	are	reduced	in	the	vasculature	of	the	E13.5	Rock2	-/-	mice	
Transverse	 sections	 taken	 at	 the	 level	 of	 the	 interventricular	 foramen	 of	 Monro	 of	 E13.5	
embryos	 were	 stained	 for	 endomucin,	 ARL13B	 and	 Htx-eosin	 (A)	 Representative	 images	 of	
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sections	 at	 the	 interventricular	 foramen	of	Monro	 level	 stained	 for	 Endomucin	 and	ARL13B,	
H&E	stain	with	endomucin	(brown)	and	ARL13B	(red)	showing	lumenal,	internal,	and	externally	
located	 endothelial	 cilia	within	 vessels.	 Scale	 bar	 =	 10µm	 (B)	 Table	 shows	 blood	 vessel	 cilia	
counts	 in	Rock2+/+	 and	Rock2-/-	 blood	 vessels	within	 the	 embryo	 parenchyma.	N=	 number	 of	
embryos;	(Rock2	-/-,	3;	Rock2	+/+,	3).		
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Figure	5.17	Treatment	with	the	ROCK	inhibitor	Y27632	increases	ciliary	length	in	HCMEC	
5x104	 HCMEC	 cells	 were	 plated	 in	 24	 well	 plates	 and	 allowed	 to	 grow	 for	 24	 hours	 before	
treatment	with	Y27632	 in	reduced	serum	media	(0.2%	FBS	DMEM)	to	 initiate	ciliogenesis	 for	
48	hours.	(A)	Representative	images	of	ciliated	HCMEC	cells	(B)	Bar	chart	shows	average	cilia	
length	 of	 ciliated	HCMECs	 cells	within	 a	 20x	 field.	 Error	 bars	 represent	 S.E.M;	N=number	 of	
fields	(control,	5;	5µM	Y27632,	5;	10µM	Y27632,	5);	from	three	independent	experiments;	at	
least	30	cells	were	counted	per	condition	in	each	experiment.	Significance	was	calculated	using	
a	two	tailed	student	T-test.	**	=	p<0.01.	
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5.8	Conclusions	
Endothelial	 cells	were	 once	 thought	 to	 be	 one	 of	 the	 few	 cell	 types	 that	 did	 not	 develop	 a	
primary	cilium.	However,	a	number	of	 recent	published	studies	have	shown	that	cilia	can	be	
found	in	the	apical	luminal	site	of	blood	vessels	in	zebrafish,	where	they	sense	blood	flow	and	
play	an	active	role	in	vascular	remodelling	(Goetz	et	al.,	2014)	.	In	the	studies	presented	in	this	
thesis,	primary	cilia	were	found	only	on	a	subset	of	endothelial	cells	both	in	vitro	for	cultured	
cell-lines	 and	 in	 vivo	 (Figure	 5.1	 and	 5.2).	 This	 finding	 correlates	 with	 the	 few	 numbers	 of	
endothelial	 cilia	 on	 HUVEC,	 identified	 in	 other	 published	 studies	 (Iomini	 et	 al.,	 2004).	 The	
reason	for	such	sparse	cilia	 incidence	on	endothelial	cells	may	be	explained	by	the	nature	of	
imaging	 analyses,	which	 only	 gives	 a	 single	 time-point	 for	 a	 population	 of	 ciliated	 cells.	 It	 is	
possible	 that	 endothelial	 cells	 respond	 dynamically	 to	 local	 environmental	 cues	 that	 control	
the	precise	 timing	of	ciliary	growth	and	dissolution.	 Indeed,	 recent	evidence	shows	 that	cilia	
appear	more	or	less	readily	in	certain	positions	within	blood	vessels	in	response	to	surrounding	
environmental	 cues:	 disturbed	 flow	 promotes	 greater	 cilia	 incidence	 compared	 to	 laminar	
flow;	 and	 onset	 of	 blood	 flow	 promotes	more	 cilia	 compared	 to	 continuous	 unbroken	 flow	
(Dinsmore	 and	 Reiter,	 2016).	 Therefore,	 it	 is	 possible	 that	 primary	 endothelial	 cilia	 only	
assemble	transiently	in	endothelial	cells	within	blood	vessels.	Another	intriguing	hypothesis	is	
that	 important	 ciliary	 functions,	 such	 as	 calcium	 signalling	 for	 vasodilation	 induced	 by	 flow	
sensing	by	endothelial	cells,	may	be	sufficiently	carried	out	by	a	small	number	of	ciliated	cells	
within	a	blood	vessel	(Egorova	et	al.,	2012).		
	
In	this	chapter	I	have	shown	that	control	of	the	actin	cytoskeleton	plays	a	fundamental	role	in	
the	 process	 of	 primary	 cilia	 lengthening	 and,	 furthermore,	 that	 it	 controls	 cilia	 incidence	 in	
endothelial	cells.	The	role	of	the	ROCK	signalling	pathway	and	its	effect	on	actin	is	well-studied	
and	as	an	effector	of	Rho	signalling,	ROCK	phosphorylates	downstream	kinases,	the	majority	of	
which	have	a	direct	effect	on	actin	dynamics.	Y27632	 is	widely	used	as	a	ROCK1	and	ROCK2	
inhibitor.	In	this	chapter	I	have	shown	that	inhibition	of	ROCK	signalling	with	Y27632	results	in	
longer	 primary	 cilia	 (Figure	 5.9,	 Figure	 5.10).	 Further	 investigation	 in	 the	 studies	 herein	
revealed	that	similar	effects	to	inhibition	of	ROCK	on	ciliary	length	are	also	seen	with	inhibition	
of	 the	downstream	effectors	 such	as	 LIM	kinase	 and	myosin	 II	 (Figure	5.11,	 Figure	5.12).	 By	
phosphorylating	 cofllin,	 LIM	kinase	 inhibits	 its	 actin	 severing	ability,	 resulting	 in	 longer	more	
stable	actin	filaments.	Inhibition	of	this	activity	with	a	commercially	available	inhibitor	for	LIM	
kinase	(BMS5-SYN1024)	resulted	in	longer	cilia.	However,	disruption	of	cofilin	activity	and	the	
subsequent	 lengthening	of	the	cilium	may	not	yield	functional	cilia,	since	published	evidence	
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has	 shown	 that	 cofilin	 knockout	 causes	 malpositioning	 of	 embryonic	 node	 cilia	 and	 hence	
defects	in	planar	cell	polarity	defects	(Mahaffey	et	al.,	2013).	Further	evidence	supporting	this	
regulatory	 role	 of	 actin	 on	 cilia	 formation	was	 also	 observed	with	 the	 actin	 depolymerising	
agent	latrunculin	B.	The	ability	of	latrunculin	B	to	sequester	G-actin	and	prevent	the	formation	
of	 F-actin	 filaments	 resulted	 in	an	 increase	 in	 ciliary	 length	 in	hTERT-RPE1	 cells	 (Figure	5.11,	
Figure	5.12).	
	
It	 has	 been	 demonstrated	 previously	 that	 actin	 branching	 and	 nucleating	 factors	 inhibit	
ciliogenesis	 (Bershteyn	et	 al.,	 2010;	 Kim	et	 al.,	 2010;	 Cao	et	 al.,	 2012;	Malicki	 and	 Johnson,	
2016).	 As	 seen	 in	 the	 results	 presented	 in	 this	 chapter,	 this	 holds	 true	 in	my	 assay,	 since	 a	
decrease	in	the	proportion	of	ciliated	endothelial	cells	occurred	after	treatment	with	the	ROCK	
inhibitor.	Furthermore,	I	have	shown	that	treatment	of	cells	with	inhibitors	of	effectors	of	the	
ROCK	pathway	have	fewer	cilia	(Table	6.1).	The	cilia	that	persisted	were	of	an	abnormal	length,	
a	 feature	 which	 may	 impede	 their	 function,	 as	 cilia	 length	 is	 known	 to	 be	 an	 important	
determinant	in	ciliary	functionality	(Avasthi	and	Marshall,	2012)	.		
	
Assays	 employing	Rock2	 knockout	MEFs	 showed	differences	 in	 ciliary	 length	 consistent	with	
the	 treatment	 of	 RPE	 cells,	 endothelial	 cells	 and	 MEFs	 with	 Y27632,	 confirming	 that	 the	
observed	 effects	 resulted	 from	 inhibition	 of	 ROCK2,	 rather	 than	 off	 target	 effects	 of	 the	
inhibitor.	 This	 was	 further	 supported	 by	 inhibition	 of	 downstream	 effectors	 resulting	 in	 a	
similar	phenotype.	 	 In	Rock2-/-	MEFs,	the	trend	towards	reduction	in	cilia	abundance	was	not	
significant.	 This	 could	 be	 due	 to	 insufficient	 number	 of	 images	 analysed,	 given	 the	 small	
differences	 anticipated.	 The	 effects	 of	 inhibition	 of	 downstream	 effectors	 argue	 that	 this	 is	
true	as	there	was	a	significant	decrease	in	ciliated	cells	with	loss	of	all	downstream	effectors.	
Consistently,	 results	 from	 the	Rock2-/-	 embryo	 studies	 showed	 differences	 in	 cilia	 incidence,	
with	fewer	cilia	in	the	mutant	null	animals	(Figure	5.16).		
	
The	loss	of	only	one	isoform	of	ROCK	(ROCK2)	and	possible	compensation	by	ROCK1,	may	also	
explain	 why	 a	 trend	 rather	 than	 statistically	 significant	 difference	 was	 observed	 in	 the	
knockout	MEFs	when	compared	with	treatment	with	Y27632-treated	cells,	in	which	both	ROCK	
isoforms	are	inhibited	by	the	inhibitor.	It	is	possible	that	both	ROCK1	and	ROCK2	are	involved	
are	required	for	regulation	of	downstream	effectors	necessary	for	maintenance	of	the	correct	
ciliary	length.	
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Pharmacological	inhibitor	 Target	 Effect	on	primary	cilia	
Y27632	 Rho	kinase	inhibitor	 Increased	length,	decrease	in	
abundance	
Blebbistatin	 Myosin	II	inhibitor	 Increased	ciliary	length	
BMS5	 Lim	kinase	inhibitor	 Increased	ciliary	length	
Latrunculin	B	 Actin	depolymerising	agent	 Increased	ciliary	length	
Table	6.1	Summary	of	effect	of	Pharmacological	inhibitors	on	ciliary	length	and	abundance	in	
ciliogenesis	assay	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	 154	
Chapter	6	
Final	discussion	
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6.1	Introduction	
Actin	 based	 cytoskeletal	 rearrangements	 are	 vital	 for	 most	 aspects	 of	 endothelial	 cell	
behaviour	 during	 angiogenesis.	 An	 intricate	 control	 of	 the	 actin	 machinery	 through	 actin	
nucleation,	branching	and	severing	proteins	orchestrated	by	the	Rho	family	of	small	GTPases	is	
necessary	for	the	changes	in	cell	shape	endothelial	cells	adopt	during	sprouting	and	migration.	
However,	at	the	start	of	this	project	it	was	not	known	whether	Rho	proteins	play	a	role	in	the	
development	of	blood	vessel	lumens,	which	are	essential	for	blood	flow.		
	
As	referred	to	in	Conclusions	of	Chapter	4,	two	key	mechanisms	have	been	put	forward	for	the	
formation	 of	 blood	 vessel	 lumens	 (Iruela-Arispe	 &	 Davis,	 2009).	 Expansion	 of	 intracellular	
vacuoles	 within	 endothelial	 cells	 to	 form	 seamless	 lumens	 (Kamei	 et	 al.,	 2006);	 and	 cord	
hollowing,	 whereby	 a	 lumen	 forms	 by	 opposing	 endothelial	 cells	 with	 lateral	 adhesions	
(Pelton,	Wright,	Leitges,	&	Bautch,	2014;	Strilić	et	al.,	2009).	It	has	been	suggested	that	a	cord	
hollowing	mechanism	operates	predominately	during	the	development	of	 larger	vessels	such	
as	 the	 aorta,	 while	 the	 cell	 hollowing	 mechanism	 of	 lumen	 formation	 operates	 during	 the	
development	of	smaller	blood	vessels	(Phng	et	al.,	2015).		
	
Early	findings	by	the	Davis	group	had	shown	that	the	Rho	GTPases	Rac1	and	Cdc42,	control	the	
process	of	cell	hollowing	via	regulation	of	intracellular	vacuoles	in	an	in	vitro	collagen	assay	of	
lumen	formation	(Bayless	and	Davis,	2002).	Further	work	by	Davis	and	colleagues	showed	the	
presence	of	intracellular	vacuoles	in	vivo	within	zebrafish	intersegmental	vessels	(ISVs)	during	
lumen	formation	(Kamei,	W.	Brian	Saunders,	et	al.,	2006).	However,	the	continued	use	of	the	
zebrafish	ISVs	as	a	model	of	lumen	formation,	and	improvement	in	imaging	techniques,	led	to	
the	finding	that	the	actual	architecture	of	the	ISVs	conflicted	with	earlier	discoveries.	In	most	
regions,	 complex	 cell	 arrangements	 led	 to	 paired	 endothelial	 cells	 forming	 the	 ISVs,	 with	
luminal	spaces	found	between	juxtaposing	endothelial	cells	 (Blum	et	al.,	2008)	and	therefore	
forming	 via	 a	 chord	 hollowing	 mechanism.	 In	 the	 ISVs	 VE-cadherin	 has	 been	 shown	 to	 be	
distributed	alongside	 lateral	 cell-cell	 contacts	 and	 to	be	essential	 for	 cell	 polarity	 and	 lumen	
opening	(Blum	et	al.,	2008).	VE-cadherin	levels	at	lateral	adhesions	are	upregulated	in	areas	of	
lower	VEGFR2	signalling	following	dephosphorylation	of	VEGFR2	via	VE-PTP.	Reduced	VEGFR2	
signalling	within	the	ISV	mediated	by	VEGFR1	in	turn	maintains	VE-cadherin	lateral	localisation	
in	the	stalk	cells	(Hayashi	et	al.,	2013).		
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Additional	 evidence	 for	 the	 importance	 of	 cell-cell	 junctions	 in	 lumen	 opening	was	 recently	
shown	 by	 the	 involvement	 of	 VE-cadherin	 and	 AmotL2	 in	 linking	 to	 contractile	 actin	 fibres	
necessary	for	aortic	lumen	expansion	in	the	mouse	(Hultin	et	al.,	2014).	Gebala	and	co-workers	
also	recently	showed	that	the	majority	of	blood	vessel	lumens	arise	at	sites	of	lateral	cell-cell	
adhesions	 in	both	 the	 zebrafish	 and	 the	mouse	models,	where	 vacuoles	may	only	provide	 a	
small	influence	on	lumen	expansion	(Gebala	et	al.,	2016).	In	this	project	I	set	out	to	investigate	
the	role	of	the	Rac1	and	Cdc42	GEFs,	DOCK4	and	DOCK9,	in	lumen	formation	using	an	in	vitro	
angiogenesis	assay	where	lumens	form	via	a	cord	hollowing	mechanism.	I	also	investigated	the	
role	 of	 the	 Rho	 effector	 ROCK2	 in	 lumen	 formation	 in	 vivo,	 and	 ciliogenesis	 using	 a	 Rock2	
knockout	model.		
	
	
6.2	Rac	GEF	DOCK4	and	Cdc42	GEF	DOCK9	control	lumen	formation	
Results	 presented	 in	 this	 thesis	 agree	 with	 previous	 work	 implicating	 lateral	 adhesions	 in	
lumen	 formation,	and	outline	a	 role	 for	DOCK4	and	DOCK9	 in	 the	process	of	 cord	hollowing	
through	 control	 of	 their	 respective	 GTPases,	 Rac1	 and	 Cdc42.	 Previous	 work	 from	 this	 lab	
(discussed	 in	 the	 ‘preliminary	 work	 leading	 to	 this	 thesis’	 section	 1.8.1)	 showed	 that	 Rac1	
activation	 mediated	 by	 DOCK4,	 controlled	 lateral	 filopodial	 protrusions	 in	 endothelial	 cells	
within	 tubules	 through	 an	 interaction	 with	 the	 Cdc42	 GEF,	 DOCK9.	 Early	 experiments	 had	
suggested	 that	 DOCK4	 may	 be	 involved	 in	 lumen	 formation	 through	 cytoskeletal	
rearrangements	and	loss	of	lateral	adhesions.		
	
Loss	 of	 DOCK4	 in	 HUVEC,	 in	 the	 angiogenesis	 coculture	 model,	 indeed	 affected	 dynamic	
protrusions	and	lateral	filopodia	(Abraham	et	al.,	2015),	and	led	to	defects	in	lumen	formation	
(Figure	3.10).	Tubules	with	DOCK4	knockdown	were	thinner	with	fewer	nuclei	per	length	and	
fewer	 lateral	 adhesions	 when	 compared	 with	 control	 (Figures	 3.7	 and	 3.8).	 These	 lateral	
adhesions	appear	important	for	deposition	of	apical	proteins	such	as	podocalyxin	prior	to	the	
opening	 of	 lumens	 in	 the	 co-culture	 assay	 (Figure	 3.5).	 Due	 to	 the	 reduction	 in	 lateral	
adhesions,	 tubules	 showed	 fewer	 nuclei	 per	 unit	 length	 indicating	 that	 fewer	 cells	 were	
making	up	the	tubules.	
	
Investigations	 in	 this	 thesis	 showed	 that	 DOCK9	 is	 also	 required	 for	 lumen	 formation	 as	
knocking	down	DOCK9	resulted	in	50%	reduction	in	lumenised	vessels	compared	with	control	
(Figure	3.15).	This	 further	 supports	 the	notion	 that	DOCK4-Rac	and	DOCK9-Cdc42	operate	 in	
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the	 same	 signalling	pathway	 (Abraham	et	 al,	 2015).	However,	 knockdown	of	DOCK9	did	not	
affect	 tubule	 thickness,	 while	 lateral	 adhesions	 also	 appeared	 unaffected	 (Figure	 3.16).	
Therefore,	 while	 DOCK4	 and	 DOCK9	 operate	 in	 the	 same	 pathway	 to	 control	 cytoskeletal	
rearrangements	 and	 filopodia	 formation	 which	 can	 impact	 on	 lumen	 formation,	 DOCK4	
appears	to	additionally	control	lateral	adhesions	through	an	unknown	mechanism	(Figure	6.1).		
	
Results	 from	 the	 AMIS	 assay	 showed	 that	 DOCK9	 does	 not	 affect	 podocalyxin	 apical	
localisation	 and	 therefore	may	be	 involved	 in	 subsequent	 steps	 of	 lumen	 formation	 such	 as	
repulsion	 and	or	 the	 establishment	 of	 curvature	 of	 cells	 to	 surround	 a	 lumen.	On	 the	 other	
hand,	DOCK9	may	be	involved	in	the	actin	organisation	of	the	apical	membrane	prior	to	lumen	
formation	(Figure	6.1),	as	supported	by	its	localisation	at	the	early	apical	membrane	initiation	
site	 (AMIS);	 together	with	 the	apical	proteins	podocalyxin	and	VE-cadherin	known	to	control	
lumen	formation	(Strilić	et	al.,	2009;	Richards,	Hetheridge	and	Mellor,	2016).	It	is	also	possible	
that	 localisation	 of	 podocalyxin	 in	 3D	 cultures	 and	 in	 vivo	 is	 a	 short-term	 event	 prior	 to	
formation	of	a	lumen.	This	idea	is	supported	by	the	2D	AMIS	experiments	(Figure	3.18)	during	
which	the	appearance	of	an	apical	membrane	is	a	transient	event,	as	the	AMIS	appears	shortly	
after	 plating	 (25	 mins)	 and	 disappears	 ~6	 minutes	 after	 attachment	 to	 the	 substratum.	 It	
would	 be	 interesting	 to	 investigate	 whether	 DOCK4	 also	 localises	 at	 the	 AMIS	 and	 controls	
actin	reorganisation	at	 the	apical	membrane,	an	experiment	that	was	not	carried	out	due	to	
time	constraints.	
	
	
Figure	6.1	Model	for	the	roles	of	DOCK4	and	DOCK9	in	blood	vessel	lumen	formation	
DOCK4
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Lateral cell adhesion
Endothelial cell filopodia
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of	pathway	downstream	of	VEGF	controlling	lumen	formation.	
Downstream	of	VEGF	signalling	the	guanine	nucleotide	exchange	factor	DOCK4	activates	Rac1	
which	 interacts	with	 the	Cdc42	GEF	DOCK9.	Cdc42	activation	by	DOCK4	and	DOCK9	controls	
filopodia	 formation	 while	 cytoskeletal	 rearrangements	 coordinated	 by	 DOCK4	 driven	 Rac1	
activation	and	DOCK9	driven	Cdc42	activation	control	lumen	formation.	DOCK4	is	also	required	
for	lateral	cell-cell	adhesions	which	also	impact	on	lumen	formation.	
	
	
Unlike	 previous	 studies	 where	 complete	 loss/knockdown	 of	 major	 Rho	 GTPases	 affected	
lumen	formation,	here	we	have	shown	 individual	activators	 (GEFs)	 responsible	 for	control	of	
some	 of	 these	 lumen	 formation	 behaviours.	 This	 more	 specific	 approach	 provides	 a	 more	
complete	 picture	 of	 the	 complex	 signalling	 involved	 in	 lumen	 formation	 and	 may	 uncover	
more	realistic	targeting	opportunities	in	the	future.		
	
During	the	course	of	this	study,	a	global	Dock4	knockout	mouse	model	was	generated	by	our	
lab.	Homozygous	deletion	of	DOCK4	 led	to	early	embryonic	lethality	before	E7.5,	prior	to	the	
onset	 of	 vascularisation	which	 precluded	 analysis	 of	 vascular	 phenotypes.	 However,	 studies	
carried	out	in	the	heterozygous	Dock4+/-	mice	showed	perturbed	blood	vessel	lumen	formation	
during	development	and	in	tumours	grown	in	heterozygous	Dock4	knockout	mice,	supporting	
the	 findings	 in	 the	 organotypic	 angiogenesis	 model	 (Abraham	 et	 al,	 2015).	 Since	 this	 was	
carried	out	 in	a	heterozygous	mouse	due	 to	 the	 lethality	of	 the	homozygous	mutant,	 future	
studies	in	vivo	will	utilize	a	conditional	Dock4	knockout	model	to	delete	both	Dock4	alleles	and	
confirm	 the	 endothelial	 cell	 autonomous	 role	 of	 Dock4	 during	 in	 vivo	 blood	 vessel	 lumen	
formation.	
	
	
6.3	Role	of	Rock2	in	blood	vessel	morphogenesis		
Previous	 work	 had	 shown	 that	 genetic	 deletion	 of	Rock2	 was	 embryonically	 lethal	 at	 E13.5	
(Thumkeo	 et	 al.,	 2003).	 In	 agreement,	 the	 Rock2	 knockout	 embryos	 analysed	 in	 this	 thesis	
exhibited	haemorrhages	in	the	head	and	neck,	and	occasionally	pooled	blood	in	the	limb	buds	
(Figure	4.1).	Further	investigation	of	the	angiozone	in	the	head	region	revealed	that	this	was	a	
site	of	ongoing	angiogenesis	at	E12.5	with	vessels	beginning	to	 lumenise	at	E13.5	(Figure	4.2	
and	 Table	 4.1).	 Loss	 of	Rock2	 led	 to	 a	 hyperfilopodial	 phenotype	 in	 that	 region,	 and	 loss	 of	
normal	blood	vessel	patterning	and	blood	vessel	 integrity,	with	blood	cells	found	outside	the	
vessels	of	the	knockout	mouse.	The	hypersprouting	phenotype	supports	earlier	findings	which	
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had	shown	loss	of	tubule	quiescence	with	ROCK	inhibition	in	tissue	culture	organotypic	assays	
(Abraham	et	al.,	2009).		
	
This	hypersprouting	phenotype	and	loss	of	integrity	could	explain	the	hemorrhages	seen	in	the	
Rock2	knockout	embryos.	Previous	studies	had	shown	that	reduced	quiescence	of	endothelial	
cells	 within	 blood	 vessels	 is	 an	 indicator	 of	 vascular	 defects	 (Liu	 et	 al.,	 2003).	 This	 result	
confirms	 the	 findings	by	Abraham	et	 al	which	 showed	 that	 in	 the	 tissue	 culture	organotypic	
model,	cell-cell	interaction	mediated	by	VE-cadherin	activation	of	RhoC	and	ROCK	is	necessary	
for	suppression	of	sprouting	and	generation	of	functional	vasculature	(Abraham	et	al.,	2009).	It	
has	also	been	shown	that	ROCK	regulates	matrix	stiffness	(Fischer	et	al.,	2009;	Samuel	et	al.,	
2011)	and	that	stimulation	of	sprouting	with	ROCK	inhibition	is	also	associated	with	changes	in	
matrix	stiffness	(Fischer,	Gardel,	Ma,	Adelstein,	&	Waterman,	2009).		
	
ROCK2	 genetic	 deletion	 did	 not	 appear	 to	 influence	 blood	 vessel	 integrity	 in	 the	 brain	
parenchyma.	 However,	 analysis	 of	 blood	 vessels	 in	 the	 brain	 parenchyma	 of	 developing	
embryos	showed	a	significant	decrease	in	blood	vessels	with	lumens.	To	investigate	the	effect	
of	Rock2	loss	on	vascular	lumen	diameter,	transverse	sections	of	the	developing	parenchyma	
provided	 large	 areas	 of	 brain	 parenchyma	 suitable	 for	 the	measuring	 of	 lumen	 parameters,	
including	diameter	and	cilia	number.	Blood	vessel	lumen	diameter	was	altered	in	the	Rock2-/-	
embryos	with	 fewer	 lumenised	 vessels	 in	 the	 parenchyma.	 Vessels	 that	 did	 lumenise	 had	 a	
larger	diameter	compared	with	wild	type.	Significant	haemorrhage	may	be	due	to	increases	in	
intravascular	pressure	due	to	the	defects	seen	in	numbers	of	lumenised	vessels.	A	proportion	
of	 vessels	 within	 Rock2-/-	 embryos	 retained	 a	 normal	 phenotype	 when	 compared	 with	
littermate	wild	 type	 controls.	 An	 explanation	 for	 differences	 see	 amongst	 different	 vascular	
beds	 in	 terms	 of	 requirement	 for	 ROCK2	 for	 vessel	 integrity	 could	 be	 that	 the	 actin	
cytoskeleton	may	be	regulated	to	different	extends	by	ROCK1	and	ROCK2	in	different	vascular	
beds,	or	may	be	under	the	control	of	different	cytoskeletal	regulators	(Lubarsky	and	Krasnow,	
2003).	Also,	in	these	studies	we	cannot	exclude	the	contribution	of	loss	of	ROCK2	expression	in	
perivascular	 cells	 in	 the	 observed	 defects	 in	 integrity	 and	 blood	 vessel	 lumen	 formation,	
although	 no	 apparent	 changes	 were	 observed	 in	 these	 cells	 macroscopically.	 Conditional	
deletion	of	Rock2	will	be	necessary	to	confirm	an	endothelial	cell	autonomous	nature	of	any	of	
the	observed	defects.			
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Aorta	 diameter	 and	 patterning	 was	 also	 affected	 in	 the	 Rock2	 -/-	 embryos,	 with	 knockout	
embryos	showing	increases	in	vessel	diameter	and	abnormal	circularity.	However,	this	may	be	
due	 to	 an	 effect	 of	 loss	 of	 ROCK2	 in	 smooth	muscle	 cells	 involved	 in	 aorta	 integrity	 which	
would	 need	 further	 investigation,	 as	 changes	 in	 smooth	 muscle	 cells	 were	 observed	 upon	
macroscopic	 observation	 of	 the	 aortas	 of	 the	 Rock2	 knockout	 embryos	 (Figure	 4.7A).	
Altogether,	 the	 results	 presented	 in	 chapter	 4	 show	 that	 ROCK	 signalling	 plays	 a	 role	 in	
angiogenesis,	and	may	highlight	the	beneficial	effects	of	therapeutic	use	of	ROCK	inhibitors	in	
cardiovascular	 disease.	 While	 these	 findings	 identify	 ROCK2	 as	 playing	 a	 role	 in	 lumen	
formation	 in	 vivo,	 it	 will	 be	 important	 to	 also	 elucidate	 the	 functional	 roles	 of	 the	 closely	
related	isoform	ROCK1.		
	
A	recently	developed	Rock1f/f/ROCK2f/f	double	knockout	mouse	model	available	in	our	lab	may	
provide	more	 insights	 into	 the	 role	 of	 ROCK1/2	 s	 in	 angiogenesis	 and	 lumen	 formation.	 The	
overall	homology	of	the	two	isoforms	of	68%,	and	the	92%	homology	they	share	in	their	kinase	
domain,	may	 allow	 a	 level	 of	 compensation	 to	 take	 place	 in	 the	 absence	 of	 ROCK2,	 so	 that	
ROCK1	may	provide	sufficient	kinase	activity	for	downstream	targets	in	the	absence	of	ROCK2,	
but	 the	 tissue	 dependency	 of	 this	 potential	 compensation	 remains	 unknown.	 Differences	 in	
the	 phenotypes	 observed	 with	 Rock2	 genetic	 deletion	 in	 different	 vascular	 beds	 could	 be	
attributed	 to	 differential	 compensation	 by	Rock1	 in	 different	 tissues.	 Furthermore,	 different	
tissues	may	have	a	different	requirement	for	the	two	different	isoforms	as	exemplified	by	the	
high	expression	levels	of	ROCK2	found	in	brain	compared	to	ROCK1	(Nakagawa	et	al.,	1996).		
	
The	majority	of	inhibitors	currently	being	trialed	in	cardiovascular	therapies	target	both	ROCK	
isoforms.	A	need	for	 isoform-specific	 inhibitors	 is	evident	with	diverging	roles	for	ROCK1	and	
ROCK2	becoming	more	evident	 (Shi	et	al.,	2013).	Results	 shown	here	elucidate	 the	potential	
roles	of	a	ROCK2	in	angiogenesis	using	a	single	isoform	knockout	mouse	model,	and	pave	the	
way	for	understanding	the	effect	of	single	isoform	specific	inhibitors	will	have	on	angiogenesis	
and	 lumen	 formation.	 These	 results	 support	 the	 early	 clinical	 results	 seen	 in	 treating	
contraction	or	stiffness,	for	example	arterial	hyperconstriction	seen	in	heart	failure	associated	
vascular	 resistance	 and	 contraction,	 which	 were	 attenuated	 with	 treatment	 with	 the	 ROCK	
inhibitor	 Fasudil.	 This	 holds	 relevance	 with	 findings	 in	 this	 study	 as	 loss	 of	 Rock2	 led	 to	
expansion	of	both	parenchymal	vessels	(Figure	4.6)	and	the	aorta	(Figure	4.5).		
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6.4	Role	of	Rock2	in	ciliogenesis	
Recent	 studies	 has	 suggested	 roles	 for	modulators	 of	 actin	 dynamics	 such	 as	 ROCK2	 in	 the	
control	of	primary	ciliogenesis	(Wheway	et	al.,	2015).	With	the	growing	evidence	for	a	role	of	
primary	cilia	 in	blood	vessel	morphology	and	development	(Goetz	et	al.,	2014;	Dinsmore	and	
Reiter,	2016),	I	explored	the	role	for	ROCK2	in	endothelial	primary	cilia.	How	cilia	are	formed	
and	how	parameters	such	as	length	and	abundance	of	cilia	are	maintained	within	different	cell	
types	 is	 still	 not	 clear.	However,	 an	essential	 role	of	 endothelial	 cells	 is	 to	 sense	mechanical	
forces	and	react	to	fluid	flow	induced	by	the	blood,	and	this	may	be	influenced	by	primary	cilia	
(Praetorius	and	Spring,	2003;	Van	der	Heiden	et	al.,	 2008;	Goetz	et	al.,	 2014).	An	 important	
aspect	of	cilia	maintenance	with	regards	to	flow	is	how	cells	maintain	cilia	length	and	flexibility	
(Avasthi	and	Marshall,	2012).	Vascular	endothelial	cells	appear	to	be	amongst	the	smallest	cilia	
in	 length,	 falling	 in	 the	 1	 to	 5µm	 range,	 whereas	 some	 neuronal	 cilia	 can	 extend	 to	 9µm	
(Dummer	et	al.,	2016).	The	effect	of	 length	on	flow	recognition	 is	 important,	as	 the	 longer	a	
cilium	 grows,	 the	more	 sensitive	 it	 will	 become	 to	 flow	 and	 also	more	 responsive	 to	 lower	
levels	of	flow-induced	sheer	stress	(Resnick	and	Hopfer,	2007).	
	
Results	from	the	ROCK2	knockout	mouse	showed	a	decrease	in	primary	cilia	in	the	vessels	of	
the	 brain	 parenchyma	 when	 compared	 with	 wild	 type	 controls	 (Figure	 5.13).	 As	 seen	 in	
chapter	4,	Rock2-/-	 embryos	at	E13.5	had	 lower	abundance	of	bigger	diameter	 lumens	when	
compared	with	wild-type	mouse	embryos	(Figure	4.7).	 I	have	also	shown	in	this	chapter	that	
cerebral	 blood	 vessels	 in	 Rock2-/-	 embryos	 displayed	 less	 primary	 cilia	 than	 in	 wild	 type	
embryos	 (Figure	 5.13).	 This	 suggests	 that	 bigger	 or	 more	 established	 lumens	 contain	 less	
primary	 cilia.	 This	 agrees	with	published	data	and	 supports	 the	hypothesis	 that	primary	 cilia	
are	 early	 flow	 sensors	 involved	 in	 detecting	 low	 levels	 of	 flow	 during	 the	 initial	 stages	 of	
angiogenesis	(Goetz	et	al.,	2014)	but	disassemble	under	continuous	flow	(Iomini	et	al.,	2004).	
	
The	findings	in	vivo	corroborated	the	findings	in	the	in	vitro	ciliogenesis	model.	In	those	assays	
the	 ROCK	 inhibitor	 Y27632	 decreased	 cilia	 number,	 but	 increased	 cilia	 length.	 Consistently,	
isolated	Rock2-/-	MEFs	also	showed	shorter	and	 less	abundant	primary	cilia	when	cultured	 in	
the	ciliogenesis	assay.		
	
As	cilia	length	seems	to	be	a	cell-type	specific	parameter,	it	seems	evident	that	length	plays	a	
role	 in	 their	 function.	 The	 findings	 in	 chapter	 5	 demonstrate	 a	 role	 for	 ROCK2	 signalling	 in	
primary	ciliogenesis	by	controlling	both	cilia	growth	which	 is	 important	 for	 flow	sensing,	and	
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overall	 cilia	 abundance.	 This	 suggests	 that	 ROCK2	may	 affect	 lumen	 formation	 both	 directly	
through	 control	 of	 endothelial	 cell	 shape,	 and	 indirectly	 through	 control	 of	 ciliogenesis.	
However,	more	work	is	needed	to	address	whether	cilia	formation	directly	affects	blood	vessel	
lumen	 morphogenesis	 (Figure	 6.2).	 In	 future	 studies,	 it	 would	 be	 interesting	 to	 explore	
whether	 increase	 in	ciliary	 length	affects	 flow	recognition	by	endothelial	 cells,	 thus	affecting	
lumen	 expansion	 (Gebala	 et	 al.,	 2016).	 As	 the	 Rock2	 knockout	 model	 employed	 in	 these	
studies	is	a	global	Rock2	knockout	model,	it	presents	the	opportunity	to	look	the	effects	of	loss	
of	Rock2	in	other	cell	types	and	tissues	where	ciliary	roles	are	better	understood,	for	example	
in	the	kidney,	where	cilia	sense	urinary	flow	and	modulate	kidney	tubule	development	(Yoder,	
2007).		
	
	
	
Figure	6.2	Model	for	the	role	of	ROCK2	in	ciliogenesis	and	lumen	formation	
ROCK2	 activity	 downstream	of	 Rho	 signalling	 influences	 endothelial	 cell	 filopodia	 formation,	
vascular	 integrity	 and	 lumen	 formation	 through	 modulation	 of	 cytoskeletal	 organisation.	
Furthermore,	ROCK2	controls	cilia	length	and	abundance	which	may	have	additional	effects	on	
lumen	expansion.		
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6.5	Concluding	remarks	
In	this	thesis,	I	have	demonstrated	how	lumen	formation	is	controlled	by	the	Rac	GEF	DOCK4	
and	Cdc42	GEF	DOCK9	in	a	tissue	culture	angiogenesis	model;	and	how	lumen	formation	and	
ciliogenesis	are	regulated	by	ROCK2.	The	analyses	have	shown	the	importance	of	cytoskeletal	
rearrangements	controlled	by	DOCK4	and	DOCK9	in	the	process	of	 lumenogenesis;	as	well	as	
the	 importance	of	 lateral	cell-cell	adhesions	controlled	by	DOCK4	for	 lumen	formation.	Work	
by	 other	 members	 of	 the	 laboratory	 showed	 that	 loss	 of	 lateral	 adhesions	 results	 from	
unidirectional	sprouting	(elongation),	and	loss	of	dynamic	lateral	remodelling	in	the	absence	of	
DOCK4	(Abraham	et	al.,	2015).	Defects	in	lumen	formation	in	response	to	loss	of	Rock2	were	
associated	 with	 i)	 cytoskeletal	 rearrangements	 as	 evidenced	 by	 changes	 in	 filopodial	
protrusions	and	ii)	the	regulation	of	primary	cilia	which	are	known	to	sense	blood	flow	(Goetz	
et	al.,	2014;	Kallakuri	et	al.,	2014),	 thus	potentially	affecting	 lumen	expansion	 (Gebala	et	al.,	
2016).	 Understanding	 the	 cellular	 and	 molecular	 mechanisms	 of	 lumen	 formation	 and	
acquisition	 of	 blood	 vessel	 functionality	 may	 help	 in	 the	 future	 develop	 protocols	 for	
therapeutic	angiogenesis,	for	example	to	overcome	ischemic	disease.		
	
The	 association	 between	 cilia	 and	 the	 circulatory	 system	 is	 supported	 by	 the	 presence	 of	
vascular	 defects	 in	 many	 ciliopathies,	 for	 example	 in	 polycystic	 kidney	 disease	 there	 is	
increased	hypertension	at	an	early	age,	and	increased	incidence	of	vascular	defects	later	in	life	
including	blood	vessel	abnormalities	and	aneurisms	 (Torres,	Harris	and	Pirson,	2007).	Recent	
published	studies	suggest	a	role	for	primary	cilia	in	blood	vessel	development	and	homeostasis	
(Goetz	et	al.,	2014;	Dinsmore	and	Reiter,	2016).	The	recent	findings	that	 loss	of	primary	cilia	
can	promote	development	of	atherosclerosis	provides	unequivocal	evidence	of	the	importance	
of	this	sensory	organelle	for	blood	vessel	homeostasis.	Further	to	this,	many	ciliopathies	show	
abnormal	cilia	length	with	both	increases	and	decreases	in	primary	cilia	length	seen	(Husson	et	
al.,	2016).	More	recent	studies	have	shown	shortening	of	ciliary	 length	to	be	associated	with	
cystic	 kidney	 disease	 (Husson	 et	 al.,	 2016).	 Results	 described	 herein	 may	 lead	 to	 a	 better	
understanding	of	the	influence	of	the	actin	cytoskeleton	on	ciliary	structure	and	function,	and	
may	provide	new	therapeutic	approaches	to	regulate	length	and	abundance	of	primary	cilia.		
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